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ABSTRACT 
 
Geyer, R. Ryan.  Ph.D., Biomedical Sciences Ph.D. Program, Wright State University, 
2007.  Investigating the Role of Subunit III in the Structure and Function of Rhodobacter 
sphaeroides Cytochrome c Oxidase. 
 
 
The role of subunit III (SIII) in cytochrome c oxidase structure and function was 
investigated using enzyme isolated from the bacterium Rhodobacter sphaeroides.  
Energy minimization calculations suggested that in the absence of SIII, subunit I (SI) 
adopted a more open conformation.  This observation was tested through the use of 
limited proteolysis using, α-chymotrypsin.  The results showed that in the absence of SIII 
the solution structures of wild-type and I/II oxidase were not significantly different, and 
that proteolysis occurred exclusively at the N and C-termini of SI.  Upon inactivation of 
I/II oxidase by catalytic turnover, and subsequent digestion with the protease α-
chymotrypsin it was concluded that SI underwent significant conformational changes.  
This change in conformation was probably due to CuB, located in the active site, 
dissociating from SI, upon turnover induced inactivation.  A similar digestion pattern was 
observed in a mutant lacking CuB, which indicated that the large scale change in 
conformation was due to the loss of CuB from the active site. 
The functional role of SIII was also investigated by predicting and mutating 
interhelical hydrogen bonds within SIII.  A cluster of amino acids consisting of Glu90, 
His212, and Tyr246 form a highly conserved triad of interhelical connectivity, perhaps 
linked by hydrogen bonds.  Mutation of Glu90 to an alanine (E90A) resulted in a 
 iv
significant loss of SIII content, accompanied by a phenotype of turnover induced 
inactivation and reduced proton pumping efficiency, when reconstituted in phospholipid 
vesicles.  Mutation of His212 to either an alanine or phenyalanine (H212A and H212F) 
resulted in wild-type expression of SIII and when reconstituted into a phospholipid 
vesicle, these mutants exhibited turnover induced inactivation as well as reduced proton 
pumping efficiency.  Mutation of Tyr246 to a phenyalanine (Y246F) resulted in a mutant 
that was indistinguishable from wild-type enzyme.  Therefore, it was concluded that 
Glu90 and His212 were involved in an interhelical hydrogen bond, and Y246 did not 
participate in this interaction.  The functional data also suggests that the Glu90-His212 
interaction may function to regulate electron transfer activity under certain conditions.  
In a second study the C-terminal helix of SIII, helix 7 was deleted from SIII via 
mutagenesis.  This helix is highly conserved and the loss of the last 13 amino acids from 
this helix, in humans, has been linked to the onset of encephalopathy.  The helix was 
deleted at amino acid G239, resulting in the mutant G239Stop.  Immunoblot analysis 
using site-specific polyclonal antibodies indicated that the mutant enzyme had reduced 
amounts of SIII and also demonstrated that there were lower molecular weight antibody 
reactive fragments.  It was later determined that the degradation process occurred during 
growth of the bacteria.  The detergent solubilized enzyme had severely inbihited electron 
transfer activity and displayed turnover induced inactivation.  Limited proteolysis of 
G239Stop showed that there was an active and inactive population of enzyme.  In 
addition, it was found that the inactive portion was due to either the full length helix 7 
deleted SIII, or the proteolytic fragments present, which accounted for the observed 
decrease in electron transfer activity.  When G239Stop was reconstituted into 
 v
phospholipid vesicles it displayed turnover induced inactivation and reduced proton 
pumping efficiency, similar to I/II oxidase.  However, the level of electron transfer 
inhibition was greater in G239Stop, which was consistent with the finding that the 
mutation was accounted for a majority of the inhibition observed earlier.   
Taken together the results suggest that functional consequences of SIII removal 
are not evident until after catalytic turnover.  SIII function to maintain the proper 
conformation of the D-channel and stabilizes the active site during turnover.  These 
studies also demonstrate that there are means to disrupt the structure of SIII, so that even 
when SIII is present it fails to function properly.  This leads to an enzyme incapable of 
sustained electron transfer and proton pumping activities.  
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I.  Introduction 
 
Mitochondrion structure and Function 
 Mitochondria are cellular organelles found in almost all eukaryotic cells, and are 
typically 3-4 µm in length and 1 µm in diameter (Scheffler 1999).  The primary function 
of the mitochondria is to aerobically generate energy in animal cells (Saraste 1999).  This 
energy is supplied in the form of ATP synthesized by oxidative phosphorylation.  The 
process of oxidative phosphorylation requires electrochemical gradients; therefore, the 
structure of the mitochondria is highly compartmentalized, with each compartment 
serving a special function. 
Mitochondria are composed of an outer membrane, an intermembrane space, an 
inner membrane, and a matrix.  Each component serves a specific role in the conversion 
of organic materials into cellular energy.  The outer membrane contains porins that are 
permeable to all molecules that are less than 5 kDa, including most metabolites required 
for ATP synthesis (Alberts 1994).  Larger molecules such as proteins are translocated 
across the outer membrane by the translocases at the outer membrane of the mitochondria 
(TOM complex) (Ahting et al 2001), while charged metabolites cross the outer 
membrane though voltage-dependent anion channels (VDAC) (Lemeshko and Lemeshko, 
2000).  Due to the free diffusion of small molecules and proteins, which are less than 5 
kDa, across the outer membrane the chemical makeup of the intermembrane space is 
similar to the cytosol (Alberts 1998).  The inner membrane surrounds the matrix and is 
 2
extremely impermeable and requires membrane transporters to move ions and molecules 
across it (Alberts 1998).  Embedded in the inner membrane are the enzyme complexes of 
the electron transport chain (Complexes I-IV) and ATP synthase.  Folds in the inner 
membrane, called cristae, serve to increase the surface area of the inner membrane and 
increase ATP production.  The matrix contains a variety of enzymes that are responsible 
for oxidation of pyruvate, oxidation of fatty acids, and the citric acid cycle (Alberts 
1994).  The matrix is also the location of the mitochondrial DNA, which synthesizes 13 
polypeptides (in humans) which are incorporated into the inner membrane and form the 
respiratory enzyme complexes (Anderson 1981). 
 In order for mitochondria to make ATP, there must be sufficient amounts of 
NADH and FADH2 fed into the electron transport chain to drive oxidative 
phosphorylation.  Constant supplies of NADH and FADH2 are generated by the 
catabolism of proteins into amino acids, polysaccharides into glucose, and lipids into 
glycerol and fatty acids.  Amino acids, glucose, glycerol, and fatty acids are further 
degraded into the common intermediate, acetyl-CoA.  Acetyl-CoA is then fed into the 
citric acid cycle, generating NADH and FADH2.  NADH and FADH2 will become 
oxidized and donate electrons to the electron transport chain, thus beginning oxidative 
phosphorylation.  
  
 Oxidative Phosphorylation 
 Oxidative phosphorylation is a biochemical process that takes place in the inner 
membrane of mitochondria or in the plasma membrane of prokaryotes, and is responsible 
for a majority of the cell's ATP production.  The final products of glycolysis and the citric 
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acid cycle are high-energy electron donors NADH and FADH2.  Electrons from these 
donors are fed into the electron transport chain and are ultimately donated to oxygen 
which is then reduced to water.  There are four metalloprotein complexes that are 
responsible for the electron flow from NADH and FADH2 to oxygen (Figure 1).    
Complex I (NADH dehydrogenase) from mammalian mitochondria is composed 
of at least 46 different subunits with a total molecular mass of 1 MDa (Carroll et al. 
2002).  The bacterial equivalent to Complex I has only 14 subunits, which are all 
homologues to mammalian subunits (Yagi et al. 1998; Yagi and Matsuno-Yagi 2003).  
Most of the structural information on Complex I is based on electron microscopy (EM) 
(Yagi and Matsuno-Yagi 2003), but a crystal structure of the hydrophilic domain of 
complex I from Thermus thermophilus has been solved (Sazanov and Hinchliffe 2006).  
All of the EM data has suggested that the enzyme complex has an L-shaped structure 
(Hofhaus et al. 1991; Grigorieff 1998; Djafarzadeh et al. 2000).  However, an active form 
of Complex I from E. coli was shown to adopt a horseshoe-like structure, suggesting that 
the L-shaped structure is an inactive form of the enzyme (Bottcher et al. 2002).   
Complex I is the first enzyme in the respiratory chain of most mitochondria and 
many bacteria (Holt et al. 2003).  Functionally, it is responsible for the oxidation of 
NADH and catalyzes the transfer of two electrons to a lipid-soluble carrier, ubiquinone 
(Q) (Walker 1992). The reduced product (QH2) is free to diffuse within the membrane.  
Complex I also pumps four protons across the membrane into the intermebrane space and 
contributes to the proton gradient, which will ultimately be used by ATP synthase 
(Walker 1992; Yagi and Matsuno-Yagi 2003).     
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Figure 1 
Mitochondrial Electron Transport Chain.  This is a picture of the enzyme complexes 
involved in electron transport in the mitochondria inner membrane or bacterial plasma 
membrane.  Electrons are initially supplied by NADH and succinate.  Electrons are 
transferred from Complex II  (PDB 1NEN) (Yankovskaya et al. 2003) to Complex III 
(PDB 1PP9) (Huang et al. 2005) by coenzyme Q and from Complex III to Complex IV 
(PDB 1V54) (Tsukihara et al. 2003) by cytochrome c (PDB 1HRC) (Bushnell et al. 
1990).  Proton pumping, necessary for the proton gradient utilized by ATP synthase 
(PDB 1QO1) (Stock et al. 1999), is provided by Complexes I, III, and IV. 
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Complex II (succinate dehydrogenase) is a functional member of both the Krebs 
cycle and the mitochondrial electron transport chain (Yankovskaya et al. 2003). Complex 
II from mammalian mitochondria and many bacteria are composed of two hydrophilic 
subunits, a flavoprotein (SdhA) and iron-sulfur protein (SdhB), and two hydrophobic 
membrane anchor subunits, which contain a heme b (SdhC) and a binding site for 
ubiquinone (SdhD) (Cecchini et al. 2002).  Therefore, SdhA-D comprises one monomer, 
with a molecular weight of approximately 120 kDa (Yankovskaya et al. 2003).  The 
crystal structure of complex II is a trimer, which is thought to be the physiological 
aggregation state (Yankovskaya et al. 2003). 
The role of complex II is to couple the oxidation of succinate to fumerate in the 
mitochondrial matrix with the reduction of ubiquinone in the membrane (Cecchini et al. 
2002).  During the Krebs cycle, succinate is oxidized by the succinate dehydrogenase 
portion of the complex and two electrons and two protons are transferred from succinate 
to FAD, which is covalently attached to a histidine residue in the enzyme, thus forming 
FADH2 (Horsefield et al. 2006).  FADH2 then transfers the two electrons to iron-sulfur 
clusters inside the enzyme and releases the protons back into the matrix of the 
mitochondria (Horsefield et al. 2004).  The iron-sulfur clusters reduce ubiquinone (Q) to 
ubiquinol (QH2) (Horsefield et al. 2006).  Complex II does not pump protons and is the 
only complex involved in oxidative phosphorylation that does not contribute to the proton 
gradient.   
Complex III (cytochrome bc1 ) has been well characterized both structurally and 
functionally.  The bovine form of this transmembrane protein complex consists of 11 
different subunits, as shown by X-ray crystallography (Gao et al. 2002); while bacterial 
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forms only have the three subunits that are involved in catalysis (Pollard and Earnshaw 
2002).  Complex III contains several prosthetic groups including: 2 heme b molecules (bL 
and bH), one heme c (c1), and a Rieske iron-sulfur protein (Saraste 1999).  The function of 
this complex is to transfer electrons from reduced coenzyme Q (QH2) to cytochrome c, 
replenish the oxidized and reduced coenzyme Q pools, and pump protons across the inner 
membrane of the mitochondria.  This is all accomplished through a process called the Q-
cycle.  One complete Q-cycle will result in two protons taken up from the matrix, four 
protons being released into the intermembrane space, and two electrons being transferred 
to two molecules of cytochrome c (Zubay 1998).    
Complex IV (cytochrome c oxidase) accepts one electron at a time from reduced 
cytochrome c and transfers them to molecular oxygen.  To complete one catalytic 
turnover event 4 molecules of reduced cytochrome c are donated to cytochrome c 
oxidase, four protons are taken up from the matrix and are used to generate two water 
molecules, and four protons will be pumped across the membrane, further contributing to 
the proton gradient used by ATP synthase (Hosler et al. 2006).  Since complex IV is the 
focus of this thesis dissertation the structure and function of this enzyme complex will be 
discussed in more detail in the next section.   
The final enzyme complex involved in oxidative phosphorylation is ATP 
synthase, which utilizes the transmembrane proton gradient generated by the complexes 
I, III, and IV to make ATP, from ADP and inorganic phosphate.  The F-ATPases consist 
of two structural domains, a membrane domain (FO) and a globular domain (F1), which 
are linked together by a central and peripheral stalk (Walker and Dickson 2006).  Once a 
sizable proton gradient is established a ring of c-subunits, which are in close proximity to 
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FO, begin to rotate clockwise by the inward passage of protons across the membrane 
(Walker and Dickson 2006).  During each 360° turn of the central stalk, the static F1 
catalytic site, which is composed of an three α and three β subunits, changes 
conformation allowing for ADP and inorganic phosphate to bind, ATP is formed and 
released (Walker and Dickson 2006).   
 
Cytochrome c Oxidase 
Cytochrome c oxidase (COX), Complex IV, is the terminal enzyme of the 
respiratory chain of mitochondria and aerobic bacteria.  COX reduces molecular oxygen 
to water by the following reaction: 4 cytochrome c2+ + O2 + 8H+ → 2H20 + 4H+ + 4 
cytochrome c3+.  COX couples the energy from electron transfer reactions to take up 
chemical protons and also pump protons across the membrane (Krab and Wikstrom 1978; 
Saraste 1999).  These pumped protons contribute four protons per catalytic cycle to the 
proton gradient that is ultimately used for the synthesis of ATP, by ATP synthase.   
A majority of the earlier work with COX was performed on enzyme derived from 
the mitochondria of mammals (ie. bovine heart COX).  COX is composed of 13 different 
subunits with the three largest subunits (subunits I-III) being encoded for by the 
mitochondrial DNA (Hare et al. 1980).  It was later determined that all of the metal sites 
were located in subunits I and II (Tsukihara et al. 1995).  Further structural 
determinations were complicated by the fact that COX is a large integral membrane 
protein.  Furthermore, mutagenesis was not possible since the genes for subunits I-III are 
encoded for by the mitochondrial DNA.  Therefore, much of the earlier work done was 
related to function.   
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In the early 1980’s it was demonstrated that when Rhodobacter sphaeroides was 
grown aerobically it synthesized a respiratory electron chain similar to that of 
mitochondria (Whatley 1981), including an aa3-type COX (Saunders and Jones 1974).  
However, it was not until the late 1980’s and early 1990’s when bacterial expression 
systems were perfected and implemented in the overexpression of COX.  These systems 
are particularly useful because they are structurally less complex and amenable to site-
directed mutagenesis.  A widely used bacterial model for COX has been developed in 
Paracoccus denitrificans (Ludwig and Schatz 1980).  Most notable is the model system 
using Rhodobacter sphaeroides which was developed by Hosler et al. (1992).  The R. 
sphaeroides cytochrome c oxidase is structurally less complex than COX isolated from 
the mitochondria of mammals since it contains only four subunits (Svensson-Ek et al. 
2002).  The three largest subunits from R. sphaeroides COX are homologues to the three 
largest mitochondrially encoded subunits of mammalian COX (Hosler et al. 1992; 
Svensson-Ek et al. 2002).  Comparison of the DNA-derived amino acid sequences of the 
genes for bovine and R. sphaeroides COX shows that there is 52% identity in subunit I 
(Shapleigh et al. 1992), 39% identity in subunit II (Cao et al. 1991), and 39% identity in 
subunit III (Cao et al. 1992).  Hosler et al. (1992) further demonstrated that the R. 
sphaeroides COX enzyme pumps protons, and that the enzyme is structurally 
homologous to the bovine enzyme as shown by optical spectroscopy, EPR, and resonance 
Raman spectroscopy.   
With the advent of the bacterial expression systems it was possible to begin 
mutating amino acid residues that were thought to play a significant role in the structure 
and/or function of the enzyme.  Hydropathy profile analysis of bovine COX subunit I 
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suggested that the enzyme has 12 transmembrane helices (Holm et al. 1987), and the 
same analysis of the R. sphaeroides COX subunit I also yielded the same result 
(Shapleigh et al. 1992).  A multiple sequence alignment of subunit I from multiple 
species shows that within the 12 membrane spanning helices there are seven histidine 
residues, in which six of the histidines are completely conserved (Shapleigh et al. 1992).  
It has also been shown through the use of spectroscopy that the heme a is ligated by two 
histidines (Gadsby and Thomson, 1990), the heme a3 is ligated by a single histidine 
(Ogura et al., 1983), and that the CuB is ligated by three histidines (Li et al. 1987).  
Resonance Raman spectroscopy of wild-type R. sphaeroides COX and mutants thought 
to be metal center ligands has shown that heme a is ligated by His102 and His421, heme 
a3 is ligated by His419, and CuB is ligated by His284, His333, and His 334 (Shapleigh et 
al. 1992).  Not only did this study identify the specific ligands of the metal centers in 
subunit I but it also provided insight into the structure of the amino acids that surround 
the active site.  This generated several hypotheses regarding the structure of COX, but 
without an x-ray crystal structure of the enzyme there was no way to verify if the 
observations from the site-directed mutagenesis data were correct.  However, these 
observations were later confirmed when (Tsukihara et al. 1995) published the x-ray 
crystal structures of the metal sites in oxidized bovine heart COX.  Iwata et al. (1995) 
solved the structure of COX from Paracoccus denitrificans, which is composed of four 
subunits.  With this structure, more specific questions could now be answered with 
respect to the mechanism of electron transfer, proton uptake, and proton pumping.           
Currently, there are COX structures from three different organisms that have been 
resolved by x-ray crystallography: bovine (PDB 1OCR and 1OCC)  
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Figure 2 
 
Crystal Structure of Bovine Cytochrome c Oxidase. 
(A) Side view of bovine cytochrome c oxidase X-ray crystal structure.  The three 
largest subunits (I-III) are encoded for by the mitochondrial DNA.Subunit I is red, 
subunit II is blue, and subunit III is green.  The remaining ten subunits, which are 
encoded for by the nucleus are shown in gray. 
(B) Top view of bovine cytochrome c oxidase X-ray crystal structure.  The color 
scheme is the same as the top image (Tsukihara et al. 2003).   
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(Tsukihara et al. 1995; Tsukihara et al. 1996), Paracoccus denitrificans (PDB 1QLE) 
(Iwata et al. 1995), and Rhodobacter sphaeroides (PDB 1M56) (Svensson-Ek et al. 
2002).  Figure 2 shows the most recent crystal structure of bovine heart COX, which was 
resolved at 1.8 Å (Tsukihara et al. 2003), this enzyme, as well as, all bovine COX 
structures were crystallized as homodimers, with each monomer being composed of 
thirteen subunits.   
The three largest subunits, which are of mitochondrial origin, are colored; subunit 
I (red), subunit II (blue), and subunit III (green), and the 10 remaining nuclear encoded 
subunit are shown in gray.  The R. sphaeriodes and P. denitrificans enzymes contain 
homologues to subunits I-III.  In addition to the three large subunits, the R. sphaeroides 
and P. denitrificans enzymes also contain a subunit IV.  While SIV from R. sphaeroides 
and P. denitrificans are highly similar to one another, the have no known homologue in 
the bovine enzyme.  The four subunit R. sphaeroides enzyme is shown in Figure 3.  
Three-dimensional alignment of bovine, P. denitrificans, and R. sphaeroides COX 
subunits I-III (Figure 4) illustrates the high degree of structural conservation among the 
three enzymes.  With the exception of some extended loops in subunits I and III, in the R. 
sphaeroides enzyme, the structures superimpose quite well.   
 In addition to being structural homologues, all of these COX enzymes transfer 
electrons in the exact same fashion, regardless of the source of the enzyme.  The only 
major difference is that the enzyme isolated from the bacterial sources turnover at much 
higher rates than that enzyme from mammalian sources (ie. bovine).  In other words, the 
path of electron transfer through the enzyme is identical; however, the kinetics of the 
electron transfer reactions are different.  Figure 5 illustrates the path of electron transfer  
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Figure 3 
Crystal Structure of Four Subunit Rhodobacter sphaeroides Cytochrome c Oxidase. 
Subunit I (Blue), subunit II (orange), subunit III (green), and subunit IV (red) (PDB 
1M56) (Svensson-Ek et al. 2002).   
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Figure 4 
Multiple Structure Alignment of COX Subunits I-III.  Multiple structure alignment of 
X-ray crystallographic structures of subunits I-III from bovine (PDB 1OCC blue) 
(Tsukihara et al. 1996), Paracoccus denitrificans (PDB 1QLE green) (Harrenga and 
Michel 1999), and Rhodobacter sphaeroides (PDB 1M56 red) (Svensson-Ek et al. 2002). 
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Figure 5 
 
Sequence of Electron Transfer in COX.   Electrons are initially donated by reduced 
cytochrome c, electrons then flow to CuA, heme a, and then to the binuclear center (heme 
a3-CuB).  Upon delivery to the binuclear center molecular oxygen is reduced to water. 
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from reduced cytochrome c to oxygen.  Four molecules of reduced cytochrome c are 
required for one complete catalytic cycle.   The initial electron acceptor from reduced 
cytochrome c is CuA, located in subunit II of COX.  Electrons from CuA are then 
transferred to heme a, which is located in subunit I.  Electrons are then transferred to the 
binuclear center, also in subunit I, which is composed of a heme a3 and a CuB.  The final 
electron acceptor is oxygen, which binds at the binuclear center and is reduced to water.  
Subunits I and II are thought to be the catalytic core of the enzyme because these two 
subunits contain all of the metal centers required for electron transfer and oxygen 
reduction. 
Table I shows all of the molecular weights for the 13 subunits from bovine COX 
as well the molecular weights for each of the 4 subunits from R. sphaeroides COX 
determined by MADLI-TOF mass spectrometry, also included are the molecular weights 
of each of the four subunits from P. denitrificans, as determined by the amino acid 
sequence.  Since the R. sphaeroides COX enzyme was chosen as the model system for all 
of the work discussed in this thesis dissertation R. sphaeroides numbering will be used 
when discussing key amino acids. 
 
Subunits I and II 
Subunit I contains twelve transmembrane helices and contains the redox metal 
centers heme a, heme a3, and CuB (Tsukihara et al. 1995).  Looking down on the enzyme 
it becomes obvious that there are three semicircular arrangements of transmembrane 
helices.  Two of these semicircles are responsible for positioning the heme groups 
perpendicular to the membrane.  In contrast to subunit II, both the N and C-termini are  
 21
 
 
 
Table I 
Molecular weights of subunits from bovine, Rhodobacter sphaeroides, and 
Paracoccus denitrificans COX.   Molecular weight of each subunit from bovine and 
Rhodobacter sphaeroides COX as determined by MALDI-TOF mass spectrometry. 
 
Bovine Subunit MALDI-TOF Massa Function 
I 57056 Contains hemes a and a3, and CuB 
II 26030 Binding site of cyt c and contains CuA
III 29793 Unknown 
IV 17142 Unknown of nuclear origin 
Va 12434 Unknown of nuclear origin 
Vb 10668 Unknown of nuclear origin 
VIa 9531 Unknown of nuclear origin 
VIb 10063 Unknown of nuclear origin 
VIc 8521 Unknown of nuclear origin 
VIIa 6676 Unknown of nuclear origin 
VIIb 6359 Unknown of nuclear origin 
VIIc 5446 Unknown of nuclear origin 
VIII 4964 Unknown of nuclear origin 
R. sphaeroides Subunit MALDI-TOF Massb  
I 63940 Contains hemes a and a3, and CuB 
II 29168 Binding site of cyt c and contains CuA
III 30022 Unknown 
IV 5273 Unknown  
P. Denitrificans Subunit Molecular Weightc  
I 60386 Contains hemes a and a3, and CuB 
II 27989 Binding site of cyt c and contains CuA
III 30690 Unknown 
IV 4701 Unknown 
 
a  Masses of the subunits was determined by mass spectrometry (Musatov et al. 2002). 
b  Masses of the subunits was determined by mass spectrometry (Distler et al. 2004). 
c Masses of the subunits was determined from the DNA derived amino acid sequences. 
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Figure 6 
Crystal Structure of D and K Channels in R. sphaeroides COX.  The K channel 
(shown in blue) begins with Glu101 in subunit II and extends all the way to the binuclear 
center along a channel of amino acids.  The D-channel (shown in red) begins with 
Asp132 and also extends to the binuclear center.  There are several highly ordered water 
molecules that provide complete connectivity between Asp132 and the terminal D-
channel amino acid Glu286. 
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located on the inside of a membrane or phospholipid vesicle.  Subunit I also contains two 
channels that are responsible for taking up substrate and pumped protons, the K-channel 
and the D-channel (Figure 6). 
The K-channel is named for a highly conserved Lys362, located in subunit I.  
However, the beginning of the K-channel has been shown to be Glu101II, in R. 
sphaeroides (Branden et al. 2002).  On the other hand, when the homologous Glu residue 
was mutated in P. denitrificans there was no effect on proton uptake.  Upon entering the 
K-channel at Glu101II protons are translocated to the binuclear center through Ser299, 
Lys362, Thr359, the hydroxyl farnesyl of heme a3, and Tyr288 (Figure 6).  Mutants of  
the K-channel have severely reduced rates of turnover, but are fully capable of pumping 
protons (Fetter et al. 1995).     
The other proton uptake pathway, the D-channel, is named for the highly 
conserved Asp132.  In the structure of R. sphaeroides COX there is complete hydrogen 
bonding connectivity from the entrance of the D-channel, at Asp132, all the way to 
Glu286.  This is accomplished by a series of ordered water molecules hydrogen bonded 
to amino acid residues (Asn121, Asn139, Asn207, Ser142, Tyr33, Ser201, Ser200, and 
Ser197) (Figure 6).  A mutant in which Asn139 was mutated to an aspartic acid resulted 
in a mutant that had a Vmax that was 2-fold higher than wild-type enzyme, but was 
incapable of pumping protons (Pawate et al. 2002).  (Namslauer et al. 2003) found that 
the mutation caused the pKa of Glu286 to shift from 9.4 to greater than 11.  More 
recently, (Branden et al. 2006) made a double mutant in which Asp132 was mutated to an 
asparagine and Asn139 was mutated to an aspartic acid.  This mutant restored the pKa of 
Glu286 back to 9.4, and restored proton pumping.  However, during single turnover 
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experiments it was found that proton pumping was not coupled to electron transfer in the 
P to F transition.  A third mutant of the D-channel involved mutating Gly204 to an 
aspartic acid, which completely blocked proton transfer through the D-channel (Han et al. 
2005).  Additionally, the location of the D-channel is adjacent to subunit III, which has 
also been shown to be necessary for efficient proton pumping in the enzyme, as well as 
sustained electron transfer.         
Subunit II has two transmembrane helices and a large extramembrane globular 
domain, which contains a dinuclear CuA (Tsukihara et al. 1995).  The extramembrane 
domain is positioned above the surface of SI and has a 10-strand β-barrel structure that 
holds the two coppers in place, through the interactions of two cysteine residues (Cys252 
and Cys256), and two histidine residues (His 217 and His260).  When inserted into a 
membrane or phospholipid vesicle the N and C-termini are located on the outside.  
Functionally subunit II serves as the primary electron acceptor from cytochrome c.  The 
interaction between SII and cytochrome c is largely electrostatic, with a set of acidic 
residues on SII interacting with a patch of lysines on cytochrome c (Roberts and Pique 
1999; Wang et al. 1999; Zhen et al. 1999; Maneg et al. 2004). 
    
Oxygen Reduction Cycle 
The exact mechanism of the reduction of molecular oxygen by fully reduced 
cytochrome c oxidase has yet to be determined.  The catalytic cycle (Figure 7) can be 
thought of as two halves: a reductive phase (R to O) and an oxidative phase (O to R) 
(Bloch et al. 2004).  Perhaps the most intriguing problem with respect to these two phases 
is the fact that when they are studied separately the full extent of proton translocation (2  
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Figure 7 
 
Cytochrome c Oxidase Catalytic Cycle.  The catalytic cycle of COX begins with the 
fully reduced form of the enzyme reacting with molecular oxygen.  The cycle can be 
divided into two halves: the reductive and oxidative phase.  Proton uptake and 
translocation have been shown to be linked to electron transfer reactions (Bloch et al. 
2004).   
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H+/e-) has not been observed (Bloch et al. 2004).  It has been hypothesized that this is 
because the reaction intermediates of the "as isolated" enzyme are different than those 
observed during continuous turnover (Verkhovsky et al. 2001).  The catalytic cycle, 
based on time-resolved spectroscopy and site-directed mutagenesis, will be discussed 
with respect to continuous turnover. 
 COX is isolated with the binuclear center in an oxidized state, O.  However, in 
order for oxygen to bind the binuclear center must be in a reduced state.  This is 
accomplished by two electrons being supplied by two molecules of ferrocytochrome c.  
Concomitant with the reduction of the binuclear center two protons are taken up from the 
matrix.  Some argue that both protons are taken up by the K-channel (Vygodina et al. 
1998; Wikstrom et al. 2000; Forte et al. 2004) while others believe one proton is taken up 
by the K-channel and one proton is taken up by the D-channel (Ruitenberg et al. 2002).  
As a result of the two electron reduction and the two protons taken up a molecule of 
water is formed, and is free to diffuse out of the enzyme and leaving the enzyme in a 
fully reduced state (R).  
The reductive phase begins with the reduction of fully reduced COX (state R) by 
oxygen which leads to the formation of the intermediate A.  The O—O bond is then 
broken and dioxygen is reduced by three electrons from the binuclear center and a fourth 
electron from Tyr288, which acts as an internal electron and proton donor.  As a result 
the P intermediate is formed and the tyrosine residue is left as a deprotonated radical.  
There is no electron transfer, proton uptake, or proton pumping during the R to P 
transition.  During the transition from P to F there is an electron transfer step associated 
with the uptake of one proton, via the D-channel, which protonates the hydroxyl ion on 
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CuB, thus forming another molecule of water, and a proton is translocated across the 
membrane, and forming the intermediate F.  Once the second electron arrives at the 
binuclear center another proton is taken up and another proton is pumped across the 
membrane, which also forms the intermediate O (Wikstrom 2004). 
The differences between as isolated and continuous turnover emerge upon the 
formation of the intermediate OH.   Intermediate OH is thought to be metastable and 
capable of relaxing to a more stable form O, which is thought to be the case for the “as 
isolated” form (Bloch et al. 2004).  Intermediate O proceeds to state E with the transfer of 
an electron and the uptake of a proton.  With the transfer of the final electron and the 
uptake of one more proton the cycle is completed, and state R is reestablished.  After the 
formation of O electron transfer and proton pumping are no longer linked.  Alternatively, 
during continuous turnover intermediate OH proceeds to intermediate E upon the transfer 
of the third electron, which is coupled to the uptake of one proton and the pumping of one 
proton.  Upon the transfer of the fourth and final electron another proton is taken up and 
another proton is pumped thus reestablishing state R.   
The presence of a metastable OH state may be a regulatory mechanism that has 
evolved to lower the charge to electron ratio (Bloch et al. 2004).  This mechanism would 
reduce the chances of generating a high protonmotive force, which can lead to the 
production of reactive oxygen species in mitochondria (Korshunov et al. 1997) 
 
Subunit III 
The remaining mitochondrially encoded subunit, subunit III, is a seven helical 
membrane spanning subunit of COX and is conserved in the bacterial form of the enzyme 
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(Haltia et al. 1988; Cao et al. 1992).  Unlike subunits I and II, SIII contains no metal 
centers and is therefore not an active participant in electron transfer.  Furthermore, a 
definitive role for SIII has yet to be elucidated, there is evidence that suggests SIII may 
have a role in proton translocation (Casey et al. 1980; Prochaska et al. 1981; Wilson and 
Prochaska 1990; Mills et al. 2003), electron transfer (Prochaska et al. 1981; Bratton et al. 
1999), or complex stabilization (Haltia et al. 1989; Haltia et al. 1994).  Subunit III 
contains a highly conserved glutamic acid residue (Glu90), which has the potential of 
carrying protons due to its negative charge.  Covalent modification of Glu90, in beef 
heart COX, by dicyclohexylcarbodiimide (DCCD) resulted in significant reduction in 
proton translocation activity and slight inhibition of electron transfer activity (Casey et al. 
1980; Prochaska et al. 1981).  It was later shown that DCCD binding induced a 
conformational change in SIII that inhibited proton pumping and electron transfer 
(Ogunjimi et al. 2000).      
COX SIII may undergo conformational changes that result in channel formation 
in SI, connecting the interior of the enzyme to the exterior surface of the enzyme.  This is 
supported by the observations that a SI mutant (R481K) (Mills et al. 2000), zinc (Mills et 
al. 2002), pH (Mills and Ferguson-Miller 2002), and removal of SIII (Prochaska and 
Reynolds 1986; Gregory and Ferguson-Miller 1988; Wilson and Prochaska 1990; Haltia 
et al. 1994; Bratton et al. 1999; Nguyen et al. 2002) all inhibit electron transfer in the 
presence of a membrane potential and proton gradient, but had no effect in the absence of 
gradients.  In addition, polyclonal antibodies against SIII were shown to upregulate 
electron transfer activity in bovine COX (Jeannine Lincoln et al. 2003).     
 31
SIII has been removed both biochemically [in bovine heart (Prochaska and 
Reynolds 1986; Wilson and Prochaska 1990; Nguyen et al. 2002), rat liver (Gregory and 
Ferguson-Miller 1988), and bacterial species (Bratton et al. 1999)] and genetically (P. 
denitrificans (Haltia et al. 1989) and R. sphaeroides (Bratton et al. 1999).  The bacterial 
forms of COX that contain SI and SII (I/II oxidase) undergo spontaneous and irreversible 
inactivation during catalytic turnover with concomitant loss of CuB (Haltia et al. 1994; 
Bratton et al. 1999).  It has also been shown that there is slower proton uptake and 
transfer through the D-channel when SIII is removed (Gilderson et al. 2003; Mills et al. 
2003).  Furthermore, all forms of SIII-deficient COX exhibit decreased proton to electron 
stoichiometries for proton-pumping (Thompson et al. 1985; Wilson and Prochaska 1990).   
 
 
Specific Aims 
The goal of this project is to elucidate the structural and functional roles of SIII in 
COX function, using Rhodobacter sphaeroides (RBS) COX as our model.  The 
hypothesis is that SIII must assume a specific three dimensional structure that helps 
maintain the proper orientation of the D-channel in SI.  To test this hypothesis the 
following specific aims are proposed: 
 
1. To characterize the molecular effects of SIII removal on COX electron 
transfer and proton pumping activities, and also investigate the effect of 
SIII removal on SI structure, by using limited proteolysis and mass 
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spectrometry.  Further analysis of SI structure will also be carried out 
on I/II oxidase that has been inactivated, by catalytic turnover. 
2. To use computational biochemistry to identify interhelical hydrogen 
bonds (H-bonds) within SIII, and then use site directed mutagenesis to 
determine the effect of H-bond removal on COX structure and electron 
transfer and proton pumping activities.  Of particular interest is the 
highly conserved triad of amino acids (Glu90, His212, and Tyr246), 
located in the V-shaped cleft of SIII.   
3. To determine the effect of removing a highly conserved portion of SIII, 
the C-terminal helix 7 on COX function.  This helix deletion mimics a 
human mutation where an early termination codon leads to the 
truncation of this highly conserved helix.   This mutation has been 
linked to encephalopathy (Hanna et al., 1998).  To determine the role of 
this helix in COX function a helix 7 truncation at Gly239 was prepared 
in SIII, and then characterized its electron transfer and proton pumping 
functions.     
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II.  Materials and Methods 
 
Removal of Subunit III from Rhodobacter sphaeroides 
Subunit III was removed either by biochemical depletion or genetic deletion.  
Biochemically depletion of subunit III from wild-type four subunit enzyme was 
performed by using the detergent Triton X-100 (TX-100).  Wild-type oxidase was stirred 
in 50 mM KH2PO4, pH 7.2, 1 mM EDTA, and 4% TX-100 for 1 h at 0 °C.  The product 
was repurified on nickel nitrilotriacetic (Ni2+-NTA) agarose by washing the column with 
5 column volumes of 10 mM Tris-HCl, pH 8.0, 40 mM KCl, and 10 mM imidazole 
running buffer containing 0.5% Triton X-100, followed by 10 column volumes of the 
same buffer containing 0.1% dodecyl maltoside (DM) (Calbiochem). TX-100 washing 
and purification was repeated, and the two subunit enzyme was then eluted from the 
column (Bratton et al. 1999).  The biochemically depleted I/II oxidase used in these 
studies was provided by Dr. Jon Hosler. 
 Figure 8 illustrates the cloning strategy involved in creating I/II oxidase.  The 
plasmid pMB307 (see Figure 10) contains a gene for SI, which contains a six histidine 
tag at the C-terminus, a gene for SII, and accessory genes cox10 and cox11.  The gene for 
SI is transcribed in one direction while the genes for SII, cox10, and cox11 are 
transcribed in the opposite direction, by endogenous promoters.  The set of genes with 
SII, cox10, and cox11 are part of the R. sphaeroides coxII/III operon, in which SIII has  
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Figure 8 
Schematic of the molecular biology behind creating a genetic deletion of COX from 
R. sphaeroides.  Plasmid pMB307 is digested with EcoRI and HindIII.  That DNA 
fragment is isolated and ligated into the broad host range vector pRK-415, thus yielding a 
15.8 kb plasmid that will be conjugated with YZ200. 
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been removed, using the restriction enzyme SmaI.  The oxidase subunit genes and 
accessory genes were removed by digesting pMB307 with EcoRI and HindIII, generating 
fragments 5.3 kb and 2.6 kb in size.  The 5.3 kb fragment was extracted and purified 
using the QIAquick Gel Extraction kit (Qiagen), and ligated into the broad host range 
vector pRK-415 (10.5 kb) (provided by Dr. Jon Hosler), using the Quick Ligation Kit 
(New England Biolabs).  The plasmid pRK-415 contains a gene encoding resistance to 
tetracycline and is mobilizable via  conjugation.  The ligation reaction, was carried out 
according to the manufacturers specifications (New England BioLabs), transformed into 
JM109 competent cells (Stratagene), spread onto Luria-Bertani (LB) plates containing 
tetracycline (10 µg/mL), and incubated at 37°C overnight.  Individual colonies were 
removed from the plates and grown overnight in 3 mL LB cultures containing 10 µg/mL 
tetracycline.  Plasmid DNA was isolated using QIAprep Spin Miniprep columns and 
screened for insertion of the 5.3 kb EcoRI/HindIII fragment.  EcoRI linearized plasmid 
with insert had a size of 15.8 kb, and EcoRI/HindIII digested plasmid with insert had 
DNA fragments of 10.5 and 5.3 kb.  This newly formed plasmid is termed pMA120H 
(Bratton et al. 2000).  All of the plasmids were supplied by Dr. Jon Hosler, from the 
University of Mississippi Medical Center. 
 
Conjugation  
The purpose of the conjugation is to transfer the pMA120H plasmid into a R. sphaeroides 
cell line that has had the coxII/coxIII operon deleted, YZ200.  In the absence of the 
coxII/coxIII operon this cell line is not capable of expressing functional COX.  
Triparental conjugation was performed by growing 3 mL cultures of the R. sphaeroides 
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strain YZ200, E. coli JM109 (containing pMA120H), and E. coli HB101.  The HB101 
cells contain a helper plasmid, pRK2013, which increases the transfer efficiency of the 
plasmid pMA120H to YZ200 (Figurski and Helinski 1979).  Conjugation was carried out 
by pelleting 2 mL of the YZ200 culture (grown to OD660 of 0.8-1.0), and 1mL of 
overnight cultures of JM109 and HB101 in three separate tubes.  The pellets were then 
washed 2 times with phosphate buffer, pH 7.0.  After the final wash, all of the buffer was 
removed from 2 of the tubes and approximately 100 µL was left in the third.  All pellets 
were resuspended in the final 100 µL and transferred without spreading to a Peptone 
yeast extract (PYE) agar plate  that contained no antibiotics, and incubated overnight at 
30°C.  The next day, a small amount of cells were scraped from the surface of the plate 
and resuspended in phosphate buffer, pH 7.0 and spread onto a Sistrom’s (Sistrom 1962) 
agar plate containing 50 µg/mL, streptomycin, 50 µg/mL spectinomycin, and 1 µg/mL 
tetracycline, and incubated at 30°C until individual colonies formed (3-4 days).  
Individual colonies were lifted from the plates and restreaked onto a fresh Sistrom’s plate 
containing 50 µg/mL, streptomycin, 50 µg/mL spectinomycin, and 1 µg/mL tetracycline, 
and incubated at 30°C until individual colonies formed (3-4 days).   
 
Bacterial Growth and Purification 
Colony forming units were then used to inoculate 3 mL Sistrom’s media 
containing 50 µg/mL, streptomycin, 50 µg/mL spectinomycin, and 1 µg/mL tetracycline.  
These cultures were allowed to grow to an OD660 of 0.8-1.2.  Then 1 mL of these cultures 
were used to inoculate a 50 mL Sistrom’s containing 50 µg/mL, streptomycin, 50 µg/mL 
spectinomycin, and 1 µg/mL tetracycline.  The 50 mL culture was allowed to grow to an 
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OD660 of 0.8-1.2.  3 mL of this culture was then used to inoculate a 150 mL culture 
containing 50 µg/mL streptomycin, 50 µg/mL spectinomycin, and 1 µg/mL tetracycline, 
which was allowed to grow to an OD660 of 0.8-1.2.  This culture was then used to 
inoculate a 3 L sparger built in house.  The spargers were constructed from using a 4L 
Kontes cytostir apparatus which was modified with two sparging stones.  A house airline 
was used as the air supply, which was fed into a water trap to filter out any particulate 
from the house airline.  Air from the water trap then flowed into the growth chamber.  
Optical density measurements were taken at various intervals until the OD660 reached 1.0-
1.2, which on average took between 22-28 hours.  Cells were then harvested by 
centrifugation at 11,300 x g, the supernatants were decanted, and the pellets were stored 
at -80°C. 
Cell lysis was accomplished by resuspending the cells (1 mL buffer per gram wet 
cell weight) in a 10 mM Tris, pH 8.0, 10 mM EDTA, 10 mM MgCl2, and 20 % glycerol.   
After homogenizing this mixture the cells were passed through a Bio-Neb apparatus three 
times in the presence of 1 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma) at a 
pressure of 100 psi, and then three additional passes through the Bio-Neb in the presence 
of 1 mM PMSF, 25 mg/mL of lysozyme (Sigma), and 50 µg/mL of DNase (Sigma).  The 
lysed cell mixture was then centrifuged at 24,000 x g for 20 minutes, at 4°C.  
Supernatants were decanted and stored on ice for later steps while the pellets were 
resuspended in 10 mM Tris-HCl, 40 mM KCl, 3% dodecyl maltoside (DM), pH 8.0, 
stirred for 30 minutes at 4°C, and centrifuged at 37,000 x g for 20 minutes, at 4°C.  The 
supernatants were collected and analyzed for heme aa3 content at 606 nm on a Hewlett 
Packard 8453 UV/Visible diode array spectrophotometer.  The supernatants were 
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decanted into Ti50.2 ultracentrifugation tubes, and 100 µL of 100 mM PMSF was added 
to each tube (0.4 mM final concentration PMSF).  These tubes were then centrifuged at 
153,000 x g, for 1.5 hours, at 4°C  in a Beckman Optima LE-80K preparative 
ultracentrifuge.  The supernatants were decanted and the pelleted membranes were 
resuspended in 10 mM Tris-HCl, 40 mM KCl, pH 8.0, and analyzed for heme aa3 content 
at 606 nm, as before.  Then 100 µL of 100 mM PMSF was added to each tube, and the 
tubes were then ultracentrifuged again at 153,000 x g, for 1.5 hours, at 4°C .  After 
decanting the supernatant, the membrane pellets were stored at -80°C until further use 
(Zhen et al. 1998). 
Purified cytoplasmic membranes (approximately 2-4 g wet weight) were 
resuspended in 10 mM Tris-HCl, 40 mM KCl, pH 8.0, DM was added to 2%, and stirred 
at 4°C for 15 minutes.  The mixture was then centrifuged at 37,000 x g for 20 minutes, at 
4°C, and the COX-containing supernanant was collected and transferred to a 50 mL 
Falcon tube.  Imidazole was added to 10 mM, and Ni2+-NTA agarose was added at 0.8-
1.0 mL/mg COX, this allows the poly-histidine tag at the C-terminus of SI to interact 
with the nickel resin.  This mixture was mixed on a rocker platform for 1 hour at 4°C.  
The slurry was then transferred to a Bio-Rad glass econo-column (inner diameter = 0.7 
cm, length = 30-50 cm) allowed to settle without flow for 10 minutes, and the column 
was packed, by gravity flow, at a slow flow rate (1 drop/3-5 seconds).  Once the sample 
reached the top of the packed resin 5-10 column volumes of running buffer (10 mM Tris-
HCl, 40 mM KCl, 10 mM imidazole, 0.1% DM, pH 8.0) were applied and flow continued 
at 1 drop/3-5 seconds.  Once the flow through was clear 2-3 column volumes of elution 
buffer (10 mM Tris-HCl, 40 mM KCl, 100 mM histidine, 0.1% DM, pH 8.0) was applied 
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to the column and flow was reduced to 1 drop/ 5-7 seconds, in order to keep the COX as 
concentrated as possible.  The column continued to run until all of the green color was 
eluted from the column.  All of the green fractions were pooled and concentrated in 
Centricon filter devices (30,000 Da molecular weight cut off (MWCO)).  After filtration 
the enzyme was resuspended in a buffer suitable for FPLC purification: 10 mM KH2PO4, 
pH 7.8, and 1 mM EDTA.  Thus, this filtration step serves three purposes: to remove 
excess histidine, reduce the volume of the samples, and exchange buffer.  
 
High-Resolution Anion-Exchange Chromatography 
 After COX was eluted from the Ni2+-NTA agarose column the 10 mM Tris-Cl, 
pH 8.0, 40 mM KCl, and 100 mM histidine was exchanged for 10 mM KH2PO4, pH 7.8, 
and 1 mM EDTA in Centricon-30 centrifugal filter devices. DM was added to a final 
concentration of 3%.  The eluted sample was incubated on ice for 15 minutes and then 
centrifuged for 15 min at 13,400 rpm in an Eppendorf Mini Spin microcentrifuge at 4°C 
and the supernatant was transferred to a new tube.  This centrifugation step removed any 
particulate that may clog the column.  The FPLC column used was a Tricorn 10/100 (GE 
Healthcare), which has an inner diameter of 10 mm and length of 100 mm, and was 
packed with the anion exchange resin DEAE-5PW (TosoHaas).  A 3 mL sample was 
loaded manually into a sample loop and applied to the FPLC column which was then run 
on a Pharmacia LKB FPLC system.  The column was preequilibrated with 10 mM 
KH2PO4, pH 7.8, 1 mM EDTA, 0.1% DM, and the oxidase was eluted with a 45-ml 
gradient of 0.01–0.35 M KCl in the same buffer at a flow rate of 0.5 ml/min. Oxidase- 
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containing fractions were collected and stored at -80°C (Zhen et al. 1998; Bratton et al. 
2000; Hiser et al. 2001). 
 
Determining the Maximum Turnover Rate of Detergent-Solubilized COX 
 The electron transfer activity of detergent-solubilized COX was measured using a 
Clark oxygen electrode (Yellow Springs Instrument Company Model 17372).  In the 
absence of enzyme, ascorbate (18 µM), cytochrome c (type III) (20-40 µM), and 0.6 mM 
TMPD were incubated in 1.7 mL 25 mM HEPES-NaOH, pH 7.0, with 0.1% DM at 25°C 
in the electrode chamber for 3 minutes.  This allowed the rate of cytochrome c auto-
oxidation to be measured.  Then 5-10 pmoles of COX was added to determine the 
maximum rate of COX activity for 3 minutes.  There has been some speculation that the 
anion exchange chromatography purification step removes essential lipids from COX 
(personal communication with Dr. Jon Hosler).  To test this, the experiment was repeated 
with 1 mg/mL asolectin added to the assay buffer, described above, prior to adding the 
enzyme. 
 
Time Course of Limited Proteolysis of COX Using α-Chymotrypsin 
For the time dependence of the limited proteolysis, 4 µg of total protein 
(calculated using heme a3 concentration and 125,000 and 95,500 daltons for the 
molecular weight of wt and I/II oxidase, respectively) were first washed with 25 mM 
Tris-HCl, 0.1% DM, pH 9.0 in a Millipore Microcon centrifugal filter device (10,000 
MWCO) and then eluted with 25 mM Tris-HCl, pH 9.0, and then brought up to the same 
volume (10 µL).  The enzymes were incubated at a ratio of 1:10 (protease:enzyme) 
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(weight/weight) with α-chymotrypsin-TLCK (Worthington Biochemical Corporation) at 
room temperature.  Reactions were quenched with 1 mM PMSF (final concentration) (in 
ethanol), after 1 and 3 hours of incubation.  The digested enzymes were then run on a 
16% polyacrylamide gel containing 6 M urea (Fuller et al. 1981), stained with Bio-Safe 
Coomassie (Bio-Rad), and analyzed for subunit content and proteolysis patterns using a 
Fuji LAS-3000 imager in precision mode. 
 
Energy Minimization of Cytochrome c Oxidase  
The four subunit structure of Rhodobacter sphaeroides cytochrome c oxidase 
(PDB 1M56, (Svensson-Ek et al. 2002)) was used for the initial energy minimization 
calculations.  Subunits IV and/or III were removed from the PDB file 1M56 using the 
program Swiss Protein Data Bank Viewer (SPDBV), which resulted in the COX 
structures with subunits I, II, and III (wild-type) and subunits I and II (I/II oxidase).  
Sybyl was then used for the energy minimization of all the structures using the following 
constraints: Steepest Descent method, Simplex initial optimization: Simplex, termination 
energy change of 1 Kcal/mol, 520 iterations, dielectric constant of 3.0, Tripos force field, 
Gasteiger-Huckel charges, and boundary conditions: 100, 100, 120 Angstroms.  This 
work was performed by Sudhir Patel in our laboratory. 
After equivalent numbers of iterations, the energy-minimized structures were 
aligned using two different programs and three different methods: Iterative Magic Fit 
(SPDBV), Magic Fit (SPDBV), and Manual Alignment (DS Viewer Pro, Accelrys).  
Alpha-carbons which moved greater than 0.5 Ǻ were identified in each alignment.  
Averages and standard deviations were then calculated for each amino acid that 
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underwent a change in position.  The residues were then displayed using DS ViewerPro 
to show where the changes in subunit I occur. 
 
Limited Proteolysis of COX Using α-Chymotrypsin 
For the time dependence of the limited proteolysis, 2 µM heme aa3 or 3 µg of 
total protein (calculated using heme concentration and 125,000 and 95,500 daltons for the 
molecular weight of wt and I/II oxidase, respectively) were first washed with 25 mM 
Tris-HCl, 0.1% DM, pH 9.0 in a Millipore Microcon centrifugal filter device (10,000 
MWCO), eluted with 25 mM Tris-HCl, pH 9.0, and brought up to the same volume (10 
µL).  For the experiment with equivalent heme concentration the same procedure 
described above but samples were diluted to a final concentration of 2 µM heme aa3 with 
25 mM Tris-HCl, pH 9.0.   The enzymes were incubated at a ratio of 1:10 
(protease:enzyme) (weight/weight) with α-chymotrypsin-TLCK (Worthington 
Biochemical Corporation) at room temperature.  Reactions were quenched with PMSF (in 
ethanol), after 1, 2, and 3 hours of incubation.  The digested enzymes were then run on a 
16% polyacrylamide gel containing 6 M urea (Fuller et al. 1981), stained with Bio-Safe 
Coomassie (Bio-Rad), and analyzed for subunit content proteolysis patterns using a Fuji 
LAS-3000 imager in precision mode. 
 
N-terminal Sequence Analysis of Subunit I and its Chymotrypsin Cleavage Products  
Approximately 10 µg COX was treated with α-chymotrypsin as described 
previously and was run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) (in the absence of urea).  The proteins were transferred to ImmobilonPSQ 
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(Millipore) using a Bio-Rad tank transfer system overnight at a constant current of 200 
mA, and 600 mA for the final 30 minutes.  The membrane was stained with Coomassie 
R-250 for 1 minute and destained with 50% methanol and 10% acetic acid.  The 
membrane was allowed to dry and the bands of interest were excised and sent to ProSeq 
Inc. for N-terminal sequence analysis using an Applied Biosystems 494 Procise 
sequencer. 
 
Histidine-Tagged Protein Detection 
Proteins from SDS-Urea-PAGE were transferred to a PVDF membrane using a 
Pharmacia LKG 2117 Multiphor II semi-dry electrophoresis unit at 42 mA for 2 hours 
(1.0 mA/cm2).  After the membrane was dried overnight, it was rehydrated in methanol 
for 10-15 seconds.  The blot was developed using the SuperSignal® West HisProbe™ 
Kit from Pierce.  The membrane was blocked in 10 ml of BSA/TBST (25 mg/mL bovine 
serum albumin/25 mM Tris, 0.15 M NaCl, pH 7.6, 0.05% Tween®-20) for 1 hour at 
room temperature on a rocker platform.  The membrane was washed twice with 15 ml of 
TBST (25 mM Tris, 0.15 M NaCl, pH 7.6, 0.05% Tween®-20) for 10 minutes each.  The 
nickel-activated derivative of horse radish peroxidase, HisProbe™-HRP (Pierce), was 
applied, at a dilution of 1:5000, in 10 mL of TBST and incubated on a rocker platform for 
1 hour.  This probe is specific for the histidine tag located at the C-terminus of COX SI.  
The blot was washed four times with 15 ml of TBST for 10 minutes each.  Next, 7.5 ml 
of SuperSignal® West Pico Substrate Working Solution (this solution is made by mixing 
equal volumes of a luminol/enhancer solution with a stable peroxide solution, which are 
supplied in the kit) was applied for 5 minutes.  The blot was removed from the Substrate 
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Working Solution and placed in a sheet protector.  Chemiluminescence was detected 
using a Fuji LAS-3000 imager in the increment mode. 
 
Mass Spectrometry of α-chymotrypsin Solution Digests 
 Wild-type and I/II oxidase were diluted with 30 mM Tris-Cl, pH 8.8 and 
concentrated down to a minimal volume (< 10 µL) in a Microcon-30.  The samples were 
then brought up to a concentration of 1 µg/µL.  α-chymotrypsin was added at a ratio of 
1:10 and the reactions were allowed to proceed at room temperature for 1, 2, and 3 hours.  
At the end of each time point 1 µL of sample was removed and spotted onto a gold chip 
from Ciphergen.  Different energy absorbing matrices (EAM’s) were used depending on 
whether low molecular weight species (<15 kD) or high molecular weight species (>15 
kD) were being analyzed.  For low molecular weight analysis the EAM α-cyano-4-
hydroxysuccinnamic acid (CHCA) was employed and for high molecular weight analysis 
the EAM sinapinic acid (SPA) was employed.  Samples were prepared by pipetting 1 µL 
of sample and 1 µL of a saturated solution of EAM into a 500 µL eppendorf tube, quickly 
mixing by flicking the tube, and a flash spin in the microcentrifuge to remove any 
material from the walls of the tube.  The mixture was then removed from the tube and 
applied to the gold chip and allowed to air dry for 30 minutes to overnight.  The gold 
protein chip was then loaded into a Ciphergen SELDI Protein Biology System II 
(Ciphergen, Palo Alto, CA) and analyzed.  Each spot was ionized 3 to 5 times over 
different areas within the spot.  Fifty laser hits were averaged for each area on the spot.  
This resulted in a mass profile for each sample.  The spectra were then externally 
calibrated using mass standards from Sigma and Ciphergen.  The peaks were identified 
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based on the mass of peptides generated from the COX subunit sequences.  The peptide 
masses were generated using a program called Peptide Mass, which is available at the 
ExPaSy website (http://us.expasy.org/cgi-bin/peptide-mass.pl), using following criterion:  
the protein subunits were digested with chymotrypsin (C-terminal to Tyr, Phe, and Trp, 
not before Pro), up to 5 missed cut sites were allowed, all Cys’s were in the reduced 
form, and the Met residues were not oxidized.         
 
In-Gel Tyrpsin Digestion of Subunit I   
After staining of the gel with Bio-Safe Coomassie, the bands containing the full 
length subunit I or the chymotrypsin fragment of interest were excised from the gel and 
completely destained in 50 mM ammonium bicarbonate in 40% ethanol.  The excised gel 
pieces were washed with 25 mM ammonium bicarbonate three times for 15 minutes  and 
then cut into small pieces <1 mm3.  The gel pieces were then dehydrated with acetonitrile 
three times for 10 minutes and completely dried in a SpeedVac (Eppendorf Vacufuge) 
(van Montfort et al. 2002).  Tryptic digestion was initiated with the addition of 750 ng 
trypsin stock.  After reswelling of the dehydrated gel pieces, a 40 µL overlay of 100 mM 
ammonium bicarbonate was added.  The protein was digested for a minimum of 14 hours 
at 30ºC. 
 
Extraction of the Tryptic Peptides of Subunit I From the Gel Pieces  
The digested gel pieces were sonicated in a bath sonicator for 10 minutes and the 
overlay was then collected.  Further extraction of peptides was performed by adding 30 
µL of 60% acetonitrile, 1% TFA, 0.1% octyl-β-glucopyranoside (OBG) to the gel pieces.  
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This was sonicated for 10 minutes, collected, and repeated one time.  The overlay 
fraction and extract fractions were dried in a SpeedVac.  The remaining ammonium 
bicarbonate was removed by the addition of 10 µL of 1% TFA and complete drying in a 
SpeedVac (van Montfort et al. 2002). 
 
Mass Spectometry of the Tryptic Peptides  
The dried overlay and extract samples were dissolved in 5 µL of 50% acetonitrile, 
0.1% TFA, and sonicated for 10 minutes.  Aliquots of 1.0 µL were applied to the 
Ciphergen protein chip target.  0.5 µL of saturated CHCA dissolved in 50% ethanol or 
alternatively CHCA plus 10% formic acid was added to and mixed.  After air drying, 
MALDI-TOF mass spectra were recorded and analyzed as described earlier. 
 
Turnover and Digestion of COX  
Inactivation of COX was carried out in a 5 mL beaker containing a 1 mL solution 
composed of 112 pmoles of wild-type oxidase or 147 pmoles of I/II oxidase, which 
corresponds to 12 µg of total protein, 50 mM ascorbate, 1.0 mM TMPD, 25 mM Tris-
HCl pH 9.0, and 0.1% DM.  Enzyme turnover was initiated by adding cytochrome c 
(Sigma, type III) to a final concentration of 3 nM.  Controls were identical to the above 
solutions, but did not contain cytochrome c.  Inactivation was monitored by removing 9 
pmoles of wild-type and I/II oxidase and assaying the activity of the enzyme in a Clark 
type oxygen electrode.  Oxygen consumption was monitored at 25°C polarographically 
using an oxygen electrode in the presence of 5.3 µM cytochrome c (Sigma, type III), 18 
mM ascorbate, 0.9 mM TMPD, 25 mM Tris-HCl pH 9.0, and 0.1% DM.  After 30 
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minutes the wild-type enzyme was inactivated by approximately 15% and the I/II oxidase 
had been inactivated 100%.  The controls showed no changes in activity over the same 
time course.   
The remainder of the inactivated oxidase and controls were then loaded into 
Centricon filter devices with a 100 MWCO.  NaCl was added to a final concentration of 
110 mM to facilitate the dissociation of cytochrome c from COX SII, and the samples 
were diluted to a final volume of 2 mL with 25 mM Tris-HCl pH 9.0.  Samples were 
centrifuged at 1,000 x g for 30 minutes and then eluted at 1,000 x g for 2 minutes.  
Further concentration of the samples was performed using Microcon centrifugal filter 
device (30,000 MWCO, Millipore) and collected.  Half of the final sample volume was 
used as a control and the other half of the sample volume was digested with α-
chymotrypsin at a ratio of 1:10 for 2 hours.  Digestion was stopped by adding 0.3 mM 
PMSF and then the samples were run out on a 16% gel.  The samples were then analyzed 
for subunit content and proteolytic patterns by SDS-Urea-PAGE. 
 
Site-Directed Mutagenesis of Cytochrome c Oxidase Subunit III from Rhodobacter 
sphaeroides 
 
 The 4.3 kb plasmid containing the gene for subunit III from R. sphaeroides was 
created by methods described in (Bratton et al. 2003) and is termed pMB301 (Figure 9).  
Appendix A shows the DNA sequence of R. sphaeroides  SIII and its derived protein 
sequence.  Site-directed mutants were made using the Stratagene QuikChange kit 
according to the manufacturer's protocols for primer design and thermocycling for primer 
annealing and extension (Appendix B).  After thermocycling, the parental DNA was 
digested using DpnI and 4µL of the reaction mixture was used to transform XL-1 Blue  
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Figure 9 
Schematic Diagram of Plasmid pMB301.  This is a 4.3 kb plasmid that contains the 
gene for SIII from R. sphaeroides.  The gene is flanked by two SmaI sites which allows 
for removal of the gene and subsequent blunt ended ligation into pMB307.  The numbers 
shown on the plasmid represent the location of the cut sites for the restriction enzyme, 
SmaI.  
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Figure 10 
Schematic Diagram of Plasmid pMB307.  This plasmid contain the genes for SI with a 
six histidine tag at the C-terminus, SII, and the accessory proteins cox10 and cox11.  
There is also an internal SmaI site, which is used for the insertion of the SIII gene.  The 
numbers shown on the plasmid represent the location of the cut sites for the restriction 
enzymes, HindIII, EcoRI, and SmaI.  
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Figure 11 
Diagram Illustrating the Digestion and Ligation of the SIII Gene into Plasmid 
pMB307.  Digesting pMB307 and pMB301 with SmaI results in the a linearized pMB307 
and bands that are 3.3 and 0.9 kb in size for pMB301.  After gel purification the 0.9 kb 
mutant SIII gene is ligated into the linearized pMB307, forming a plasmid that is 8.8 kb 
in size.  The numbers shown on the plasmid represent the location of the cut sites for the 
restriction enzymes, HindIII, EcoRI, and SmaI.  
   
 
 54
 
 
 
 
 
 
 
 
 
 55
supercompetent cells (Stratagene).  The transformation reaction was spread onto LB 
plates containing 40 µg/mL chloroamphenicol and incubated overnight at 37°C.   The 
following day colonies were used to inoculate 3 mL cultures of LB containing 40 µg/mL 
chloroamphenicol and were grown overnight, with shaking, at 37°C.  Plasmid DNA from 
the 3 mL cultures was isolated using QIAprep Spin Miniprep columns (Qiagen).  The 
DNA was then submitted to Davis Sequencing (Davis, CA) for sequencing.  Restriction 
digestion of pMB307 (7.9 kb), which was described earlier, and mutant pMB301 (4.3 
kb), with SmaI, results in the linearization of pMB307 and 3.3 kb and 0.9 kb fragments 
from pMB301.  The linearized pMB307 and 0.9 kb fragment from pMB301 were 
extracted and purified using the QIAquick Gel Extraction kit (Qiagen), and then a blunt-
end ligation was performed using the Quick Ligation Kit (New England Biolabs) (see  
Figure 11) (Appendices C Figures 1 and 2).  The ligation reaction was transformed into 
XL10-Gold ultracompetent cells (Stratagene), plated onto LB with ampicillin, and 
incubated at 37°C overnight.  Individual colonies were removed from the plates and 
grown overnight in 3 mL LB cultures in the presence of ampicillin.  Plasmid DNA was 
isolated using QIAprep Spin Miniprep columns (Qiagen).  Plasmids were screened for 
insert and proper orientation using EcoRI, EcoRI/HINDIII, and XhoI  (Appendix C 
Figure 3).  Plasmids containing the subunit III insert in the proper orientation had a size 
of 8.8 kb when linearized with EcoRI, DNA fragments of 6.2 kb and 2.6 kb when cut 
with EcoRI/HINDIII, and DNA fragments of 6.2 kb and 2.6 kb when cut with XhoI.  If 
the subunit III were inserted backwards during the blunt-end ligation procedure XhoI 
digestion would have resulted in DNA fragments of 5.7 kb and 3.1 kb.  The 6.2 kb 
fragment from the double digest with EcoRI/HindIII was then extracted and purified  
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Figure 12 
Diagram of the Procedure for Digesting and Ligating the pMB307 + 0.9 kb SIII 
Gene into the Broad Host Range Vector pRK415.  In order to transfer the mutant SIII 
gene to a R. sphaeroides it must be placed into a broadhost range vector capable of 
transferring the newly formed plasmid.  This is done by digesting pMB307 + 0.9 kb SIII 
and pRK415 with EcoRI and HindIII.  This results in a 6.2 kb from pMB307 + 0.9 kb 
SIII that can be ligated into the linearized  pRK-415.  This forms a new plasmid with a 
size of 16.7 kb.  The numbers shown on the plasmid represent the location of the cut sites 
for the restriction enzymes HindIII and EcoRI. 
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using the QIAquick Gel Extraction kit.  This DNA fragment was then ligated into the 
broad host range vector pRK-415 (10.5 kb), using the Quick Ligation Kit (Figure 12) 
(Appendix C Figure 4).  The ligation reaction was then transformed into JM109 
competent cells (Stratagene), and spread onto LB plates containing 10 µg/mL 
tetracycline, and incubated at 37°C overnight.  Individual colonies were removed from 
the plates and grown overnight in 3 mL LB cultures containing 10 µg/mL tetracycline.  
Plasmid DNA was then isolated using QIAprep Spin Miniprep columns and screened for 
insertion of the 6.2 kb EcoRI/HINDIII fragment.  EcoRI linearized plasmid with insert 
had a size of 16.7 kb, and EcoRI/HINDIII digested plasmid with insert had DNA 
fragments of 10.5 and 6.2 kb (Appendix C Figure 5).  Bacterial conjugation, growth, 
purification were performed as described previously. 
 
Estimating Subunit III Content Using Site-Directed Polyclonal Antibodies 
 Polyclonal antibodies were designed to react with loop regions within subunit III 
of COX.  Figure 13 shows the location of the epitopes used for the synthesis of the 
antibodies.  The epitope of the cleft antibody (yellow) contains amino acids 64-77, the  
epitope of the loop antibody (red) contains amino acids 110-123, and the epitope of the 
zinc antibody (blue) contains amino acids 225-238.  These antibodies were produced by 
conjugating the peptides to KLH, through a cysteine included at the C-terminus of the 
peptide, which were then initially mixed into Complete Freund’s Adjuvant and injected 
into two New Zealand White rabbits.  Five subsequent injections were performed by 
mixing the conjugated peptide into Incomplete Freund’s Adjuvant over the course of 70 
days.  The antibodies were first purified by ammonium sulfate precipitation, using a 40%  
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Figure 13 
Crystal Structure Depicting the Location of Polyclonal Antibodies Directed 
Towards Loop Regions of COX SIII.  Shown is SIII from R. sphaeroides COX.  The 
epitopes for the polyclonal antibodies are as follows: yellow is amino acids 64-77, red is 
amino acids 110-123, and blue is amino acids 225-238.   
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cut and were further purified on a Protein A column.  The purity of the antibodies and the 
titer of each antibody were determined by David Riegler M.S. in our laboratory using 
established protocols (Jeannine Lincoln et al. 2003).   
 Wild-type and mutant COX were routinely run on 16% polyacrylamide gels 
containing 6 M urea (Fuller et al. 1981) for 2.5 to 3 hours.  The gels were then transferred 
to a transfer buffer composed of 10 mM CAPS, pH 11.0 and 10% methanol and 
incubated for 10-15 minutes.  At the same time two sheets of PVDF, cut to the same 
dimensions as the gel, were first hydrated in methanol for 15 seconds, transferred to 
water for 2 minutes, and then incubated in transfer buffer for 10-15 minutes.  A sandwich 
containing a sheet of Whatman 3M blotting paper, the two sheets of PVDF, the gel, and 
another sheet of Whatman 3M blotting paper was stacked and placed in a tank transfer 
apparatus.  The transfer was performed at a constant current of 200 mA for 1.5 hours and 
then increased to 500 mA for an additional 30 minutes.  The sandwich was taken apart 
and the gel was washed three times with water, 5 minutes each, and then stained with 
Bio-Safe Coomassie to determine the transfer efficiency.  Both sheets of PVDF were 
rinsed with water and allowed to dry overnight.  The blots were rehydrated by immersion 
in methanol for 10-15 seconds and then transferred to 50 mL of 50 mM Tris-HCl, 170 
mM sodium chloride, and 5% milk, pH 7.5 (TBS-B).  To block non specific binding the 
PVDF membranes were mixed with TBS-B on a rocker platform for one hour with three 
changes of the blocking buffer.  The cleft and zinc antibodies were applied at dilution of 
1:250 and the loop antibody was applied at a dilution of 1:500 and incubated for at least 
one hour on the rocker platform.  The blots were washed with three changes of TBS-B, 
allowing 5-10 minutes between each change.  The secondary antibody, goat anti-rabbit 
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(GAR) IgG conjugated to horseradish peroxidase (Bio-Rad), was applied at 1:3000 and 
was incubated for one hour on a rocker platform.  The blots were washed again with three 
changes of TBS-B, allowing 5-10 minutes between each change.  The blots were 
developed using the Homemade Renaissance Chemiluminescence Reagents: 50 µL of 
250 mM luminal, 22 µL of 90 mM p-coumaric acid, 1 mL of 1.0 M Tris-HCl, pH 8.5, 
and 9.0 mL of water.  The reaction was initiated by adding 10 µL of 30% hydrogen 
peroxide to the mixture, and it was then poured over the blots.  The blots remained in the 
reaction mixture for one minute, the blots were transferred to a sheet protector, and 
developed using a Fuji LAS-3000 imager in the increment mode. 
 As a means to determine of there was any non-specific binding occurring 
competition assays were performed.  The same procedure, as described above, was used 
except that 0.1 mg of free peptide (the same peptide used to create the polyclonal 
antibodies) was included in during the incubation with the primary antibodies.       
 
Mass Spectrometry of Wild-type and Mutant Forms of COX 
 To determine the purity and subunit composition of various preparations of 
enzyme samples were routinely analyzed using MALDI-TOF mass spectrometry.  
Samples were concentrated to approximately 2 µg/µL, using Microcon YM-30 filter 
devices.  Then 1 µL of the sample was mixed with 1 µL of an EAM.  When examining 
low molecular weights (<15,000 Da) the EAM CHCA was used, and when examining 
higher molecular weights (>15,000 Da) the EAM SPA was used.  Samples were then 
spotted onto a Gold chip (Ciphergen) and analyzed on the MALDI-TOF instrument. 
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 pH Dependence of Wild-type and Mutant COX Enzymes 
 The electron transfer activity of detergent-solubilized COX, at different pH 
values, was measured using a Clark oxygen electrode.  Electron transfer assays are 
typically performed in 50 mM phosphate buffer, pH 7.4, which has an ionic strength (I) 
of approximately 100 mM.  Therefore, all buffers were adjusted to an I = 100 mM using 
KCl.  25 mM HEPES-NaOH was used for pH values 7.0-8.5 and 25 mM CHES-NaOH 
was used for pH values 9.0-10.0.  Buffer composition was calculated using an online 
buffer calculator, which can be found at http://www.liv.ac.uk/buffers/buffercalc.html.  
The enzymes were diluted to 5 nM (5 pmole/µL) in 25 mM HEPES-NaOH, pH 7.5.  As a 
result of the dilution the enzymes began to lose activity after about 1 hour.  To avoid this 
loss in activity, over time, three to four dilutions of the enzyme were made, and those 
samples not being assayed were stored at -80°C until needed.   
In the absence of enzyme, ascorbate (18 µM), cytochrome c (type III) (20-40 
µM), and 0.6 mM TMPD were incubated in either 25 mM HEPES-NaOH or 25 mM 
CHES-NaOH at each pH value, with 0.1% DM at 25°C in the electrode chamber for 3 
minutes.  This allows the rate of cytochrome c auto-oxidation to be measured.  Then 5-10 
pmoles of COX was added to determine the maximum rate of COX activity.  Each 
sample was assayed at each pH value at least three times and the averages and standard 
deviations were then calculated for each sample and pH.  
  
Reconstitution into phospholipid vesicles 
Wild-type and mutant proteins of COX were reconstituted into phospholipid vesicles by 
the cholate dialysis procedure (Figure 14) using asolectin (alpha-  
 64
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 
 
Reconstituting COX into Phospholipid Vesicles.  Asolectin, cholate and HEPES buffer 
are combined and sonicated until clear.  At the same time COX is incubated on ice with 
the detergent TX-100.  This step dissociates any large aggregates of enzyme.  Then the 
lipid mixture and enzyme are mixed and dialyzed against 1 L of 100 mM HEPES-NaOH, 
pH 7.2 (4-6 hours) to remove the cholate and allow vesicles to form around COX.  This 
step also ensures that there is 100 mM HEPES-NaOH, pH 7.2 on the inside of the vesicle.  
The second dialysis step is against 10 mM HEPES-NaOH, pH 7.2, 50 mM KCl, and 50 
mM sucrose (4-6 hours).  The third dialysis step is against 1 mM HEPES-NaOH, pH 7.2, 
50 mM KCl, and 50 mM sucrose (4-6 hours). The fourth and final dialysis step is against 
50 µM HEPES-NaOH, pH 7.4, 50 mM KCl, and 50 mM sucrose (4-6 hours).   
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phosphotidylethanolamine, Sigma) (Wilson and Prochaska 1990).   Asolectin (90 
mg/mL) was dispersed in 60 mM HEPES-NaOH, pH 7.2, and 8% cholate in an ice bath 
using a Branson Sonifier 250.  The phospholipid mixture was sonicated (Duty cycle 50%, 
Output control 5) to clarity in one minute intervals.  The clarified mixture was 
centrifuged (20,000 x g at 4°) for 10 minutes to remove metal fragments from the tip of 
the sonicator. 
 Phospholipid vesicles containing wild-type or mutant R. sphaeroides COX were 
prepared by first incubating COX with TX-100 (3.5 mg TX-100/mg COX) for 30 minutes 
on ice, then adding 500 µL of the asolectin mixture, and finally adding 100 mM HEPES-
NaOH, pH 7.2 to bring the final volume of the mixture to 1.0 mL.  The samples were 
then loaded into Slide-A-Lyzer dialysis cassettes with a molecular weight cut off of 
10,000 Da, and subjected to dialysis with decreasing concentrations of HEPES-NaOH, 
pH 7.2.  The first dialysis step was against 1 L of 100 mM HEPES-NaOH, pH 7.2 (4-6 
hours) and was necessary to remove the cholate and allow vesicles to form around COX.  
This step also ensures that there is 100 mM HEPES-NaOH, pH 7.2 on the inside of the 
vesicle.  The second dialysis step was against 10 mM HEPES-NaOH, pH 7.2, 50 mM 
KCl, and 50 mM sucrose (4-6 hours).  The third dialysis step was against 1 mM HEPES-
NaOH, pH 7.2, 50 mM KCl, and 50 mM sucrose (4-6 hours). The fourth dialysis step was 
against 50 µM HEPES-NaOH, pH 7.4, 50 mM KCl, and 50 mM sucrose (4-6 hours). 
 
Electron Transfer Activity and Respiratory Control Ratios (RCR)  
The electron transfer activity of phospholipid vesicles containing COX was 
measured using a Clark oxygen electrode (Yellow Springs Instrument Company Model 
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17372).  Ascorbate (18 µM), cytochrome c (type III) (20-40 µM) were incubated in 50 
mM KHPO4, pH 7.4, at 25°C in the electrode chamber for 3 minutes.  This allows the 
rate of cytochrome c auto-oxidation to be measured.  Then 5-15 pmoles of COX 
containing vesicles were added to determine the basal rate of COX activity for 3 minutes.  
The basal rate of COX is inhibited due to the presence of a membrane potential and pH 
gradient.  To dissipate the membrane potential, the potassium ionophore, valinomycin 
(Val) (6 µM) is added.  As a result the rate of oxygen consumption is stimulated, and this 
rate is measured for 3 minutes.  Next the pH gradient is dissipated by using the proton 
ionophore, carbonyl cyanide m-chlorophenylhydrazone (CCCP) (6 µM).  By eliminating 
the membrane potential and pH gradient maximum electron transfer activity is observed, 
and measured for 3 minutes. 
Endogenous proton permeability of phospholipid vesicles containing wild-type or 
mutant COX was characterized using respiratory control ratios (RCR) (DiBiase and 
Prochaska 1985; Wilson and Prochaska 1990).  These ratios are measured with a Clark-
type oxygen electrode (as described above) and are used to quantitate the relationship of 
electron transfer in the absence of a membrane potential and a proton gradient to the rate 
of electron transfer in the presence of both gradients (DiBiase and Prochaska 1985).  
Generally, higher RCR values (>3) are indicative of low endogenous permeability of the 
COX containing vesicles to protons.  
  
Turnover Induced Inactivation 
 When COX, from R. sphaeroides, is reconstituted into a phospholipid vesicle, and 
is allowed to undergo catalytic turnover for several thousand to several million cycles it 
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begins to lose activity, a phenomenom known as suicide inactivation or turnover induced 
inactivation.  While the wild-type COX is fairly resistant to this process, turnover 
induced inactivation occurs rapidly in I/II oxidase and some mutants of COX.  Electron 
transfer rates were measured using a Clark-type oxygen electrode and using the assay 
conditions described above.  To determine the severity of the inactivation process, COX 
containing vesicles were allowed to turnover in the presence of the membrane potential 
and pH gradient for various time points from 0 to 10 minutes and were then uncoupled by 
the addition of Val and CCCP.  Electron transfer rates for the 0 time point represented the 
maximum rate of electron transfer, or 0% inactivated.  Electron transfer rates for the 
remaining time points were compared to the maximum rate, and calculated as a 
percentage of inactivation over time.  
 
Proton translocation and Proton Pumping Stoichiometries 
Proton translocation activity of COX containing vesicles was measured on an 
Applied Photophysics SX.18MV Stopped-Flow Reaction Analyser.  Assays were 
performed at 4 and 8 turnovers.  For these experiments two samples were prepared:  a 
COX containing vesicle sample and a reduced cytochrome c sample.  The COX 
containing vesicle sample contained 50 µM HEPES-NaOH, pH 7.4, 50 mM KCl, 50 mM 
sucrose, 100 µM phenol red, 0.1 µM aa3, and 5 µM Val or 5 µM Val and 5µM CCCP.  
The cytochrome c containing sample contained 50 µM HEPES-NaOH, pH 7.4, 50 mM 
KCl, 50 mM sucrose, 100 µM phenol red, 3.2 µM (4 turnovers) or 6.4 µM (8 turnovers) 
reduced cytochrome c (type IV), and 5 µM Val or 5 µM and 5µM CCCP.  Reduced 
cytochrome c was prepared by reducing Type IV cytochrome c (Sigma) with sodium  
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Figure 15 
 
Schematic Representation of COX Reconstituted into a Phospholipid Vesicle. (Top) 
In the presence of valinomycin the membrane potential is dissipated and potassium ions 
can reenter the interior of the vesicle.  Proton pumping is monitored with phenol red on 
the outside of the vesicle.  As protons are pumped to the outside there is a net 
acidification, which is seen as a decrease in absorbance at 556 nm.  (Bottom)  In the 
presence of both valinomycin and CCCP both the membrane potential and proton 
gradient are dissipated.  As a result both potassium ions and protons are capable of 
reentering the interior of the vesicle.  The protons that enter the vesicle go towards the 
production of water, which results in a net alkalization on the outside.  This is process is 
also monitored with phenol red and is shown as an increase in absorbance at 556 nm.  
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dithionite and then loading the sample onto a Sephadex G-25 column in order to separate 
the dithionite away from the cytochrome c (Wilson and Prochaska 1990).  Fractions were 
then analyzed by optical spectroscopy to ensure full reduction of the heme.  The samples 
were adjusted to the same pH, within .005 pH units, and then loaded into the sample 
handling unit of the stopped flow instrument.  The reactions were initiated by pressing an 
external trigger, which allowed millisecond mixing of the two samples.  Proton pumping 
activity was determined by monitoring the absorbance changes of the pH sensitive dye, 
phenol red, at 556 nm (Figure 15).  There is an increase in absorbance in the presence of 
Val and CCCP, indicating alkalinization.  This is due to both the membrane potential 
being dissipated by Val and the proton gradient being dissipated by the CCCP.  This 
results in proton consumption for water production by COX.  There is a decrease in 
absorbance in the presence of Val, indicating acidification.  This is due to only the 
membrane potential being dissipated, while the proton gradient is still intact.  As a result 
potassium ions move into the intravesicular space allowing protons to be pumped to the 
outside, by COX.  By comparing the net absorbance changes for each phase, proton to 
electron stoichiometries (H+/e- ratios) were determined.   
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III. Results 
 
Previous work has shown that removal or genetic deletion of SIII from P. 
denitrificans or R. sphaeroides COX leads to an enzyme which exhibits irreversible 
inactivation of electron transfer after several thousand catalytic cycles of oxygen 
reduction (Haltia et al. 1994; Bratton et al. 1999; Hosler 2004; Mills and Hosler 2005), a 
phenomenom that will be referred to as turnover-induced inactivation.  In addition, 
removal of SIII from bovine mitochondrial COX results in inhibition of steady-state 
electron transfer activity (Wilson and Prochaska 1990; Nguyen et al. 2002).   
The role of SIII in stabilization of the quaternary structure of COX was examined 
using energy minimization, limited proteolysis, and mass spectrometry to determine the 
structural consequences of SIII removal in COX from R. sphaeroides.   
 
Energy Minimization of Rhodobacter sphaeroides COX  
SIII was first removed from COX in silica using the Swiss Protein Data Bank 
Viewer (SPDBV) and then the structure of the SIII-deficient COX was examined using 
energy minimization with the Sybyl software suite.  This work was done in collaboration 
with Sudhir Patel in our laboratory.  Figure 16 shows the energy minimized structures of 
three subunit wt (Figure 16A) and two subunit I/II oxidase (Figure 16B), after 520 
iterations of minimization.  Originally, 700 iterations were used for the energy 
minimization; however, the simulation of I/II oxidase was prematurely terminated due to 
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large changes in energy.  No difference in structure between the three subunit and four 
subunit wt enzyme (at 520 iterations) was observed (data not shown); therefore the three 
subunit wt COX was used for subsequent calculations.  Subunits I and II were aligned in 
the presence and absence of SIII, using the three different methods described in Materials 
and Methods.  Removal of SIII had no effect on the structure of SII, conversely, some α-
carbon atoms of amino acids within transmembrane helices of SI adjacent to SIII changed 
positions between approximately 0.5 and 2.2 Å (Figure 16C).  More specifically, 
transmembrane helices (3-7) of SI were displaced outward in the absence of SIII in I/II 
oxidase, as a result SI in I/II oxidase appears to have a more open conformation.  Table II 
summarizes the amino acid residues which underwent the largest changes in position in 
I/II oxidase.  D-channel residues D132, M133, P136, and S197 had the largest changes in 
position (1.24-2.28 Å) and other D-channel residues N139, G198, and G204 also changed 
position about 1 Å.   In contrast, K-channel residues, E101II (SII) and K362, did not 
undergo significant changes in position.  Since the energy minimized structure of I/II 
oxidase appears to have a more open conformation it seemed likely that this observation 
could be tested using limited proteolysis.   
Since there are two methods for generating I/II oxidase from R. sphaeroides it 
was necessary to determine whether or not the two forms of the enzyme were structurally 
and functionally equivalent.  If these two forms of I/II oxidase were not structurally and 
functionally equivalent it would be necessary to determine which form of the enzyme 
should be used in the structural studies and subsequent functional work.  
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Figure 16 
 
Energy Minimized Structures of Rhodobacter sphaeroides COX.     
Structures for the three subunit COX (A), two subunit COX (B), and alignment of the 
energy minimized SI from three subunit (red) and two subunit (green) COX (C) are 
shown.  Energy minimization of three subunit and two subunit COX was performed by 
Sudhir Patel. 
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Table II 
 
List of K-channel and D-channel Residues and the Distances Moved During 
Energy Minimization 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
a  Average Distance is represented as α-carbon movement in Angstroms between wt and 
I/II oxidase SI amino acid residues, using the three methods of alignment described in 
Materials and Methods.  A move greater than 1.0 Angstroms was considered a large 
change.      
 
 
 
 
 
 
 
 
 
 
Residue Average Distancea 
E101II 0.19 + 0.11 
K362 0.15 + 0.13 
D132 1.3 + 0.16 
M133 1.24 + 0.16 
P136 2.28 + 0.17 
N139 1.07 + 0.14 
S197 1.60 + 0.13 
G198 1.04 + 0.12 
G204 1.08 + 0.17 
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Growth and Purification of Genetically Deleted SIII Cytochrome c Oxidase 
 When SIII is genetically deleted from COX and grown aerobically, the R. 
sphaeroides bacteria exhibit the same growth properties as the wt bacteria and the 
expression levels of COX (ie. milligram protein / gram cell weight) also appeared 
unaffected.  However, the reduced α-peak of heme aa3 of the enzyme eluted from the 
nickel column is shifted by 6 nm to 600 nm as compared to 606 nm in wt COX.  This 
shift in absorbance is due to the fact that there is a considerable amount of free subunit I 
present in the membrane preparations.  Free subunit I has a characteristic absorption 
maximum at 600 nm and is copurified with the assembled I/II oxidase because it also 
contains a poly-histidine tag at the C-terminus of SI; however, it lacks SII.  The free 
subunit I can be purified away from I/II oxidase through the use of ion exchange 
chromatography, on a high affinity DEAE sepharose column.   
 Figure 17 shows an elution profile of wt and genetically deleted SIII I/II oxidase 
(I/IIGD), at 280 nm (Figure 17A) and 420 nm (Figure 17B), from the DEAE column.  The 
heme containing peaks that appear early in the elution profile, fractions 7-20, all contain 
free subunit I, which was further confirmed by SDS-Urea-PAGE (Figure 18A and 18B).  
Lanes 2 and 3 from Figure 18A, which correspond to fractions 9 and 12, illustrate this 
point well, since it is clear that there is no SII or SIII present in these lanes.  The gels in 
Figure 18A and 18B also demonstrate that only the fractions from the right-hand side of 
the final heme containing elution peak contain pure COX, fractions 37-44 (Figure 18A 
lanes 5-13) for wt and fractions 43-48 (Figure 18B lanes 15-20) for I/IIGD oxidase.  While 
this reduces the final yield of the enzyme, SDS-Urea-PAGE shows that this yields  
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Figure 17 
 
FPLC Elution Profile of wild-type and I/IIGD oxidase. 
Prior to loading COX, onto the high affinity ion exchange DEAE sepharose column, the 
buffer was exchanged to 10 mM KH2PO4, pH 7.8, and 1 mM EDTA in a Centricon-30 
centrifugal filter devices. DM was added to a final concentration of 3%.  The sample was 
then incubated on ice for 15 minutes and then centrifuged for 15 min at 13,400 rpm in a 
microcentrifuge at 4°C.  The FPLC column used was a Tricorn 10/100 (GE Healthcare), 
which has an inner diameter of 10 mm and length of 100 mm, and was packed with the 
anion exchange resin DEAE-5PW (TosoHaas).  The sample was loaded into a sample 
loop and applied to the FPLC column which was then run on a Pharmacia LKB FPLC 
system.  The column was preequilibrated with 10 mM KH2PO4, pH 7.8, 1 mM EDTA, 
0.1% DM, and the oxidase was eluted with a 45-ml gradient of 0.01–0.35 M KCl in the 
same buffer at a flow rate of 0.5 ml/min (Gradient shown in black).  A.  Elution profile of 
wild-type and I/II oxidase measured at 280 nm (blue and red, respcectively).  B.  Elution 
profile of wild-type and I/II oxidase measured at 420 nm (blue and red, respcectively). 
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Figure 18 
 
SDS-Urea-PAGE of wild-type and I/IIGD Peak Fractions. 
A small volume (10 µL) of each fraction was removed and run out on 16% SDS-Urea 
gels (Fuller et al. 1981).  Pure COX containing fractions were pooled and the 
concentration was determined by measuring the absorbance at 606 nm. 
A. Lane 1: wild-type purified on nickel column, lane 2: fraction 9, lane 3: fraction 12, 
lane 4: wild-type purified on nickel column, lanes 4-13: fractions 36-44, respectively 
B.  Lane 1: wild-type FPLC pure, lanes 2-8: fractions 32-37, respectively, lane 9: wild-
type FPLC pure, lanes 10-20: fractions 38-48, respectively, lane 21: I/II oxidase nickel 
column purified.  
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extremely pure COX (Figure 18B, lanes 15-20).  Purity can be measured by determining 
the heme to protein ratio, and while this was not performed, the SDS-Urea-PAGE result 
shows that the FPLC purifed fractions (Figure 18B, lanes 15-20) do not contain any 
protein bands except for SI and SII.  In the literature, it has been shown that after the 
FPLC purification the α-peak of heme aa3 reverts back to 606 nm (Bratton et al. 2000); 
however, in this preparation the α-peak remains shifted by 4 nm to 602 nm, indicating 
that the active site is perturbed in I/IIGD oxidase, a result that will be addressed in the 
discussion.  I/IIBD is made by depleting the the wt enzyme of SIII, using the nonionic 
detergent TX-100.  The resulting I/II oxidase has an α-peak of heme aa3 maximum of 
606 nm.  The spectral properties of I/IIGD and I/IIBD were initially characterized and 
subsequent analysis of subunit content was performed prior to the functional 
characterization of the enzymes. 
      
Subunit Composition of I/IIBD and I/IIGD 
 Subunit content of wt and the two preparations I/II oxidase were monitored by 
SDS-Urea-PAGE.  Figure 19 shows a gel containing FPLC purified wt enzyme (lane 1), 
I/II that was biochemically depleted of SIII (I/IIBD) and purified using the nickel agarose 
column (lane 2), and FPLC purified I/IIGD oxidase (lane 3).  Subunits I, II, and III are all 
present in the wt enzyme, while only subunits I and II are present in the two different 
preparations of I/II oxidase.  Occasionally SIV can be visualized on the gel, but because  
of the size (5,273 Da) this subunit often times runs off the gel, or is present in quantities 
 
too small to be detected by Coomassie staining.  The presence of SIV has been confirmed 
by MALDI-TOF mass spectrometry in the wt enzyme (Distler et al. 2004).  MALDI-TOF  
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Figure 19 
 
SDS-Urea-PAGE of wild-type, I/IIBD, and I/IIGD.  
Approximately 4 µg of wild-type, I/IIBD, and I/IIGD R. sphaeroides COX were run on a 
16% SDS-Urea-PAGE gel and stained with Bio-Safe Coomassie.  Lane 1 is wild-type 
enzyme that has been FPLC purified, lane 2 is I/IIBD that was purified on a nickel 
column, as described in Materials and Methods, and Lane 3 is I/IIGD that has been FPLC 
purified.  Wild-type enzyme contains all three subunits and both preparations of I/II 
oxidase contain only subunits I and II.  
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Figure 20 
 
MALDI-TOF Mass Spectrometry Showing the Presence and Absence of SIV in 
wild-type, I/IIBD, and I/IIGD. 
Wild-type, I/IIBD, and I/IIGD oxidase were diluted with 30 mM Tris-Cl, pH 7.4 and 
concentrated down to a minimal volume (< 10 µL) in a Microcon-30.  The samples were 
then brought up to a concentration of 1 µg/µL.  1 µL of each sample was mixed with the 
EAM CHCA and then pipetted onto a Ciphergen Gold chip.  The gold protein chip was 
then loaded into a Ciphergen SELDI Protein Biology System II (Ciphergen, Palo Alto, 
CA) and analyzed.  Each spot was ionized 3 to 5 times over different areas within the 
spot.  Fifty laser hits were averaged for each area on the spot.  This resulted in a mass 
profile for each sample.  The spectra were then externally calibrated using mass standards 
from Ciphergen.  A. wild-type, B. I/IIBD, C. I/IIGD 
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has also been used to show that SIV is present in I/IIBD; however, SIV is absent in I/IIGD 
(Figure 20).  Based on spectral properties and subunit content it appeared that I/IIGD and 
I/IIBD were not equivalent.  The shift in heme aa3 absorbance, in I/IIGD, will probably 
affect the steady state activity of I/IIGD, as compared to wt and I/IIBD.  The function of 
SIV is unknown; therefore, it is also unknown how this could affect the function of I/IIGD.  
Functional characterization of the wt, I/IIBD, and I/IIGD COX was performed by 
measuring the maximum electron transfer activity of dodecyl maltoside (DM) detergent 
solubilized enzyme.   
           
Steady-State Electron Transfer Activity of I/IIBD and I/IIGD 
 The maximum turnover numbers (also referred to as Vmax) for wt, I/IIBD, and 
I/IIGD were measured in the oxygen electrode (Figure 21).  The DM-solubilized wt 
enzyme has a high turnover number of approximately 1,400 s-1, which is about 2-3 fold 
faster than the bovine enzyme.  However, the rate of the detergent solubilized enzyme 
can vary from 1,000 to1,500 s-1 depending on the enzyme preparation being used.  I/IIBD 
has a maximum turnover number of about 1,000 s-1, which is comparable to the wt 
enzyme.  However, in the absence of SIII this enzyme begins to undergo turnover 
induced inactivation, which was mentioned at the beginning of this section.  On the other 
hand, I/IIGD oxidase has a maximum turnover number of about 320 s-1, which corresponds 
to a reduction in Vmax of 75-80% when compared to I/IIBD and wt, respectively.  
Furthermore, I/IIGD oxidase also displays the turnover induced inactivation phenotype. 
Functionally it was evident that the two forms of I/II oxidase were not equivalent; 
however, it was unclear what could account for this large change in Vmax.   
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Figure 21 
 
Determination of Maximum Turnover Numbers for wild-type, I/IIBD, and I/IIGD.   
The maximum electron transfer activity of detergent solubilized COX was measured 
using a Clark oxygen electrode.  In the absence of enzyme, ascorbate (18 µM), 
cytochrome c (type III) (20-40 µM), and 0.6 mM TMPD were incubated in 25 mM 
HEPES-NaOH, pH 7.0, with 0.1% DM at 25°C in the electrode chamber for 3 minutes.  
This allows the rate of cytochrome c auto-oxidation to be measured.  Then 5-10 pmoles 
of COX was added to determine the maximum rate of COX electron transfer activity for 
3 minutes.  The assays were also done under the same conditions as described above 
except that 1 mg/mL asolectin was added to the assay buffer, prior to adding the enzyme.  
The graph depicts the detergent solubilized Vmax for wt, I/IIBD, and I/IIGD in the absence of 
exogenous lipid (black) and wt, I/IIBD, and I/IIGD in the presence of exogenous lipid 
(gray).  The data presented is from multiple assays of one preparation of enzyme.     
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FPLC purification may delipidate I/IIGD oxidase of all but one lipid molecule (personal 
communication, Dr. Jon Hosler).  If the enzyme was being delipidated during purification 
then the addition of exogenous lipids to the enzyme should stimulate the electron transfer 
activity to the level of I/IIBD oxidase.  This possibility was examined by adding 
exogenous lipids into the assay buffer and determining the Vmax of each enzyme.  Figure 
21 shows that in the presence of exogenous lipids (gray bars) the Vmax of I/IIGD is 
increased by 40% to 550 s-1 , which is still about a 50% reduction in electron transfer 
activity compared to wild-type or I/IIBD enzymes.  Figure 21 also shows that the same 
level of stimulation in activity (35-40%) was also observed in wild-type and I/IIBD 
enzymes, thus suggesting that there must be another explanation for the reduction in 
activity displayed by I/IIGD.  Since the electron transfer activity of wild-type and I/IIBD 
was comparable it was decided to use I/IIBD as the model enzyme when assessing the 
structural consequences of SIII removal from COX, using limited proteolysis.  However, 
since the activity of I/IIGD is severely inhibited, it was used to monitor the solution 
structure of this enzyme to test if the structural changes in the enzyme could account for 
the decrease in electron transfer activity. 
 
Limited Proteolysis of COX Using α-Chymotrypsin 
 One of the goals of this thesis was to investigate the role of SIII in COX structure.  
One method that has been used to assess conformation in proteins is limited proteolysis 
(Keil, 1992).  Limited proteolysis of wt and SIII deficient forms of COX was performed 
by dispersing the enzymes in the non-denaturing detergent, DM, and then treating the 
enzymes with the protease α-chymotrypsin.  Figure 22A shows the digestion of wt and 
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Figure 22 
 
SDS-Urea PAGE of Wild-type and I/II Oxidase Digested with α-chymotrypsin.  
All procedures were as described in the Experimental Procedures.  In part A, protein 
content between wt and I/II oxidase was normalized by heme concentration (2µM).  
The lanes on the gel are: 1, wt and 2, I/II oxidase (untreated controls);  3, wt and 4 I/II 
oxidase (after 1 h of treatment with α-chymotrypsin); 5, wt and 6, I/II oxidase (2 h); 
and 7, wt, and 8, I/II oxidase (3 h).  In part B, protein content was normalized by 
protein concentration (0.2 µg/µL).  The lanes on the gel are: 1, wt and 2, I/II oxidase 
(untreated controls); 3, wt and 4, I/II oxidase (after 1 h of treatment with α-
chymotrypsin); 5, wt, and 6, I/II oxidase (2 h), and 7, wt and 8, I/II oxidase (3 h).  The 
symbol (* ) indicates the migration of α-chymotrypsin. 
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I/IIBD oxidase using equivalent heme concentration with the same amount of α-
chymotrypsin.  After 1 hour of treatment, two new protein bands were generated from SI: 
subunit I’ (SI’) and subunit I’’ (SI’’), in both wt and I/IIBD.  Quantitation of the protein 
bands was performed using scanning densitometry and showed that after 3 hours, wt 
oxidase contained approximately equal amounts of SI’ and SI’’, while I/IIBD oxidase had 
at least 65% of SI digested to SI’’, suggesting that I/II oxidase is more labile to 
proteolysis by α-chymotrypsin. 
A limitation of using equivalent heme concentration to milligram α-chymotrypsin 
ratio, shown in Figure 22A, is that there is less total protein in I/II oxidase due to the 
absence of SIII.  Thus, the enzyme to protease ratio would be greater than 1:10 for I/II 
oxidase, which could cause a false increase in the rate of digestion observed in I/IIBD 
oxidase.  To ensure that the ratio of enzyme to protease was constant for both enzyme 
preparations, equal amounts of total protein of wt and I/IIBD oxidase were digested 
(Figure 23B).  Figure 22B shows results similar to Figure 22A.  After 1 hour of 
treatment, all of SI was digested to either SI’ or SI’’ in wt and I/IIBD oxidase.  However, 
there was 25% more SI’’ in I/IIBD oxidase compared to wt.  After 2 hours, wt had 35% 
more SI’ compared to SI’’ and I/IIBD oxidase had equivalent amounts of SI’’ compared to 
SI’.  After 3 hours, wt oxidase had about equal amounts of SI’ and SI’’, however, 70% of 
I/IIBD oxidase had been reduced to SI’’.  Thus, the rate of digestion of SI in I/IIBD oxidase 
was faster than wt enzyme and the proteolytic products (ie. SI’ and SI’’) of wt and I/IIBD 
oxidase were similar in size.  It should be emphasized that although the experiments, with 
wild-type and I/IIBD, were carried out at pH 9.0, similar cleavage patterns of SI to SI’ and 
SI’’ were obtained in wt and I/IIBD oxidase dispersed in DM at pH 8.0, although the 
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kinetics of the digestion were slowed (data not shown).  It should also be mentioned that 
the sum of the band intensities from SI’ and SI’’ is equal to the band intensity of 
undigested SI, which further demonstrates that the proteolysis taking place is limited and 
specific, in both wt and I/IIBD oxidase.  If the solution structure of I/IIGD is different than 
wt and/or I/IIBD then the proteolytic cleavage pattern of I/IIGD should be different.   
Figure 23 shows the same experiment as shown in Figure 22B except that wt, 
I/IIBD, and I/IIGD were digested for one and three hours with α-chymotrypsin.  While the 
proteolytic patterns for wt and I/IIBD are the same as in Figure 22B the proteolytic 
patterns seen in I/IIGD are quite different.  After just one hour, I/IIGD has undergone 
extensive digestion as evidenced by the smeared appearance in lane 6, and nearly 50% of 
the total intensity has been lost.  SI’ and SI’’ are formed, but at quantities much smaller 
than what was shown for wt or I/IIBD.  After 3 hours there is little evidence of SI’ being 
present and only a small fraction of SI’’ present, which accounts for about 30% of the 
original intensity.  Compared to wt and I/IIBD there is evidence that there is a large 
fraction of I/IIGD oxidase that is in an alternative conformation.  Taking the functional 
and structural data together it is thought that this fraction of enzyme in a presumably 
alternative conformation is most likely inactive.  Support for this observation will be 
provided later in this section and possible explanations for these differences will be 
addressed in the discussion.  Taken together, the data from Figures 22 and 23 suggest that 
wt COX that has been biochemically depleted of SIII (I/IIBD) is the best model of I/II  
oxidase and subsequent experiments performed in this thesis used I/IIBD oxidase, which 
will now be referred to as I/II oxidase.         
The limited proteolysis data suggest that the conformation of SI is changed in the 
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Figure 23 
 
SDS-Urea-PAGE of wild-type, I/IIBD, and I/IIGD  After Being Digested with α-
Chymotrypsin.   
Approximately 4 µg of wild-type, I/IIBD, and I/IIGD R. sphaeroides COX were digested 
with a 1:10 ratio (w/w) of α-chymotrypsin and run on a 16% gel and stained with Bio-
Safe Coomassie.  Lane 1 is wild-type enzyme that was not treated with α-chymotrypsin, 
lane 2 is I/IIBD that was not treated with α-chymotrypsin, Lane 3 is I/IIGD that was not 
treated with α-chymotrypsin, lane 4 is wild-type enzyme that was treated with α-
chymotrypsin for 1 hour, lane 5 is I/IIBD that was treated with α-chymotrypsin for 1 hour, 
Lane 6 is I/IIGD that was treated with α-chymotrypsin for 1 hour, Lane 7 wild-type 
enzyme that was treated with α-chymotrypsin for 3 hours, lane 8 is I/IIBD that was treated 
with α-chymotrypsin for 3 hours, Lane 9 is I/IIGD that was treated with α-chymotrypsin 
for 3 hours, and lane 10 α-chymotrypsin control. 
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absence of SIII, and that this conformational change causes SI to become more labile to 
proteolytic digestion by α-chymotrypsin.  However, it is not clear whether new cleavage 
sites were exposed in the absence of SIII or the same sites were digested in I/II oxidase at 
a faster rate.   Therefore, it was necessary to identify the proteolytic cleavage sites in SI 
that lead to the generation of SI’ and SI’’ in wt and I/II oxidase. 
 
N-terminal Sequencing of SI and SI’’   
 To identify the α-chymotrypsin cleavage site at the N-terminus, wt and I/II 
oxidase were run on SDS-PAGE in gels without urea, transferred to a PVDF membrane, 
and stained.  Protein bands corresponding to undigested SI and the proteolytic fragment 
SI’’ were excised and submitted for N-terminal amino acid sequencing.  The predominant 
sequence obtained from each protein band is shown in Table III.  The N-terminus of SI 
from wt and I/II oxidase is Ala2, which is the second amino acid from the DNA sequence 
of COX SI.  The N-terminal amino acid of SI encoded by the DNA sequence is a Met 
residue (Shapleigh and Gennis 1992); however, (Distler et al. 2004)) showed with mass 
spectrometry that preparations of R. sphaeroides COX SI have the N-terminal Met 
removed.  SI’’ from both preparations has Gly8 as the N-terminal amino acid, which 
meant that α-chymotrypsin cuts on the C-terminal side of His7, which has been shown 
previously for water soluble proteins (Keil 1992).  Furthermore, SI’’ from I/II oxidase 
also had two minor sequences that began with residues Phe16 and Phe17.  Based on the 
sequencing data it appeared that the N-terminus of I/II oxidase is more flexible and 
perhaps the phenylalanines, in I/II oxidase, are more solvent exposed in the absence of 
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Table III 
 
N-terminal Amino Sequencing of Subunit I and its α-chymotrypsin Cleavage Products 
from Rhodobacter sphaeroides Cytochrome c Oxidase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
G8HEHDRRGFFT18 I/II SI``
G8HEHDRRGFFT18 wt SI`` 
A2DAAIHGHEHD12 I/II SI 
A2DAAIHGHEHD12 wt SI 
N-terminal Sequence  Species 
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SIII.  The next step in identifying the cleavage sites was to address possible cleavage at 
the C-terminus. 
 
Identification of the Cleavage Sites at the C-terminus of SI  
   Wt and I/II oxidase both contain a poly-histidine tag (six residues) at the C-
terminus of SI.  Using a nickel-activated derivative of horseradish peroxidase that is 
specific for the poly-histidine tag, it was possible to determine if the tag was retained on 
SI’ or SI’’ and thus, if the C-terminus of SI was cleaved.   
Figure 24 shows a transfer of SDS-Urea PAGE α-chymotrypsin treated wt and I/II 
oxidase, to a PVDF membrane, using the same digestion conditions as shown in Figure 
22B and developed with a nickel-activated HRP.  Untreated SI from wt and I/II oxidase 
are shown in lanes 1 and 2, respectively.  After 1 hour (lanes 3 and 4), greater than 90% 
of the poly-histidine tag signal, on SI, was removed in wt and I/II oxidase.  This 
demonstrated that the poly-histidine tag was rapidly removed from SI during proteolysis.  
Additionally, a small (less than 5%), but measurable signal was retained in wt oxidase 
after 2 hours (lane 5) and 3 hours (Lane 7); however, the signal was completely lost in 
I/II oxidase (Lanes 6 and 8) at the same time points.  Therefore, a cleavage event at the 
C-terminus occurs extremely rapidly and results in the loss of the poly-histidine tag.  
However, there was some uncertainty as to the specific location of the cleavage event, 
since there are several aromatic residues at the C-terminus of SI. 
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Figure 24 
 
Detection of the C-Terminal Poly-Histidine Tag on SI of COX and I/II Oxidase 
Before and After Proteolysis with α-chymotrypsin.   
Wild-type and I/II oxidase were digested using a 1:10 enzyme to protease ratio for 1, 
2, and 3 hours.  Each lane was loaded with 3 µg of total protein.  The lanes on the gel 
are:  1, wt, and 2, I/II oxidase (untreated controls), 3, wt and 4, I/II oxidase (after 1 h 
of treatment with α-chymotrypsin); 5, wt, and 6, I/II oxidase (2 h), and 7, wt and 8, 
I/II oxidase (3 h).  The polyhistidine tag was detected by using Ni2+-horse radish 
peroxidase as described in Experimental Procedures. 
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In-Gel Tryptic Digests of SI, SI’, and SI’’ 
 Further characterization the proteolytic cleavage sites at the C-terminus of SI was 
examined using exhaustive in-gel tryptic digests of undigested SI and the α-chymotrypsin  
products SI’ and SI’’.   Proteolysis was performed as described in Figure 22 and SI, SI’, 
and SI’’ were separated by SDS-Urea-PAGE.  The gels were then stained with Bio-Safe 
Coomassie and the bands of interest were excised, completely destained, and subjected to 
exhaustive in-gel tryptic digests.  
Figure 25 shows that the peptide at the C-terminus had a mass of 1,420 and 
corresponded to residues 563-574, which includes the poly-histidine tag.  This peptide is 
not present in the spectrum of SI’ (Figure 25, panel C and D) or SI’’ (data not shown), 
which further confirms the result from the histidine tag detection experiment.  Figure 26 
shows an additional peptide identified in the spectrum of wt and I/II oxidase which has a 
mass of 3,767 and corresponded to residues 525-556.  This peptide was present in the 
spectrum of SI’ of wt and I/II oxidase (Figure 26 C and D), but was absent in the 
spectrum of SI’’ (Figure 26 E and F).  This suggested that the formation of SI’’ involved 
the cleavage of an amino acid in the region of residues 525-556.  The data thus far has 
extensively examined the cleavage events at the N and C-termini; however, there is a 
possibility that some peptides were not detected.  This could be attributed to low 
abundance of the peptides or that some peptides are insoluble because of the amino acid 
composition.  To address these limitations, MALDI-TOF experiments were performed to 
determine the absolute molecular weights of SI' and SI''.  Using this information in 
conjunction with the previous data will provide a detailed map of the cleavage sites in SI, 
in the presence and absence of SIII.  
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Figure 25 
 
In Gel Tryptic Digest of Undigested SI and SI’.   
After staining of the gel with Bio-Safe Coomassie, the bands containing the full 
length subunit I or the chymotrypsin fragment of interest were excised from the gel and 
completely destained in 50 mM ammonium bicarbonate in 40% ethanol, then washed 
with 25 mM ammonium bicarbonate, and then cut into small pieces <1 mm3.  The gel 
pieces were then dehydrated with acetonitrile and dried in a SpeedVac (Eppendorf 
Vacufuge) (van Montfort et al. 2002).  Tryptic digestion was initiated with the addition of 
750 ng trypsin stock.  After reswelling of the dehydrated gel pieces, a 40 µL overlay of 
100 mM ammonium bicarbonate was added.  The protein was digested for a minimum of 
14 hours at 30ºC.  The digested gel pieces were sonicated and the overlay was then 
collected.  Further extraction of peptides was performed by adding 30 µL of 60% 
acetonitrile, 1% TFA, 0.1% octyl-β-glucopyranoside (OBG) to the gel pieces, sonicating, 
and collecting the extract overlay.  This was repeated one time.  The overlay fraction and 
extract fractions were dried in a SpeedVac (van Montfort et al. 2002).  The dried overlay 
and extract samples were dissolved in 5 µL of 50% acetonitrile, 0.1% TFA, and 
sonicated.  Aliquots of 1.0 µL were applied to the Ciphergen protein chip target.  0.5 µL 
of saturated CHCA dissolved in 50% ethanol or alternatively CHCA plus 10% formic 
acid was added to and mixed.  The chip was then loaded into a Ciphergen SELDI Protein 
Biology System II (Ciphergen, Palo Alto, CA) and analyzed.  Fifty laser hits were 
averaged for each area on the spot.  This resulted in a mass profile for each sample.  The 
spectra were then externally calibrated using mass standards from Sigma.                        
Panel A is wild-type SI exhaustively digested with trypsin.  Panel B is I/II oxidase SI 
exhaustively digested with trypsin.  Panel C is wild-type SI' exhaustively digested with 
trypsin.  Panel D is SI' exhaustively digested with trypsin.  A peptide corresponding to 
the C-terminus (residues 563-574) was detected in the trypsin digested  SI, but was 
absent in the tyrpsin digested SI’. (*) denotes peaks that were assigned to trypsin which 
underwent autoproteolysis. 
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Figure 26 
 
MALDI-TOF Mass Spectroscopy of an Internal Peptide From Exhaustive In-Gel 
Trypsin Digest.    
After staining of the gel with Bio-Safe Coomassie, the bands containing the full 
length subunit I or the chymotrypsin fragment of interest were excised from the gel and 
completely destained in 50 mM ammonium bicarbonate in 40% ethanol, then washed 
with 25 mM ammonium bicarbonate, and then cut into small pieces <1 mm3.  The gel 
pieces were then dehydrated with acetonitrile and dried in a SpeedVac (Eppendorf 
Vacufuge) (van Montfort et al. 2002).  Tryptic digestion was initiated with the addition of 
750 ng trypsin stock.  After reswelling of the dehydrated gel pieces, a 40 µL overlay of 
100 mM ammonium bicarbonate was added.  The protein was digested for a minimum of 
14 hours at 30ºC.  The digested gel pieces were sonicated and the overlay was then 
collected.  Further extraction of peptides was performed by adding 30 µL of 60% 
acetonitrile, 1% TFA, 0.1% octyl-β-glucopyranoside (OBG) to the gel pieces, sonicating, 
and collecting the extract overlay.  This was repeated one time.  The overlay fraction and 
extract fractions were dried in a SpeedVac (van Montfort et al. 2002).  The dried overlay 
and extract samples were dissolved in 5 µL of 50% acetonitrile, 0.1% TFA, and 
sonicated.  Aliquots of 1.0 µL were applied to the Ciphergen protein chip target.  0.5 µL 
of saturated CHCA dissolved in 50% ethanol or alternatively CHCA plus 10% formic 
acid was added to and mixed.  The chip was then loaded into a Ciphergen SELDI Protein 
Biology System II (Ciphergen, Palo Alto, CA) and analyzed.  Fifty laser hits were 
averaged for each area on the spot.  This resulted in a mass profile for each sample.  The 
spectra were then externally calibrated using mass standards from Sigma.                        
Panels A is wild-type SI exhaustively digested with trypsin.  Panel B is I/II oxidase SI 
exhaustively digested with trypsin.  Panel C wild-type SI' exhaustively digested with 
trypsin.  Panel D is I/II oxidase SI' exhaustively digested with trypsin.  Panel E is wild-
type SI'' exhaustively digested with trypsin.  Panel F is I/II oxidase SI'' exhaustively 
digested with trypsin.  A peptide corresponding to the amino acid residues 525-556 was 
detected in the trypsin digested SI and SI', but was absent in the tyrpsin digested SI’'.  (*) 
denotes peaks that were assigned to trypsin which underwent autoproteolysis. 
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MALDI-TOF of the High Molecular Weight Species SI, SI’, and SI’’ 
Preliminary experiments showed that by using the EAM SPA it was possible to 
accurately determine the molecular weight of SI.  Therefore, it is likely that the masses of 
SI’ and SI’’ could also be determined using MALDI-TOF mass spectrometry.  Wt and 
I/II COX were digested with α-chymotrypsin at a ratio of 1:10 for 0, 1, and 3 hours and 
were then analyzed in the mass spectrometer.  Figure 27 shows the mass spectra of wt 
and I/II oxidase after 0, 1, and 3 hours of digestion with α-chymotrypsin and Table IV 
summarizes the mass of the peaks and amino acid composition of each peak that was 
identified for each time point.  At 0 hours there is no proteolytic digestion and all that is 
seen is full length SI at 64,000 m/z, for wt and I/II oxidase (Figure 27 A and 27 B, 
respectively).  After 1 hour the wt peak at 64,000 is no longer present, but a new peak at 
62,756 formed, as well as another peak at 58,094 (Figure 27 C).  The peaks at 62,756 and 
58,094 represent SI’ and SI’’, respectively.  I/II oxidase, after 1 hour, had slightly 
different peak distribution with SI’ being assigned to a peak at 62,053 and SI’’ being 
assigned to 57,633 (Figure 27 D).  After 3 hours of digestion the peaks in the wt spectra 
shifted slightly with peaks at 62,524 and 57,633 (Figure 27 E).  The loss of an additional 
1 to 3 amino acids at either the N or C terminus could explain the change in mass for the 
peak at 62,524.  Further digestion at the C-terminus accounts for the change in mass in 
the peak at 57,633.  In contrast, the 3 hour time point with I/II oxidase showed more 
pronounced changes with peaks being identified at 60,962 and 56,587 (Figure 27 F).  
Based on the changes in mass there is more extensive cleavage at the N-terminus both SI’ 
and SI’’, while the cleavage at the C-terminus resembled that of wt.  The detergent 
solubilized solution structures of wt and I/II oxidase are slightly different, which is a  
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Figure 27 
 
MALDI-TOF Mass Spectra of wt and I/II oxidase Digested with α-chymotrypsin for 
1 and 3 hours.   
Wild-type and I/II oxidase were diluted with 30 mM Tris-Cl, pH 8.8 and 
concentrated down to a minimal volume (< 10 µL) in a Microcon-30.  The samples were 
then brought up to a concentration of 1 µg/µL.  α-chymotrypsin was added at a ratio of 
1:10 and the reactions were allowed to proceed at room temperature for 1 and 3 hours.  
At the end of each time point 1 µL of sample was removed and mixed with the EAM 
SPA with 0.25% TFA and spotted onto a gold chip from Ciphergen.  The gold protein 
chip was then loaded into a Ciphergen SELDI Protein Biology System II (Ciphergen, 
Palo Alto, CA) and analyzed.  Each spot was ionized 3 to 5 times over different areas 
within the spot.  Fifty laser hits were averaged for each area on the spot.  This resulted in 
a mass profile for each sample.  The spectra were then externally calibrated using the 
masses of SI, SII, and SIII from the undigested samples   
Panel A and B show subunit I from wild-type and I/II oxidase, respectively.  Panel C 
shows the formation of SI' and SI'' in wild-type as a result of α-chymotrypsin digestion 
for 1 hour.  Panel D shows the formation of SI' and SI'' in I/II oxidase as a result of α-
chymotrypsin digestion for 1 hour.  Panel E shows the formation of SI' and SI'' in wild-
type as a result of α-chymotrypsin digestion for 3 hours.  Panels F shows the formation of 
SI' and SI'' in I/II oxidase as a result of α-chymotrypsin digestion for 3 hours    
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Table IV   
 
Molecular Weights of Subunit I and Subunit I α-chymotrypsin Cleavage Products  
After Digestion for 1 and 3 hours Determined by MALDI-TOF 
 
 
 
 
 
Speciesa α-chymob
Average 
MWc SDd 
Primary Amino Acid 
Sequence Assignment
wt SI No 63993.7 52.0 2-574 
I/II SI No 64032.7 64.1 2-574 
wt SI' 1 hour 62756.3 66.5 2-561, 8-569 
wt SI‘’ 1 hour 58094.3 60.1 8-530 
I/II SI' 1 hour 62053.3 203.9 8-560, 17-570, 16-569 
I/II SI‘’ 1 hour 56920.0 191.9 8-517, 17-530 
wt SI' 3 hours 62524.0 45.9 8-566, 2-560 
wt SI‘’ 3 hours 57633.3 200.6 2-517 
I/II SI' 3 hours 60962.7 128.3 16-560, 17-560 
I/II SI‘’ 3 hours 56587.0 38.6 8-516 
 
 
 
a  This refers to the species identified using SDS-Urea-PAGE, which is now assigned to a 
specific mass.  
b  Represents the amount of time the enzyme was digested with α-chymotrypsin 
c  The average molecular weight is calculated by averaging the mass to charge ratio taken                        
from 50 laser shots on three different areas of a spot on the protein chip. 
d  The standard deviation calculated from the average mass to charge ratio. 
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result of the N and C-termini of I/II oxidase being more solvent exposed and as a result 
more susceptible to proteolytic digestion.  This form of I/II oxidase is still active and did 
not undergone turnover induced inactivation.  Therefore, it is necessary to next determine 
the structure of I/II oxidase that has been inactivated by catalytic turnover and assess the 
structural changes associated with the inactivation process.                                 
 
Electron Transfer Induced Conformational Changes in I/II Oxidase 
 One goal of our studies was to examine the conformation of R. sphaeroides COX 
in the presence and absence of SIII towards the goal of finding a molecular mechanism 
for the inactivation of I/II oxidase during catalytic turnover.  To further assess the 
structural consequences of SIII removal, wt and I/II oxidase were digested with α-
chymotrypsin before and after undergoing 30 minutes of steady state electron transfer 
(Figure 28).  If large conformational changes occurred during COX turnover, then limited 
proteolysis could detect altered conformational states of the enzyme.  The wt and I/II 
oxidase controls (Figure 28, Lanes 1 and 5) that did not undergo turnover exhibit a 
similar pattern of proteolysis that was previously shown in Figure 22.  The only 
difference between Figures 22 and 28 is that very little SI’’ was formed, however, SI’ 
was generated in wt and I/II oxidase.  The wt enzyme was approximately 15% inactivated 
after the 30 minute incubation (about 6 x 106 turnovers) with cytochrome c, ascorbate, 
and TMPD, the proteolytic pattern on SDS-Urea PAGE, however, did not change (Figure 
28, Lane 4).  There may be some change in conformation at the C-terminus of SI which 
makes the cleavage site between residues 525-556 inaccessible (shown in Figure 26),  
 
 
 112
 
 
 
 
 
 
 
 
 
 
Figure 28 
 
SDS-Urea PAGE of Wild-type and I/II Oxidase Digested with α-chymotrypsin After 
Undergoing Multiple Catalytic Cycles.   
All conditions were as described in Experimental Procedures.  After 30 minutes of steady 
state turnover wild-type and I/II oxidase were inactivated by 15% and 100%, 
respectively.  4 µg of protein for each experimental condition was loaded into each lane 
of the gel.  Lane 1 shows wt COX, lane 2, wt after catalytic turnover, lane 3, wt digested 
2 hours with α-chymotrypsin, lane 4, wt after catalytic turnover and digested 2 hours with 
α-chymotrypsin, lane 5, I/II oxidase, lane 6, I/II oxidase after catalytic turnover, lane 7, 
I/II oxidase digested 2 hours with α-chymotrypsin, lane 8, I/II oxidase after catalytic 
turnover and digested 2 hours with α-chymotrypsin.  The symbol (*) indicates the 
migration of α-chymotrypsin. 
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thus not creating SI’’.  In contrast, after 30 minutes of steady state turnover, I/II oxidase 
was 100% inactivated and exhibited little or no detectable levels of SI’ or SI’’, indicating 
that SI was completely digested (Figure 28, Lane 8).  Compared to wt there were 
numerous new bands that appeared on the gel.  This result demonstrated that I/II oxidase 
underwent significant conformational changes upon turnover, which led to a 
conformation that is catalytically inactive and highly susceptible to proteolytic cleavage.  
It has been shown previously that turnover induced inactivation leads to the loss of CuB at 
the active site (Bratton et al. 1999).  The copper is coordinated by four histidine residues 
(Shapleigh et al. 1992); therefore, with the loss of CuB,  these histidines would no longer 
be bound to the copper atom, which could cause SI to open up and adopt a more relaxed 
conformation.   
To test this hypothesis, a mutant which lacks CuB, ∆COX11 (Hiser et al. 2000), 
was digested with α-chymotrypsin and compared to I/II oxidase that had been inactivated 
by catalytic turnover.  Figure 29 shows that after 2 hours, the digestion of ∆COX11 does 
not form any appreciable amounts of SI’ and SI’’ but is digested in a manner similar to 
that of the inactivated I/II oxidase (Figure 28).  Therefore, a logical extension of these 
results is that CuB is partially responsible for maintaining the proper three dimensional 
strucutre of SI and the loss of CuB causes a large scale conformational change in SI, 
which makes SI more susceptible to proteolysis.  However, these results do not explain 
what accounts for the loss of CuB.  One explanation is that during catalytic turnover SI 
begins to relax in its structure and as a result the ligands of CuB (His284, His333, His334, 
and His419) dissociate, causing SI to become more susceptible to proteolytic cleavage.   
Alternatively, while undergoing catalytic turnover I/II oxidase generates reactive oxygen 
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Figure 29 
 
SDS-Urea-PAGE of wild-type, I/II oxidase, and ∆COX11 Digested with α-
chymotrypsin for 2 Hours. 
All conditions were as described in Experimental Procedures.  After 30 minutes of steady 
state turnover wild-type and I/II oxidase were inactivated by 15% and 100%, 
respectively.  The electron transfer activity of the ∆COX11 enzyme was 2.5% that of 
wild-type, and was only treated with substrates.  4 µg of protein for each experimental 
condition was loaded into each lane of the gel.  Lane 1: α-chymotrypsin control, Lane 2: 
wild-type enzyme no turn over, Lane 3: wild-type enzyme turned over and digested for 2 
hours with α-chymotrypsin, Lane 4: I/II oxidase no turn over, Lane 5: I/II oxidase turned 
over and digested for 2 hours with α-chymotrypsin, Lane 6:  ∆COX11 control no turn, 
Lane 7: ∆COX11 no turn over but digested with α-chymotrypsin for 2 hours. 
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species which could hydroxylate nearby tyrosine residues, which in turn could cause SI to  
undergo an irreversible relaxation in conformation.  In an effort to more accurately 
determine the underlying mechanism of turnover inactivation MALDI-TOF mass  
spectrometry was performed on wt and I/II oxidase under the same conditions as shown 
in Figure 28.   
 Due to the sensitivity limitations of the mass spectrometer at Wright State 
University, the α-chymotrypsin digested enzymes which underwent and did not undergo 
turnover were sent to the University of Minnesota for MALDI-TOF analysis of the   
peptides.  In the samples of wt and I/II oxidase which exhibited 15% and 100% 
inactivation, respectively, there was only one unique peptide that appeared in the 
inactivated samples that was absent in the samples which were not turned over.  This 
peptide had a m/z of 2,368 Da (Figure 30), which could be assigned to residues 237-258 
or 328-347 in SI.  In either case an internal peptide was formed, and supports the 
argument that SI underwent a conformational change resulting in the cleavage of an 
internal aromatic residue that was not accessible previously.  The peptide containing 
residues 237-258 has an absolute mass of 2,368, while the peptide containing residues 
328-347 requires hydroxylation of two tyrosine residues to have the same mass.  The 
peptide 328-347 is of particular interest because it contains two of the histidines (His333 
and His334) responsible for liganding CuB.  Therefore, if the peptide were hydroxylated 
this could result in a conformational change of this peptide around the active site, which 
would cause CuB to dissociate from the active site.   
The peptide was submitted for peptide sequencing; however, the parental peptide 
did not fragment very well and only larger fragments from the peptide were generated.   
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Figure 30 
 
MALDI-TOF Mass Spectra of wt and I/II oxidase Digested with α-chymotrypsin for 
2 hours Before and After Turnover Induced Inactivation.  Inactivation of COX was 
carried out in a 5 mL beaker containing a 1 mL solution composed of 112 pmoles of 
wild-type oxidase or 147 pmoles of I/II oxidase, which corresponds to 12 µg of total 
protein, 50 mM ascorbate, 1.0 mM TMPD, 25 mM Tris-HCl pH 9.0, and 0.1% DM.  
Enzyme turnover was initiated by adding cytochrome c (Sigma, type III) to a final 
concentration of 3 nM.  Controls were identical to the above solutions, but did not 
contain cytochrome c.  Oxygen consumption was monitored at 25°C polarographically 
using an oxygen electrode in the presence of 5.3 µM cytochrome c (Sigma, type III), 18 
mM ascorbate, 0.9 mM TMPD, 25 mM Tris-HCl pH 9.0, and 0.1% DM.  After 30 
minutes the wild-type enzyme was inactivated by approximately 15% and the I/II oxidase 
had been inactivated 100%.  The remainder of the inactivated oxidase and controls were 
then loaded into Centricon filter devices with a 100 MWCO.  NaCl was added to a final 
concentration of 110 mM to facilitate the dissociation of cytochrome c from COX SII, 
and the samples were diluted to a final volume of 2 mL with 25 mM Tris-HCl pH 9.0.  
Samples were centrifuged at 1,000 x g for 30 minutes and then eluted at 1,000 x g for 2 
minutes.  Further concentration of the samples was performed using Microcon centrifugal 
filter device (30,000 MWCO, Millipore) and collected.  The samples were then brought 
up to a concentration of 1 µg/µL.  α-chymotrypsin was added at a ratio of 1:10 and the 
reactions were allowed to proceed at room temperature for 2 hours.  After two hours 1 µL 
of each sample was removed and mixed with the EAM SPA with 0.25% TFA and spotted 
onto a gold chip from Ciphergen.  The gold protein chip was then loaded into a 
Ciphergen SELDI Protein Biology System II (Ciphergen, Palo Alto, CA) and analyzed.  
Each spot was ionized 3 to 5 times over different areas within the spot.  Fifty laser hits 
were averaged for each area on the spot.  This resulted in a mass profile for each sample.  
The spectra were then externally calibrated using mass standards from Sigma.  Panel A is 
wild-type control that was treated for 2 hours with α-chymotrypsin, but did not undergo 
turnover induced inactivation.  Panel B is I/II oxidase control that was treated 2 hours 
with α-chymotrypsin, but did not undergo turnover induced inactivation..  Panel C is 
wild-type that experienced 15% inactivation by catalytic turnover and was treated with α-
chymotrypsin, for 2 hours.  Panel D is I/II oxidase that was 100% inactivated by catalytic 
turnover and was treated with α-chymotrypsin, for 2 hours.  Based on the mass of this 
peptide and the result of the peptide sequencing data, this peptide corresponds to amino 
acid residues 237-258.   
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The masses of the fragments were used to try to identify the parental peptide assuming 
both specific and nonspecific cleavage of the peptide by the protease α-chymotrypsin.  
The fragments were matched to all but the last five C-terminal amino acids of the peptide 
237-258 (76% coverage), and only one fragment could be matched to the putatively 
hydroxlyated peptide 328-347, which would suggest that the peptide composed of 
residues 328-347 was not the parental peptide.  It was shown earlier with the N-terminal 
sequencing data (Table III) that α-chymotrypsin was capable of cleaving at the C-
terminal side of histidines.  Therefore, working under the assumption that there could be 
nonspecific cleavage occurring at the C-terminal side of any amino acid three other 
peptides became possibilities.  However, the fragments generated could not be 
unequivocally assigned to any of those possibilities, either.  Therefore it was concluded 
that the peptide corresponding to residues 237-258 was the peptide of interest.   This 
portion of SI must adopt an alternative conformation leading to the rearrangement of 
amino acids in the vicinity of CuB, which leads to the dissociation of CuB.  Furthermore, 
dissociation of CuB must induce a large scale conformational change in the SI since the 
SDS-Urea-PAGE result shows that I/II oxidase is exhaustively digested after catalytic 
turnover, which is also seen when ∆COX11 is digested with α-chymotrypsin.  
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Investigating the Role of Interhelical Hydrogen Bonds in Subunit III of 
Rhodobacter sphaeroides Cytochrome c Oxidase 
 
 As described in the previous section, biochemical depletion or genetic deletion of 
SIII from R. sphaeroides COX leads to an enzyme that is structurally and functionally 
quite different from wt enzyme.  Interhelical hydrogen bonds (H-bonds) have been shown 
to play an important role in the structure of membrane proteins (Adamian and Liang 
2001; Adamian and Liang 2002).  Towards the goal of determining whether or not 
interhelical H-bonds play a role in COX SIII structure and function a computer program 
called HBPLUS was used to identify interhelical H-bonds in SIII from fully reduced 
bovine (1OCR), fully oxidized bovine (10CC), R. sphaeroides (1M56), and P. 
denitrificans (1QLE).  The interhelical H-bonds were displayed on the respective x-ray 
crystal structures of SIII from each organism.  Figure 31 shows the interhelical H-bonds 
identified in the three COX SIII structures, Figure 32 shows a close-up of each 
interhelical H-bond in R. sphaeroides COX SIII, and Table V provides a list of all the 
interhelical H-bonds found in R. sphaeroides COX SIII.  While not all of the interhelical 
H-bonds are conserved, the networks of hydrogen bonds create complete connectivity 
among all seven transmembrane helices in SIII.  Furthermore, there are two well 
conserved clusters of amino acids that form interhelical H-bond networks.  The first is a 
triad of amino acids consisting of Glu90, His212, and Tyr246 (R. sphaeroides 
numbering) (Figure 32 A). The second cluster involves Arg161, which makes two 
contacts with the oxygen atoms of the peptide backbone (Figure 32 B).  A third 
interhelical hydrogen bond is also found between Thr138 and Trp254 (Figure 32 C), and 
is present in both R. sphaeroides and bovine SIII, but is absent in the P. denitrificans SIII 
structure.  Two other interhelical H-bonds were also identified between Thr149 and  
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Figure 31 
 
Superimposed Crystal Structures from Bovine, P. denitrificans, and R. sphaeroides 
COX SIII.  The bovine enzyme (PDB 1OCC, red), P. denitrificans (PDB 1QLE, cyan), 
and R. sphaeroides (PDB 1M56, green) are shown looking at the side of SIII, with the 
membrane coming out of the page.  All of the interhelical H-bonds for R. sphaeroides are 
shown and the conserved H-bonds from the other two organisms are also included. 
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Figure 32 
 
Interhelical H-Bonds Predicted to Occur in R. sphaeroides COX SIII. 
The interhelical H-bonds were determined by the program HBPLUS.  The crystal 
structure coordinates of 1M56 were analyzed by the program HBPLUS.  This program 
first determines the positions of hydrogens within a structure, and then examines each H-
bond donor/acceptor pair to determine to if it fits distance and angle requirements.  The 
H-bonds were then displayed in the structure of R. sphaeroides SIII using the program 
DSViewer Pro.  A. H-bond triad formed by E90, H212, and Y246; B.  H-bond cluster 
formed by R161, V227, and F232; C.  H-bond formed by T138 and W254; D.  H-bond 
formed by T149 and H248; E.  H-bond formed by D163 and W150.  
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Table V 
 
List of Interhelical H-Bonds Predicted to be Found in R. sphaeroides SIII 
 
Residuea H-Bond Partnerb Distance (Å)c Conservedd 
E90 H212 and Y246 3.2 and 3.2 Yes 
H212 E90 3.2 Yes 
Y246 E90 3.2 Yes 
R161 V227 and F232 2.8 and 2.8 Yes 
T138 W254 2.8 In bovine 
T149 H248 3.0 No 
D163 W150 2.3 No 
 
a Amino acid residue in R. sphaeroides COX SIII 
b Hydrogen bond partner as predicted by the program HBPLUS. 
c Distance between donor and acceptor atoms, measured, in Angstroms, using the 
program DSViewer Pro. 
d The interhelical H-bonds were predicted for COX SIII for bovine, P. denitrificans, and 
R. sphaeroides.  The interhelical H-bonds were then displayed on the respective 
structures as shown in Figure 15.  The conservation of the H-bond is based primarily on 
location and is also based on the amino acid residues involved in the H-bond. 
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His248, and between Asp163 and Trp150 (Figures 32 D and 32 E, respectively).  These 
two interactions are not found in either of the other two structures (bovine or P. 
denitrificans) used in the prediction.  A multiple sequence alignment among 19 
organisms shows that residues Glu90, His212, Tyr246, Arg161, and Thr138 are 100% 
conserved in SIII (Appendix D).       
 Even though there is a high level of conservation among the amino acids involved 
in the triad, the interactions among the three triad residues, responsible for forming the 
interhelical connectivity varies in each organism.  For example, when examining the triad 
in the fully reduced and fully oxidized bovine SIII it is evident that the hydrogen bonding 
partner of Glu90 could change depending on the redox state of the enzyme.  In the fully 
reduced state Glu90 is hydrogen bonded to both His212 and Tyr241, while in the fully 
oxidized state Glu90 is only hydrogen bonded to Tyr241.  In the P. denitrificans the  
interhelical H-bond is predicted to form between His212 and Y246, thus excluding Glu90 
as a potential H-bond partner.  The triad interaction within the R. sphaeroides SIII 
involves Glu90 forming H-bonds with both His212 and Tyr246 (Figure 32 A).       
 The interhelical H-bonding involving the Arg161 is less complex than the 
interactions described above for the triad.  In the bovine enzyme, regardless of reduction 
state, Arg156 interacts with backbone oxygen groups of Gln222 and Leu223.  In the P. 
denitrificans enzyme Arg168 makes H-bonds with backbone oxygen groups of Leu234 
and Met239.  While in the R. sphaeroides enzyme Arg161 forms interhelical H-bonds 
with Val227 and Phe232 also through interactions with the backbone oxygen atoms 
(Figure 32 B).  The interaction between Thr138 and Trp254 is interesting because it is 
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found in both R. sphaeroides and bovine SIII, and also because the threonine residue 
interacts with an amino acid residue located on helix 7, which is a highly conserved helix 
in SIII (Figure 32 C).   
To investigate the role of these interhelical H-bonds, site-directed mutants at each 
position were constructed, which contained a polyhistidine tag on the C-terminus of SI.  
Table VI shows the mutations made at each position.  Each mutation was designed to 
disrupt the interhelical H-bond, but not to perturb the overall structure of SIII.  Amino 
acid residues were either mutated to an alanine, and/or a residue of similar size, but 
incapable of forming an H-bond.  All of the proposed mutations were made and 
expressed in R. sphaeroides, with the exception of T138V.  The mutation was made in 
the pMB301 plasmid and confirmed by DNA sequencing; however, the protein was never 
expressed in R. sphaeroides. 
 
Subunit Content of H-Bond Mutants 
 Figure 33 A shows SDS-Urea-PAGE gels of wild-type enzyme (lane 1), the 
mutants H212A (lane 2 ), H212F (lane 3), E90A (lane 4), and I/II oxidase (lane 5).  
Figure 33 B shows wild-type (lane 1), the mutants Y246F (lane 2), H212A (lane 3), and 
R161I (lane 4).  It was possible to estimate the amount of SIII present in each mutant, by 
comparing the staining intensity of the mutants to the staining intensity of wild-type.  
Mutation of the highly conserved Glu90 to alanine (E90A) resulted in loss of about 75% 
of subunit III as detected by Coomassie Blue staining intensity (Figure 33 A lane 4).  
However, mutation of His212 to either alanine (H212A) or phenylalanine (H212F) had 
no effect on SIII content (Figure 33 A lanes 2 and 3, respectively and Figure 33 B lane 3  
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Table VI  
 
List of Proposed Mutations 
 to Disrupt Predicted Interhelical Hydrogen Bonds 
 
 
Residue Proposed Mutation 
E90 E90Aa 
H212 H212Ab, H212Fb 
Y246 Y246F 
R161 R161I 
T138 T138V 
 
 
a Enzyme provided by Dr. Jon Hosler 
b Enzyme provided by Dr. Christine Pokalski 
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Figure 33 
 
SDS-Urea-PAGE of wild-type and SIII Mutants. 
Approximately 4 µg nickel column purified of wild-type and SIII mutant of R. 
sphaeroides COX were run on a 16% SDS-Urea gel for 3 hours and stained with Bio-
Safe Coomassie.  In panel A., lane 1 contains wild-type, lane 2 contains H212A, lane 3 
contains H212F, lane 4 contains E90A, and lane 5 contains I/II oxidase.  In panel B., lane 
1 contains wild-type, lane 2 contains Y246F, lane 3 contains H212A, and lane 4 contains 
R161I.  With the exception of the E90A enzyme all of the mutants contain wild-type 
amounts of SIII. 
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(H212A)).  Subunit III content was also not affected when Tyr246 was mutated to 
phenylalanine (Y246F) or when R161 was mutated to an isoleucine (R161I) (Figure 33 B 
lanes 2 and 4, respectively). 
 
Detergent Solubilized Activities of Interhelical H-bond Mutants 
 Electron transfer activity of H212A was similar to wt enzyme (Table VII) and did 
not undergo turnover induced inactivation.  The detergent solubilized activities of Y246F 
and R161I also showed no changes in electron transfer activity when compared to wild-
type.  The electron transfer rates of detergent solubilized E90A and H212F were not 
investigated.  These results suggest that these mutations did not affect the structure of the 
active site and that the solubilized form of these mutant enzymes function similarly to the 
wild-type enzyme.  Since COX is a membrane bound protein it is also necessary to 
investigate the electron transfer and proton pumping functions of these mutants after 
reconstitution into phospholipid vesicles, or liposomes. 
 
Electron Transfer and Proton Pumping Activitities of Reconstituted Triad Mutants 
Table VIII summarizes the electron transfer rates of wild-type, each triad mutant, 
and I/II oxidase when reconstituted into liposomes under three different conditions: 
controlled, in the presence of Val, and uncontrolled.  In the controlled state, the enzyme 
turns over in the presence of both a membrane potential and proton gradient.  In the 
presence of Val, the membrane potential is dissipated; however, the proton gradient is 
still present.    
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Table VII 
 
The Maximum Electron Transfer Activity of Detergent Solubilized 
Wild-type and SIII Mutant COX. 
 
 
 
Enzyme Activitya 
wt 1124 
H212A 1075 
Y246F 1433 
R161I 1214 
 
 
 
a The maximum electron transfer activity of detergent solubilized wild-type and SIII 
mutant COX was measured using a Clark oxygen electrode (Yellow Springs Instrument 
Company Model 17372).  The assay buffer contained: ascorbate (18 µM), cytochrome c 
(type III) (20-40 µM), and 0.6 mM TMPD in 25 mM HEPES-NaOH, pH 7.0, with 0.1% 
DM at 25°C.  The reactions were initiated by adding 5-10 pmoles of nickel purified DM 
solubilized enzyme COX enzyme after 3 minutes. This allows the rate of cytochrome c 
auto-oxidation to be measured.  The activity of the COX enzymes was measured for three 
minutes and are expressed as moles cytochrome c oxidized/sec/mole heme aa3  
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Table VIII 
 
Electron Transfer Activities of wild-type and SIII Mutants, Reconstituted into 
Phospholipid Vesicles.  
 
 
Enzymea Controlled Rateb Val Ratec Uncontrolledd RCRe RCRvalf 
wt 96 + 15.0 246 + 23.0 934 + 26.0 10.0 + 1.7 3.8 + 0.4 
H212A 96 + 9.8 119 + 9.8 1039 + 65.0 12.4 + 1.6 8.7 + 0.8 
H212F 84 + 10.0 119 + 10 997 + 52 12.8 + 2.0 8.8 + 1.1 
E90A 54 + 0.0 72 + 0.0 913 + 78 17.0 + 1.5 12.8 + 1.1 
Y246F 93 + 21.0 242 + 10.4 1156 + 121 12.9 + 2.8 4.8 + 0.4 
I/II 63 + 10.4 94 + 8.5 1128 + 49 18.3 + 2.6 12.1 + 1.3 
 
 
 
a The enzymes used in the experiment were nickel column purified.  Approximately 5-10 
pmoles of enzyme was used for each assay.  The assay buffer used in all experiments 
consisted of ascorbate (18 µM), cytochrome c (type III) (20-40 µM), which were 
incubated in 50 mM KHPO4, pH 7.4, at 25°C for three minutes prior to the addition of 
enzyme.  All rates were corrected for the auto-oxidation of cytochrome c. 
b The controlled rate represents the electron transfer activity of each enzyme in the 
presence of both a membrane potential and proton gradient. 
c The Val rate represents the electron transfer activity of each enzyme in the presence of a 
proton gradient, but in the absence of a membrane potential, which was dissipated by the 
addition of Val (6 µM). 
d The uncontrolled rate represent the maximum electron transfer activity of the enzymes 
when reconstituted into a phospholipid vesicle.  The membrane potential was dissipated 
by the addition of Val (6 µM) and the proton gradient was dissipated by the addition of 
CCCP (6 µM). 
e RCR is the ratio of the uncoupled rate of electron transfer (with both Val and CCCP 
present) to the basal rate of electron transfer, both rates are corrected for the auto-
oxidation of cytochrome c. 
f RCRval is the ratio of the uncoupled rate of electron transfer (with both Val and CCCP) 
to the Val rate of electron transfer, both rates are corrected for the auto-oxidation of 
cytochrome c. 
Averages and standard deviations for each rate were calculated based on two liposome 
preparations for each enzyme.  
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Finally in the uncontrolled state, both the membrane potential and proton gradient are 
dissipated.  The uncontrolled rate represents the maximum rate of turnover in the 
presence of a membrane bilayer.  Based on these rates respiratory control ratios (RCR) 
and respiratory control ratios in the presence of valinomycin (RCRval) values were 
calculated and are presented in Table VIII.  
In a controlled state, the turnover numbers of wild-type, H212A, H212F, and 
Y246F are all similar, while the controlled turnover numbers for E90A and I/II oxidase 
are inhibited by 40-50%.  The inhibition displayed by E90A could be attributed to the 
loss of SIII as shown in Figure 33 A, lane 4.  In the presence of Val, the rate of electron 
transfer is stimulated about 2.5 fold in wild-type and Y246F, and the turnover numbers 
for H212A, H212F, E90A, and I/II oxidase are only stimulated by 20-30%.  This 
indicates that the proton gradient is exhibiting an inhibitory effect on the electron transfer 
activities of these mutants.  In contrast, the uncontrolled rate of all the enzymes, in the 
absence of all gradients, are similar.  Since the controlled rates and uncontrolled rates of 
wild-type, H212A, H212F, and Y246F are similar, the RCR ratios are also similar; 
however, the RCR ratios of E90A and I/II oxidase are elevated due to the fact that the 
controlled rate of electron transfer in these enzymes is inhibited compared to the other 
enzymes studied.  Since the electron transfer activity is only modestly stimulated in the 
presence of Val, for H212A, H212F, E90A, and I/II oxidase the RCRVal ratios are quite 
high, which further emphasizes the inhibitory effect of the proton gradient on the activity 
of these mutants.  
 When I/II oxidase is allowed to turnover in the presence of a membrane potential 
and proton gradient the enzyme undergoes turnover induced inactivation.  The severity of 
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the inactivation process increases over time, and if I/II oxidase is allowed to turnover 
long enough it will become completely inactivated.  The inactivation process also occurs 
in the wild-type enzyme, but to a much lesser degree.  Figure 34 shows a time course of 
turnover induced inactivation on the uncoupled rate of electron transfer when wild-type 
and SIII mutant enzymes are allowed to turnover in the presence of both a membrane 
potential and proton gradient.  The uncoupled electron transfer rates of wild-type and 
Y246F enzymes are inactivated by 20% and 25%, respectively, after being turned over in 
the presence of a membrane potential and proton gradient for six minutes.  The 
uncoupled electron transfer rate of reconstituted E90A enzyme was inactivated by 70% 
when it was allowed to turnover in the presence of a membrane potential and proton 
gradient for six minutes.  The H212A and H212F mutants also underwent turnover 
induced inactivation when allowed to turnover in the presence of both gradients for six 
minutes, which resulted in as much as 60-70% reduction in the uncoupled electron 
transfer rate.  The uncoupled electron transfer rate of I/II oxidase was inactivated by 80% 
when it was allowed to turnover for 6 minutes in the presence of both gradients.  Figure 
34 also illustrates the time dependence of the turnover induced inactivation process.  
With the exception of I/II oxidase none of the mutants displayed turnover induced  
inactivation until after being reconstituted into a liposome.  The results presented in Table 
VIII also suggested that the proton gradient was causing an inhibitory effect on the rate of 
electron transfer.  Since COX has two functions, electron transfer and proton pumping, it 
was necessary to determine whether or not the inhibitory effect of the proton gradient was 
also inhibiting the proton pumping function of the enzymes.   
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Figure 34 
 
Turnover Induced Inactivation of Wild-type and Triad Mutants. 
Turnover induced inactivation of the reconstituted wild-type and SIII mutants COX 
enzymes was measured in a Clark oxygen electrode.  The assay buffer components 
consisted of ascorbate (18 µM), cytochrome c (type III) (20-40 µM), which were 
incubated in 50 mM KHPO4, pH 7.4, at 25°C in the electrode chamber for 3 minutes.  
This allows the rate of cytochrome c auto-oxidation to be measured.  Then 5-15 pmoles 
of COX containing vesicles were added and allowed to turnover in the presence of both a 
membrane potential and proton gradient for 0 to 6 minutes.  At each time point Val (6 
µM) and CCCP (6 µM) were added and the uncoupled rate of electron transfer was 
measured.  Electron transfer rates for the 0 time point represented the maximum rate of 
electron transfer, or 0% inactivated.  Electron transfer rates for the inactivated time points 
were compared to the maximum rate, and were calculated as a percentage of inactivation 
over time.  Wild-type (black), E90A (green), H212A (blue), H212F (cyan), Y246F 
(magenta), and I/II oxidase (red). 
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 Figure 35 shows the proton pumping activity of wild-type and mutant enzymes, as 
assessed in a stopped-flow rapid kinetic absorbance spectrophotometer.  Proton pumping 
activity was determined by monitoring the absorbance changes of the pH sensitive dye, 
phenol red, at 556 nm.  There is an increase in absorbance in the presence of Val and 
CCCP, indicating alkalinization.  This is due to both the membrane potential being 
dissipated by Val and the proton gradient being dissipated by the CCCP.  This results in 
proton consumption for water production by COX.  There is a decrease in absorbance in 
the presence of Val, indicating acidification.  This is due to only the membrane potential 
being dissipated, while the proton gradient is still intact.  As a result potassium ions move 
into the intravesicular space allowing protons to be pumped to the outside, by COX.  The 
vectorial protons pumped to electrons transferred (H+/e-) ratios of wild-type enzyme is 
1.0 (Krab and Wikstrom 1978) and typically range from between 0.8-1.0 depending on 
the liposome preparation.   
The H+/e- ratio of I/II oxidase is 0.4, which corresponds to a 50-60% decrease in 
proton pumping efficiency.  This is consistent with previously published results (Wilson 
and Prochaska 1990; Mills et al. 2003) and suggests that SIII has a role in proton 
pumping.  The proton pumping activity of the E90A mutant was decreased by 90%. 
however, it could not be determined whether this decrease in pumping was caused by the 
mutation or whether it could be attributed to the 75% loss in SIII.  However, since the 
observed decrease in the H+/e- ratio, for E90A, is greater than that observed with I/II 
oxidase it appears as though the mutation is contributing to the decrease in proton 
pumping function.  Proton pumping efficiency was also substantially decreased in the  
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Figure 35 
 
Proton Pumping of wild-type and Triad Mutants. 
Proton translocation activity of COX containing vesicles was measured on an Applied 
Photophysics SX.18MV Stopped-Flow Reaction Analyser.  Assays were performed at 4 
turnovers.  For these experiments two samples were prepared:  a COX containing vesicle 
sample and a cytochrome c sample.  The COX containing vesicle sample contained 50 
µM HEPES-NaOH, pH 7.4, 50 mM KCl, 50 mM sucrose, 100 µM phenol red, 0.1 µM 
aa3, and 5 µM Val or 5 µM Val and 5µM CCCP.  The cytochrome c containing sample 
contained 50 µM HEPES-NaOH, pH 7.4, 50 mM KCl, 50 mM sucrose, 100 µM phenol 
red, 3.2 µM (4 turnovers) reduced cytochrome c (type IV), and 5 µM Val or 5 µM and 
5µM CCCP.  Wild-type and triad mutants were monitored for proton ability at 556 nm.  
An increase in absorbance indicates an alkalinization of the exterior of the liposome, 
which occurs when both Val and CCCP are present.  A decrease in absorbance indicates 
acidification of the exterior of the liposome, which occurs in the presence of Val.  Wild-
type (black and brown), E90A (magenta), H212A (green), H212F (red), Y246F (orange), 
I/II oxidase (blue). 
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H212 mutants, with 60% inhibition observed in H212A and 70% inhibition observe in 
H212F.  These mutants contain wild-type amounts of SIII; therefore, the decreases in the 
H+/e- ratios can be attributed to the mutation and not the loss of SIII.  The remaining 
mutant in this triad of amino acids, Y246F, pumped protons at the same H+/e- ratio as 
wild-type.     
 All of the functional data on these H-bond mutants is summarized in Table IX.  
Based on the functional data presented above it appears as though E90 and H212 are 
involved in an interhelical H-bond, while there is no compelling evidence for Y246 being 
involved.   
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Table IX  
 
 
Summary of Triad Mutant Activities 
 
 
Enzyme Vmaxa RCRb H+/e-c T.I.Ad SIII  
Contente 
Wt 934 ± 26 10.0 ± 1.7 0.9 ± 0.08 No 100% 
I/II 1128 ± 49 18.3 ± 2.6 0.4 ± 0.03 Yes 0% 
H212A 1039 ± 65 12.4 ± 1.6 0.4 ± 0.05 Yes 100% 
H212F 997 ± 52 12.8 ± 2.0 0.3 ± 0.1 Yes 100% 
E90A 913 ± 78 17 ± 1.5 0.1 ± 0.05 Yes 25% 
Y246F 1156 ± 121 12.9 ± 2.8 0.8 ± 0.1 No 100% 
 
 
 
a The Vmax was measured in a Clark oxygen electode.  These values and represent the 
maximum electron transfer activity of reconstituted wild-type or SIII mutant COX, and 
are expressed as moles ccytochrome c oxidized/sec/mole heme aa3.   
b RCR is the ratio of the uncoupled rate of electron transfer (with both Val and CCCP 
present) to the basal rate of electron transfer, both rates are corrected for the auto-
oxidation of cytochrome c. 
c The proton pumping activity of wild-type and SIII mutant COX was measured on an 
Applied Photophysics SX.18MV Stopped-Flow Reaction Analyser.  All of the results 
presented in this Table are for 4 catalytic turnovers (one catalytic turnover consumes one 
molecule of reduced cyt. c).  The standard deviations were calculated from 15 individual 
traces taken on the stopped flow apparatus. 
d T.IA. stands for turnover induced inactivation.  The inactivation process was measured 
in a Clark oxygen electrode. 
e SIII content was estimated by measuring the Coomassie Blue staining intensity of wild-
type enzyme and comparing that value to the SIII staining intensity for each mutant.  
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Investigating the Role of Helix 7 in SIII Structure and Function 
 The C-terminal helix of SIII, helix 7 is highly conserved with respect to amino 
acid composition and sequence (Cao et al. 1992), which in R. sphaeroides is the last 27 
amino acids.  A multiple sequence alignment of 19 organisms illustrates the high degree 
of conservation within this helix, in which 44% of the residues are conserved and an 
additional 26% of the residues are similar (Appendix D).  Due to this high level of 
conservation, it is likely that this helix serves some structural and/or functional role in 
SIII.  Visual inspection of SIII structure also suggests that helices 3-6 may pack around 
helix 7.  There has also been a mutation reported which results in the early insertion of a 
stop codon, at amino acid position Trp249 and causes the loss of the last thirteen amino 
acid residues of helix 7, the patient with the mutation exhibited symptoms of 
mitochondrial encephalomyopathy, lactic acidosis and strokelike episodes (MELAS), 
myopathy, and exercise intolerance (Hanna et al., 1998).  Evidence for the structural 
importance of helix 7 comes from unsuccessful attempts of adding a poly-histidine tag at 
the C-terminus of SIII (personal communication Dr. Jon Hosler).  Additionally, 
interhelical H-bond analysis performed in Specific Aim II suggested that there may be as 
many as three amino acids in helix 7 (Tyr246, His248, Trp254) that form interhelical H-
bonds with the surrounding helices (helices 3-6) in SIII.  Due to the high degree of 
conservation and the location of helix 7, there is the potential that in the absence of helix 
7, SIII will misfold, become unstable, and affect the activity of the enzyme.   
 As a means to assess the role of helix 7 in COX function, a mutant was 
constructed which inserts a premature stop codon at Gly239, which results in the mutant 
G239Stop (see Materials and Methods and Appendix A).  Figure 36 illustrates the 
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location of helix 7 and depicts the site at which the helix is removed.  The helix deletion 
was designed so that the entire helix 7, shown in cyan, would be removed, and that the 
epitope for a polyclonal site-directed antibody (Figure 36, violet portion of SIII amino 
acids 225-238), which was developed in our laboratory, was retained.  Two additional 
epitopes for other polyclonal site-directed antibodies, developed in our laboratory are also 
shown in Figure 36; the yellow portion of SIII is amino acids 64-77, and the red portion 
of SIII is amino acids 110-123. 
 
Growth, Purification, and Subunit Content of G239Stop1 Mutant 
The transformed R. sphaeroides bacteria containing the G239Stop mutant was 
grown in 12 liter batches to ensure that adequate amounts of enzyme was purified.  
Nickel column purification yielded milligram quantities of mutant G239Stop1 COX, and 
the expression levels appeared comparable to wt YZ300 cells.  FPLC ion exchange 
chromatography, using a DEAE sepharose column, reduced the final yield to about 1.5-
2.0 milligrams from 36.6 grams of cells.  Figure 37 is an elution profile from the FPLC  
purification of wt, I/IIGD, and G239Stop1; the large peaks present in the early fractions (9-
12) contain a large amount of heme containing protein based on A280 and A420 absorption 
values.  These fractions contain an abundance of free subunit I, which was described 
earlier when describing the purification of I/IIGD oxidase that has had SIII genetically 
deleted (see Figure 17 A).  This observation was confirmed by SDS-Urea-PAGE of peak 
fractions (data not shown), which show that fractions 9 and 12 contain SI, but do not 
contain SII.  Figure 37 shows that during the elution of oxidase with the salt gradient only 
the right side of the final elution peak contains highly pure enzyme, which is similar to  
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Figure 36 
 
Crystal Structure of R. sphaeroides SIII Illustrating the Location of Helix 7. 
Helix 7 is shown in cyan and is located at the C-terminus of SIII and the location of the 
deletion is at amino acid residue Gly239 (also in cyan).  Also shown are the epitopes for 
the SIII site-directed antibodies: the yellow portion of SIII is residues 64-77, the red 
portion of SIII is residues 110-123, and the violet portion of SIII is residues 225-238.   
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Figure 37 
 
FPLC Elution Profile of wt, I/IIGD, and G239Stop1.   
Prior to loading COX onto the high affinity ion exchange DEAE sepharose column, the 
buffer was exchanged to 10 mM KH2PO4, pH 7.8, and 1 mM EDTA in a Centricon-30 
centrifugal filter devices. DM was added to a final concentration of 3%.  The sample was 
then incubated on ice for 15 minutes and then centrifuged for 15 min at 13,400 rpm in a 
microcentrifuge at 4°C.  The FPLC column used was a Tricorn 10/100 (GE Healthcare), 
which has an inner diameter of 10 mm and length of 100 mm, and was packed with the 
anion exchange resin DEAE-5PW (TosoHaas).  The sample was loaded into a sample 
loop and applied to the FPLC column which was then run on a Pharmacia LKB FPLC 
system.  The column was preequilibrated with 10 mM KH2PO4, pH 7.8, 1 mM EDTA, 
0.1% DM, and the oxidase was eluted in with a 45-ml gradient of 0.01–0.35 M KCl in the 
same buffer at a flow rate of 0.5 ml/min (shown in black) and 1.0 mL fractions were 
collected.  A.  Elution profile of wt, I/IIGD oxidase, and G239Stop1 measured at 280 nm 
(black, red, and blue, respcectively).  B.  Elution profile of wt, I/IIGD oxidase, and 
G239Stop measured at 420 nm (black, red, and blue, respcectively). 
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what was observed when describing the purification of I/IIGD oxidase that has had SIII 
genetically deleted.  This observation was confirmed by SDS-Urea-PAGE of peak 
fractions (data not shown), which show that fractions 9 and 12 contain SI, but do not 
contain SII.  Figure 38 shows that during the elution of oxidase with the salt gradient only 
the right-hand side of the elution peak contains highly pure enzyme, which is similar to 
what was observed with wild-type and I/IIGD (see Figure 17A and 17B).   
After pooling the highly pure fractions, visible absorbance spectroscopy showed 
that there was a 2 nm blue shift in the α-peak (Figure 39), when compared to FPLC 
purified wt enzyme.  For a comparison I/IIBD oxidase has a similar absorbance maximum 
as wt.  Additionally, SDS-Urea-PAGE demonstrated that there was very little of the helix 
7 deleted SIII (Figure 40).  However, Coomassie staining could underestimate SIII 
content since the mutant SIII is smaller in size and does not have the same amino acid 
composition as native SIII.  Therefore, immunoblots using three polyclonal antibodies 
towards different loop regions in SIII were used to quanitate SIII content (see Figure 36 
for eptiope location).  Figure 41 shows that all three antibodies react with wt SIII and 
helix 7 deleted SIII, albeit with different avidities.  Furthermore, there are some antibody 
reactive protein bands at lower molecular weight values which were detected by the 
antibodies directed towards amino acids 64-77 and 225-238; however, the antibody 
directed towards amino acids 110-123 did not react with any other protein bands besides 
the full length helix 7 deleted SIII.  Based on molecular weight markers, it was estimated 
that molecular weight of these bands was about 6 kD.  Once it was established which 
antibodies were reacting with the lower molecular weight protein bands, a cocktail of all  
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Figure 38 
 
SDS-Urea-PAGE of G239Stop1 FPLC Fractions. 
A small volume of each fraction was removed and run out on 16% SDS-Urea gels (Fuller 
et al. 1981) and stained with Bio-Safe Coomassie..  Pure COX containing fractions were 
pooled and the concentration was determined by measuring the absorbance at 606 nm. 
Lane 1: wt FPLC purified COX, lanes 2-11 are fractions 32-40, respectively, and lanes 
12-21 are fractions 41-49, respectively.  One milliliter fractions were collected; therefore, 
the elution volume reported in Figure 21 is the same as the fraction number reported here.     
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Figure 39 
 
Optical Absorbance Measurements of the α-peak of Heme aa3 in wt and G239Stop1. 
The FPLC purified enzymes were diluted into KHPO4, pH 7.4, at a ratio of 1:20.  The 
enzymes were first oxidized with ferricyanide and optical absorbance measurements were 
taken on a Hewlett Packard diode array spectrophotometer.  The same enzyme samples 
were then reduced with sodium dithionite and optical absorbance measurements were 
taken again.  The oxidized spectrum was subtracted from the reduced spectrum to yield a 
reduced minus oxidized spectrum (R – O) of the enzyme preparations.  The wt α-peak 
has a peak absorbance of 606 nm (black line) and the mutant G239Stop1 enzyme (red 
line) were compared to the spectra of wt enzyme to determine if the active site was 
perturbed.  G239Stop1 has a shift in peak absorbance of 2 nm.          
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Figure 40 
 
SDS-Urea-PAGE of wild-type and G239Stop1 After FPLC Purification. 
Approximately 4 µg and 8 µg of wild-type and G239Stop mutant R. sphaeroides COX 
were run on a 16% SDS-Urea gel and stained with Bio-Safe Coomassie. 
Lane 1: wt 4 µg, lane 2: G239Stop1 4µg, lane 3 wt 8 µg, and lane 4 G239Stop1 8 µg. 
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Figure 41 
 
Immunoblot of wild-type and G239Stop1 with Each of the Three Polyclonal Site-
Directed Antibodies. 
Approximately 4 µg of wt and G239Stop1 mutant R. sphaeroides COX were run on a 
16% Fuller SDS-Urea gel and were then transferred to PVDF membrane, and probed for 
with one of three primary antibodies.  The antibodies directed towards amino acid 
residues 64-77 and 225-238 were diluted 1:250 in TBS-B.  The antibody directed towards 
amino acid residues 110-123 was diluted 1:500 in TBS-B. Lanes 1 and 2 are wt and 
G239Stop, repectively, developed with the antibody directed towards amino acid residues 
110-123.  Lanes 3 and 4 are wt and G239Stop, repectively, developed with the antibody 
directed towards amino acid residues 225-238.  Lanes 5 and 6 are wt and G239Stop, 
repectively, developed with the antibody directed towards amino acid residues 64-77.   
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three antibodies was used.  This approach demonstrated that 87% of the SIII content was 
absent compared to wt.  The 13% that remained was found in the form of full length helix 
7 deleted SIII and the low molecular fragments (see Figure 46A).  Additionally, the 
presence of the lower molecular weight bands that were being detected by the antibodies 
(64-77 and 225-238) suggested that there may be some proteolytic digestion of SIII 
occurring either during purification or during growth.  Two separate preparations of 
G239Stop (G239Stop2 and G239Stop3) were grown to investigate at what point the 
degradation process was occurring.  It is also worth mentioning that the bands at the top 
of the immunoblot could not be competed away with free peptide, used to generate the 
polyclonal antibodies (see Figure 46B).  This means that the bands at the top of the blot 
are non-specific.  In contrast, the full length helix 7 deleted SIII and the lower molecular 
weight fragments could be competed away.  This illustrates that the bands at the top of 
the blot are due to nonspecific binding and that the polyclonal antibodies are only binding 
to specific portions of SIII.   
  
Growth, purification, and Subunit Content of G239Stop2 Purified in the Presence of 
Protease Inhibitors 
 
 To investigate the possibility of proteolysis occurring during purification, an 
additional 12 liters of the G239Stop mutant were grown (G239Stop2) and a commercially 
available protease inhibitor cocktail for use with bacterial cell extracts (Sigma).  This 
cocktail included a mixture of protease inhibitors with broad specificity for the inhibition 
of serine, cysteine, aspartic and metallo-proteases, and aminopeptidases and contained 4-
(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), pepstatin A, E-64, bestatin, and 
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sodium EDTA.  The protease inhibitor cocktail was included in the cell lysis buffer and 
throughout the purification procedure.  Nickel column purification of the cell extracts,  
from 25.2 grams of cell, resulted in the same milligram enzyme per liter yield of 
G239Stop2 enzyme compared to the G239Stop1, which was subsequently purified by 
FPLC.  After FPLC purification, fractions were run on SDS-Urea-PAGE and the pure 
fractions were pooled as before.  Visible spectroscopy of the pooled G239Stop2 enzyme 
(Figure 42) exhibited a 3 nm blue shift in the reduced α-peak of heme aa3.  SDS-Urea-
PAGE was performed to determine the SIII content in this preparation (Figure 43).  
Based on Coomassie Blue staining intensity, the protease inhibitor cocktail did not appear 
to significantly increase the amount of SIII present and subsequent immunoblots (shown 
in Figure 46A) confirmed this observation. 
 
Growth, purification, and Subunit Content of G239Stop3 Grown to a Lower Optical 
Density 
 
A third preparation (G239Stop3) of the enzyme was isolated to determine if the 
proteolysis was occurring during log phase growth of the cells.  Previous work has shown 
that during exponential phase growth, R. sphaeroides will degrade improperly folded 
proteins, and when the growth of a mutant COX was terminated at a lower optical density 
(less cell density), more SIII was present in this preparation (Bratton et al. 2003).  This 
approach was used with the G239Stop3 mutant, where typically the cells are harvested at 
an OD660 between 1.0 and 1.2 (which was the case with the previous two preparations).  
However, in this situation, the cells were harvested at an OD660 = 0.75.  Since the cells 
were harvested at a lower optical density there are fewer cells, and as a result the yield of  
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Figure 42 
 
Optical Absorbance Measurements of the α-peak of Heme aa3 in wt and G239Stop2. 
The FPLC purified enzymes were diluted into KHPO4, pH 7.4, at a ratio of 1:20.  The 
enzymes were first oxidized with ferricyanide and optical absorbance measurements were 
taken on a Hewlett Packard diode array spectrophotometer.  The same enzyme samples 
were then reduced with sodium dithionite and optical absorbance measurements were 
taken again.  The oxidized spectrum was subtracted from the reduced spectrum to yield a 
reduced minus oxidized spectrum (R – O) of the enzyme preparations.  The wt α-peak 
has a peak absorbance of 606 nm (black line) and the mutant G239Stop2 enzyme (green 
line) were compared to the spectra of wt enzyme to determine if the active site was 
perturbed.  G239Stop2 has a shift in peak absorbance of 3 nm.                   
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Figure 43 
 
SDS-Urea-PAGE of wild-type and G239Stop2  FPLC Pure Enzyme. 
Approximately 4 µg and 8 µg of FPLC purified wt and G239Stop2 mutant R. sphaeroides 
COX, from the second preparation of enzyme, were run on a 16% Fuller gel (see 
Materials and Methods) and stained with Bio-Safe Coomassie. 
Lane 1: wt 4 µg, lane 2: G239Stop2 4 µg, lane 3: wt 8 µg, lane 4 G239Stop2 8 µg.  
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protein was significantly less.  After purification using the nickel affinity column and 
DEAE FPLC column chromatography the α-peak of heme aa3 of G239Stop3 mutant was 
shifted 1 nm (Figure 44).  Figure 45 is an SDS-Urea-PAGE run after FPLC purification, 
and there did not appear to any noticable difference in SIII content when compared to the 
other two preparations; however, subsequent immunoblots (Figure 46A) showed that this 
preparation of enzyme had the highest content of helix 7 deleted SIII, among the three 
preparations of enzyme. 
 
Immunoblot of wt and the Three Different Preparations of G239Stop1-3  
 A direct comparison was performed to quantitate the amounts of helix 7 deleted 
subunit III present, in each of the three preparations, by developing immunoblots using a 
cocktail of the three SIII antibodies.  Figure 46 shows an immunoblot of wt and the three 
different preparations of G239Stop1-3 developed with the cocktail of primary antibodies.  
During the transfer process two sheets of PVDF were used because some protein passes 
through the top membrane.  To accurately estimate the amount of SIII, both immunoblots 
were developed with anti-SIII antibodies.  It is clear that all three preparations of 
G239Stop have reduced amounts of truncated SIII compared to wt full length SIII; 
however, each preparation also had different amounts of helix 7 deleted SIII.  Each 
preparation also contained the band at about 6 kD that was detected by the antibodies, 
and was also included in the calculation of SIII content.  When the truncated SIII and the 
6 kD band were quanitated, the preparation that was grown to an OD660 = 0.75 
(G239Stop3) contained 26% helix 7 deleted SIII, as compared to wt. The preparation that 
was lysed and purified in the presence of the protease inhibitor cocktail (G239Stop2)  
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Figure 44 
 
Optical Absorbance Measurements of the α-peak of Heme aa3 in wt and G239Stop3. 
The bacteria were grown to an OD660 = 0.75 before being harvested.  The enzyme was 
first purified using nickel column affinity chromatography and further purified using ion 
exchange chromatography.  The FPLC purified enzymes were diluted into KHPO4, pH 
7.4, at a ratio of 1:20.  The enzymes were first oxidized with ferricyanide and optical 
absorbance measurements were taken on a Hewlett Packard diode array 
spectrophotometer.  The same enzyme samples were then reduced with sodium dithionite 
and optical absorbance measurements were taken again.  The oxidized spectrum was 
subtracted from the reduced spectrum to yield a reduced minus oxidized spectrum (R – 
O) of the enzyme preparations.  The wt α-peak has a peak absorbance of 606 nm (black 
line) and the mutant G239Stop3 enzyme (blue line) were compared to the spectra of wt 
enzyme to determine if the active site was perturbed.  G239Stop3 has a shift in peak 
absorbance of 1 nm.                   
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Figure 45 
 
SDS-Urea-PAGE with wild-type and G239Stop3 FPLC Pure Enzyme. 
Approximately 4 µg and 8 µg of wt and G239Stop3 mutant, which was grown to an 
OD660 = 0.75, R. sphaeroides COX were run on a 16% Fuller gel and stained with Bio-
Safe Coomassie. 
Lane 1: wt 4 µg, lane 2: G239Stop3 4 µg, lane 3: wt 8 µg, lane 4: G239Stop3 8 µg.  
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Figure 46 
 
Immunoblot of wild-type and All Three G239Stop1-3  Preparations Using a Cocktail 
of the Three Polyclonal Antibodies To R. sphaeroides COX SIII. 
Approximately 4 µg of wild-type and G239Stop1-3 mutant R. sphaeroides COX were run 
on a 16% gel, were then transferred to PVDF membrane, and probed for with a cocktail 
of three primary antibodies.  In panel A, the antibodies directed towards amino acid 
residues 64-77 and 225-238 were added at a dilution of 1:250 and the antibody directed 
towards amino acid residues 110-123 was added at a dilution of 1:500 in TBS-B.  In 
panel B, the antibodies directed towards amino acid residues 64-77 and 225-238 were 
added at a dilution of 1:250 and the antibody directed towards amino acid residues 110-
123 was added at a dilution of 1:500 in TBS-B, and 0.1 mg of free peptide was also 
included in the primary antibody incubation. 
A.  Lane 1: wt, lane 2: G239Stop1, lane 3: G239Stop2, lane 4: G239Stop3.  
B.  Lane 1: wt, lane 2: G239Stop1, lane 3: G239Stop2, lane 4: G239Stop3.  
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contained 19% helix 7 deleted SIII, compared to wt. The preparation that was grown to 
an OD660 = 1.0-1.2 (G239Stop1) had 13% of helix 7 deleted SIII, compared to wt.   
Therefore, the proteolytic degradation of the helix 7 deleted SIII occurred during the 
growth of the mutant, which would suggest that this mutation is creating a highly  
unstable form of SIII that is being targeted for degradation.  Furthermore, it remained 
unclear what was reacting with the antibodies at 6 kD.  Through the use of MALDI-TOF 
mass spectrometry it was possible to determine the exact molecular weight of the 
proteolytic fragments and then assign that molecular weight to a region of SIII, based on 
the immunoblot results. 
 
Low Molecular Weight MALDI-TOF Mass Spectrometry of wt and G239Stop 
Mutant Enzyme 
 
In an effort to identify the lower molecular weight proteins MALDI-TOF mass 
spectrometry was performed using the matrix CHCA.  In the wt spectra there is only one 
peak found below 10,000 Da, and it is SIV, which has a mass/charge (m/z) equal to 5,273 
(see Figure 20).  This peak is present or absent in I/II oxidase depending on the source of 
the enzyme as discussed previously, but is absent in the G239Stop1 and G239Stop3 
mutant (Figure 47).    However, there are several peaks present in G239Stop1 and 
G239Stop3 enzyme that are not present in the wt enzyme or I/II oxidase (Figure 48).  
G239Stop2 was not analyzed using MALDI-TOF mass spectrometry because of technical 
issues with the instrument.  A limitation to this analysis is that the R.  sphaeroides 
protease specificities are not well characterized.  There is no published literature that  
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Figure 47 
 
MALDI-TOF Mass Spectrometry of wt, G239Stop1, and G239Stop3 Mutant 
Enzymes Showing the Absence of SIV.  wt, G239Stop1, and G239Stop3 were diluted 
with 30 mM Tris-Cl, pH 7.4 and concentrated down to a minimal volume (< 10 µL) in a 
Microcon-30.  The samples were then brought up to a concentration of 1 µg/µL.  1 µL of 
each sample was mixed with the EAM CHCA and then pipetted onto a Ciphergen Gold 
chip.  The gold protein chip was then loaded into a Ciphergen SELDI Protein Biology 
System II (Ciphergen, Palo Alto, CA) and analyzed.  Each spot was ionized 3 to 5 times 
over different areas within the spot.  Fifty laser hits were averaged for each area on the 
spot.  This resulted in a mass profile for each sample.  The spectra were then externally 
calibrated using mass standards from Ciphergen.  FPLC purified wt (A) and G239Stop1 
(B) and G239Stop3 (C) enzyme.  G239Stop1 and G239Stop3 do not contain SIV. 
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Figure 48 
 
MALDI-TOF Mass Spectrometry of wt, G239Stop1,and G239Stop3 Mutant 
Enzymes Showing the Presence and Molecular Weights of the Proteolytic 
Fragments.  wt, G239Stop1, and G239Stop3 were diluted with 30 mM Tris-Cl, pH 7.4 
and concentrated down to a minimal volume (< 10 µL) in a Microcon-30.  The samples 
were then brought up to a concentration of 1 µg/µL.  1 µL of each sample was mixed 
with the EAM CHCA and then pipetted onto a Ciphergen Gold chip.  The gold protein 
chip was then loaded into a Ciphergen SELDI Protein Biology System II (Ciphergen, 
Palo Alto, CA) and analyzed.  Each spot was ionized 3 to 5 times over different areas 
within the spot.  Fifty laser hits were averaged for each area on the spot.  This resulted in 
a mass profile for each sample.  The spectra were then externally calibrated using mass 
standards from Ciphergen.  FPLC purified wt (A) G239Stop1 (B) G239Stop3 (C) are 
shown.  
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addresses this issue, which means that it is difficult to unequivocally assign the masses to 
a specific portion of SIII.  The peak with m/z = 6,081 could be assigned residues 185-238  
of SIII.  This is because this is the only peptide that retains the full epitope for the 
antibody directed towards the loop region containing amino acid residues 225-238.  The  
source of the other three peptides is uncertain, but possible candidates are shown in Table 
X.  There is also the possibility that one or more of those three peaks could be SIII 
fragments that do not contain an epitope for either antibody and are simply degradation 
products.  Several peptides could be excluded from the list because the antibody directed 
towards amino acids 110-123 fails to react with the low molecular fragments.  
Regardless, it was clear that each preparation of G239Stop1-3 had different amounts of 
helix 7 deleted SIII and that each preparation underwent significant proteolytic 
degradation during growth.  The stoichiometry of the fragments to SI and SII is unknown.  
Therefore, it is likely that anti-SIII antibodies are underestimating the content of SIII in 
these preparations.  Additonally, it remained unclear how this mutation would affect the 
activity of the enzyme.   
 
Detergent Solubilized Electron Transfer Rates of wt and G239Stop1-3 
Initial electron transfer activity measurements of G239Stop1-3 were performed 
with enzyme solubilzed in the detergent DM.  Figure 48 shows the Vmax for wt, I/IIBD 
oxidase, G239Stop1, G239Stop2, and G239Stop3 (the black bars represent no exogenous 
lipid added, while the gray bars represent exogenous lipid added).  All three G239Stop 
preparations have severely reduced Vmax values; however, the preparation that had the 
highest Vmax was G239Stop3, which contained 26% of helix 7 deleted SIII (see Figure 46)  
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Table X 
 
MALDI-TOF Peak Masses and Residue Assignments 
in G239Stop1 and G239Stop3. 
 
 
 
Sample m/za Residuesb Antibody Epitopec 
G239Stop1 and 3 6061 2-56, 44-99, 33-85, 34-
86, 59-110, 42-94 
64-77 
 6081 184-238 225-238 
 6101 23-78, 64-115, 50-100, 
60-111, 38-91  
64-77 
 6164 32-85, 41-93, 37-91, 
45-97, 52-102, 26-80, 
39-92  
64-77 
 
 
a Average mass to chrage ratio as determined by MALDI-TOF mass spectrometry using 
the EAM CHCA. 
b Amino acid residues that could match the average m/z determined in a 
c Antibody epitopes that correspond to the amino acid residues. 
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Figure 49 
 
Vmax of Electron Transfer Activity in wt, I/II, and G239Stop1-3 Mutants. 
The maximum electron transfer activity of detergent solubilized COX was measured 
using a Clark oxygen electrode (Yellow Springs Instrument Company Model 17372).  In 
the absence of enzyme, ascorbate (18 µM), cytochrome c (type III) (20-40 µM), and 0.6 
mM TMPD were incubated in 25 mM HEPES-NaOH, pH 7.0, with 0.1% DM at 25°C in 
the electrode chamber for 3 minutes.  This allows the rate of cytochrome c auto-oxidation 
to be measured.  Then 5-10 pmoles of COX was added to determine the maximum rate of 
COX electron transfer activity for 3 minutes.  The assays were also done under the same 
conditions as described above except that 1 mg/mL asolectin was added to the assay 
buffer, prior to adding the enzyme.  The graph depicts the detergent solubilized Vmax for 
wild-type, I/IIBD, G239Stop1, G239Stop2, and G239Stop3 in the absence (black) and in 
the presence (gray) of exogenous lipids.     
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Table XI 
Summary of Detergent Solubilized Enzyme Functional Data, Subunit Content, and 
Visible Spectroscopy in wt and G239Stop1-3. 
 
Preparation Electron Transfer 
Activitya 
% SIII Content by 
Immunoblotb 
Shift in Reduced  
α-Peak Absorbancec 
wt 1361 ± 78 100 0 
G239Stop1 301 ± 9 13 2 
G239Stop2 236 ± 37 19 3 
G239Stop3 469 ± 18 26 1 
 
a  Electron transfer activity was monitored in an oxygen electrode (see Materials and 
Methods).  The averages and standard deviations were calculated from three assays for 
each enzyme. 
b  SIII content was measued using a cocktail of polyclonal antibodies.  The sum of the 
intensities was used to determine the amount of SIII present, compared to wild-type 
enzyme. 
c  The shift in α-peak absorbance was measured using a diode array spectrophotometer. 
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and the smallest shift in the α-peak absorbance (1 nm) (see Figure 45).  The preparation 
that had the lowest activity was G239Stop2, which had 19% of helix 7 deleted SIII (see  
Figure 46A) and the largest shift in α-peak absorbance (3 nm) (see Figure 42).  Table XI 
provides a summary of the optical absorbance, immunoblot, and electron transfer activity 
data.  Exogenous lipids were added to the assay buffer to rule out the possibility of 
delipidation being the reason for the decrease in activity (Figure 49).  Added lipids 
increased electron transfer activity from 35-40% in all of the samples, which was similar 
to I/IIGD.   
 Based on the optical absorbance measurements and the immunoblot data it is 
apparent that all three preparations of G239Stop contain a mixture of enzyme 
populations.  The optical absorbance data suggests that there is a mixture of active and 
inactive enzyme, while the immunoblot data indicates that there are at least three 
populations of enzyme present in each of the three preparations of G239Stop mutant 
enzymes.  One population contains I/II oxidase and accounts for between 74-87% of the 
total enzyme population, and the other two populations contain either the helix 7 deleted 
SIII or the proteolytic fragments of SIII and account for the other 13-26% of the total 
enzyme population.  It remained unclear which enzyme population was being measured 
in the oxygen electrode.   
 Previous pH dependence experiments, using flow-flash stopped-flow optical 
spectroscopy, have shown that the pKa is shifted from about 9 down to 7.5 when SIII is 
removed from COX (Gilderson et al. 2003).  Therefore, if the pH dependencies of the 
G239Stop1-3 mutants are the same as I/II oxidase then it could be assumed that the 
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electron transfer activity being measured is that of I/II oxidase, and that the observed loss 
in activity can be attributed to the inactivation of the enzyme during growth.   
 Figure 50 shows the pH dependence of wt, I/IIBD, Gly239Stop1, Gly239Stop2, and 
Gly239Stop3 (black, red, green, blue, and magenta lines, respectively).  Since the  
activities are different for each enzyme assayed, the activities are plotted as a percentage 
of the Vmax.  The wt enzyme has the highest electron transfer activity at pH 7.5 and  
retains a high level of activity until about pH 8.5 to 9.0.  On the other hand, I/IIBD, 
Gly239Stop1, Gly239Stop2, and Gly239Stop3 enzymes have the highest electron transfer 
activity at pH 7.0, and exhibit a loss of most of the activity between pH 7.5 to 8.0.  This 
is not only consistent with what has been reported in the literature with regards to I/II 
oxidase (Gilderson et al. 2003), but it also supports the earlier suggestion that the 
observed activity of the G239Stop mutants is driven by the activity of I/II oxidase present 
in each of the preparations.  However, it was unclear whether G239Stop contributed 
either to the increase or the decrease in electron transfer activity in these preparations.  
The second preparation of enzyme, G239Stop2, had more helix 7 deleted SIII than the 
first preparation and less SIII than the third preparation, and exhibited the lowest activity.  
This would suggest that the reduction in electron transfer activity is independent of 
mutant SIII content and dependent upon the amount of inactivation occurring during 
growth.   
 Previously it was shown that when I/II oxidase was inactivated by catalytic 
turnover it became more susceptible to proteolytic digestion by α-chymotrypsin (see 
Figure 28).  If the above suggestion is true and there are two distinct populations of  
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Figure 50 
 
pH Dependence of wild-type, I/II, and G239Stop Mutants. 
The electron transfer activity of detergent solubilized COX, at different pH values, was 
measured using a Clark oxygen electrode (Yellow Springs Instrument Company Model 
17372).  All buffers were adjusted to an I = 100 mM using KCl.  25 mM HEPES-NaOH 
was used for pH values 7.0-8.5 and 25 mM CHES-NaOH was used for pH values 9.0-
10.0.  Buffer composition was calculated using an online buffer calculator, described in 
Materials and Methods.  The enzymes were diluted to 5 pmole/µL in 25 mM HEPES-
NaOH, pH 7.5.  In the absence of enzyme, ascorbate (18 µM), cytochrome c (type III) 
(20-40 µM), and 0.6 mM TMPD were incubated in either 25 mM HEPES-NaOH or 25 
mM CHES-NaOH at each pH value, with 0.1% DM at 25°C in the electrode chamber for 
3 minutes.  This allows the rate of cytochrome c auto-oxidation to be measured.  Then 5-
10 pmoles of COX was added to determine the maximum rate of COX activity.  Each 
sample was assayed at each pH value at least three times and the averages and standard 
deviations were then calculated for each sample and pH.  The pH dependence of wt is 
shown in black, I/II oxidase is shown in red, G239Stop1 is shown in green, G239Stop2 is 
shown in magenta, and G239Stop3 is shown in blue. 
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enzyme, an inactive fraction and an active fraction, then digestion with α-chymotrypsin 
of the G239Stop mutants should show the active portion of the enzyme being digested to  
SI’ and SI’’ and the inactive portion of the enzyme which had undergone turnover 
induced inactivation being exhaustively digested away into small fragments.   
 
Time Course of α-Chymotrypsin Digestion with wild-type, I/IIBD, I/IIGD, and 
G239Stop1-3 
 
 Figure 51 shows a 2 hour time point of digestion of wild-type, I/IIBD, I/IIGD, and 
G239Stop1-3 using α-chymotrypsin.  The digestion of wild-type and I/IIBD are similar to 
what has been shown previously.  SI is digested to SI’ and SI’’ and the sum of the two 
bands is approximately equal to undigested SI.  This is consistent with both wt and I/IIGD 
containing 100% active enzyme.  In contrast, I/IIGD undergoes significant digestion into 
small fragments, which results in a loss of 60% of the SI band intensity, which leaves 
about 40% of SI in the form of SI’ or SI’’.  G239Stop1 losses about 25% of its total SI 
intensity to complete digestion and retains about 75% of its total intensity in the forms of 
SI’ or SI’’.  G239Stop2 exhibits a loss of about 40% of the SI intensity, which means that 
about 60% of the total intensity in the form of SI’ or SI’’.  G239Stop3 had the  
smallest loss in its total SI intensity of about 10%, while retaining nearly 90% of the 
original intensity.  The functional and structural data presented thus far is summarized in 
Table XII.   
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Figure 51 
 
SDS-Urea-PAGE of wild-type, I/IIBD, I/IIGD and G239Stop1-3 After Digestion with α-
chymotrypsin for 2 Hours.  
Approximately 4 µg of wild-type, I/IIBD, I/IIGD , and G239Stop1-3 R. sphaeroides COX 
were digested with a 1:10 ratio (w/w) of α-chymotrypsin for 0 and 2 hours, run on a 16% 
gel and stained with Bio-Safe Coomassie.  Lane 1: wild-type no digestion, lane 2: I/IIBD 
no digestion, lane3 I/IIGD no digestion, lane 4: G239Stop1 no digestion, lane 5: G239Stop2 
no digestion, lane 6: G239Stop3  no digestion, lane 7: wild-type 2 hour digestion, lane 8 
I/IIBD 2 hour digestion, lane 9: I/IIGD 2 hour digestion, lane 10: G239Stop1 2 hour 
digestion, lane 11: G239Stop2 2 hour digestion, lane 12: G239Stop3 2 hour digestion. 
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Table XII 
 
Summary of Electron Transfer Activities, SIII Content, and Active Enzyme Content. 
 
Enzyme Turnover 
Numbera 
% Inhibitedb α-peak 
Max 
(nm) 
% SIII Content 
Immunoblotc 
T.I.Ad % Active 
Enzyme Based 
on Proteolysise 
 
wt 1361 ± 78 
 
0 606 100 No 100 
I/IIBD 931 ± 94 
 
31 606 0 Yes 100 
I/IIGD 322 ± 0 
 
76 602 0 Yes 40 
G239Stop1 301 ± 9 
 
79 604 13 Yes 75 
G239Stop2 236 ± 37 
 
83 603 19 Yes 60 
G239Stop3 469 ± 18 
 
66 605 26 Yes 90 
 
a Turnover numbers were measured in an oxygen electrode.  The assay buffer was 
composed of ascorbate (18 µM), cytochrome c (type III) (20-40 µM), and 0.6 mM TMPD 
were incubated in 25 mM HEPES-NaOH, pH 7.0, with 0.1% DM at 25°C.  5-10 pmoles 
of COX was added to determine the maximum rate of COX electron transfer activity for 
3 minutes. 
b Percent (%) inhibition refers to the decrease in maximum turnover number compared to 
wt enzyme. 
c SIII content for wt and G239Stop mutants was measured using a cocktail of three site-
directed antibodies towards SIII.  The immunoblots were developed in a Fuji LAS-3000 
Imager (see Materials and Methods). 
d Turnover Induced Inactivation (T.I.A.) refers to the process of COX undergoing 
inactivation as result of catalytic turnover. 
e The percent (%) active enzyme was estimated based on staining intensity on SDS-Urea-
PAGE.  The staining intensity of the α-chymotrypsin products SI' and SI'' was summed 
and that value was divided by the staining intensity of undigested SI. 
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Electron Transfer and Proton Pumping Activities of Reconstituted wt, I/IIBD, and 
G239Stop3 
 
 Due to the fact that G239Stop3 contained the most helix 7 deleted SIII, exhibited 
the highest activity, and displayed the smallest shift in absorbance it was reconstituted 
into phospholipid vesicles and functionally characterized.   Table XIII summarizes the  
electron transfer activities and proton pumping function of wt, I/IIBD oxidase, and 
G239Stop3 when reconstituted into liposomes.   Electron transfer activity was measured 
under three different conditions: controlled, in the presence of Val, and uncontrolled.  In  
the controlled state, the enzyme turns over in the presence of both a membrane potential 
and proton gradient.  In the presence of Val, the membrane potential is dissipated; 
however, the proton gradient is still present.   Finally, in the uncontrolled state, both the 
membrane potential and proton gradient are dissipated.  The uncontrolled rate represents 
the maximum rate of turnover in the presence of a membrane bilayer.  Based on these 
results RCR and RCRval values were calculated and are also presented in Table XIII.   
 In a controlled state, the turnover number of wt exhibits an electron transfer rate 
of 88 s-1, while the controlled turnover number for I/IIBD oxidase and G239Stop3 are 
inhibited by 50% and 66%, respectively.  In the presence of Val, the rate of electron 
transfer is stimulated about 2 fold in wt and I/IIBD oxidase, while in contrast the addition  
of Val only stimulated the electron transfer rate of G239Stop3 by 20%.  This indicates 
that the proton gradient is exhibiting an inhibitory effect on the electron transfer activities 
of G239Stop3.  The uncontrolled rate of wt and I/IIBD oxidase, in the absence of both 
gradients, are similar.  However, the uncontrolled rate of electron transfer in G239Stop3 
is inhibited by 64%, as compared to wt.  The RCR values of I/IIBD oxidase and 
G239Stop3 are elevated due to the fact that the controlled rate of electron transfer in these  
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enzymes is inhibited, compared to wt COX.  Since the electron transfer activity of I/IIBD 
oxidase and G239Stop3 is still inhibited, compared to wt, the RCRval values are quite 
high, which further emphasizes the inhibitory effect of the proton gradient on the activity 
of these enzymes.   
 When G239Stop3 was reconstituted into phospholipid vesicles the Vmax is reduced 
by about 64% compared to wt or I/II oxidase (Table XIII).  After undergoing six minutes 
of turnover in the presence of membrane potential and pH gradient the enzyme is 60-65% 
inactivated, which is comparable to the inactivation rate of I/IIBD oxidase.  Furthermore, 
in experiments in which wt, I/IIBD oxidase, and G239Stop3 were assayed for proton 
pumping efficiencies: the proton pumping of I/IIBD oxidase and Gly239Stop3 were both 
reduced by 40% compared to wild-type (Figure 52).     
 The structural and functional data suggest that there is a mixed population of 
active and inactive COX enzyme in the three preparations of G239Stop.  The severity of  
the shift in α-peak absorbance can be minimized by harvesting the bacterial cultures at a 
lower optical density.  This shift in absorbance appears to be indicative of inactive 
enzyme, because G239Stop3 had the smallest shift in α-peak absorbance and the highest 
rate of electron transfer activity, while the G239Stop2 had the largest shift in α-peak  
absorbance and the lowest rate of electron transfer activity.  The pH dependency 
experiments also showed that the activity of the G239Stop mutants was governed by the 
activity of I/II oxidase.  This result is not surprising since I/II oxidase accounts for 74-
87% of the total enzyme content.  Furthermore, the inactive population of enzyme can be  
estimated throught the use of limited proteolysis because this fraction of enzyme is in an 
alternative, more relaxed, conformation and as a result it is more susceptible to  
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Figure 52 
 
Proton Pumping of wild-type, I/II, and G239Stop3.  
Proton translocation activity of COX containing vesicles was measured on an Applied 
Photophysics SX.18MV Stopped-Flow Reaction Analyser.  Assays were performed at 4 
turnovers.  For these experiments two samples were prepared:  a COX containing vesicle 
sample and a cytochrome c sample.  The COX containing vesicle sample contained 50 
µM HEPES-NaOH, pH 7.4, 50 mM KCl, 50 mM sucrose, 100 µM phenol red, 0.1 µM 
aa3, and 5 µM Val or 5 µM Val and 5µM CCCP.  The cytochrome c containing sample 
contained 50 µM HEPES-NaOH, pH 7.4, 50 mM KCl, 50 mM sucrose, 100 µM phenol 
red, 3.2 µM (4 turnovers) reduced cytochrome c (type IV), and 5 µM Val or 5 µM and 
5µM CCCP.  Wt, I/II oxidase, and G239Stop3 were monitored for proton pumping ability 
at 556 nm.  An increase in absorbance indicates an alkalinization of the exterior of the 
liposome, which occurs when both Val and CCCP are present.  A decrease in absorbance 
indicates acidification of the exterior of the liposome, which occurs in the presence of 
Val.  Wild-type (black), I/II oxidase (red), and G239Stop3 (blue). 
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Table XIII 
 
Summary of Electron Transfer Activities and Proton Pumping Function of 
wt, I/IIBD, and G239Stop3. 
 
Enzymea Con. Rateb 
Val 
Ratec 
Uncon. 
Rated RCR
e RCRvalf H+/e-g T.I.A.h 
SIII 
Contenti 
wt 88 + 7 187 + 7 900 + 42 10.3 + 1.2 4.8 + 0.1 
0.75 ± 
0.05 No 100% 
I/II 44 + 7 84 + 0 844 + 25.0 19.6 + 3.0 
10.1 + 
0.3 
0.4 ± 
0.03 Yes 0% 
G239Stop3 30 + 6 38 + 3 320 + 18 
11.0 + 
2.9 8.5 + 1.0 
0.4 ± 
0.05 Yes 26% 
 
 
a The enzymes used in the experiment were nickel column purified.  Approximately 5-10 
pmoles of enzyme was used for each assay. 
b The controlled rate represents the electron transfer activity of each enzyme in the 
presence of both a membrane potential and proton gradient. 
c The Val rate represents the electron transfer activity of each enzyme in the presence of a 
proton gradient, but in the absence of a membrane potential, which was dissipated by the 
addition of Val. 
d The uncontrolled rate represent the maximum electron transfer activity of the enzymes 
when reconstituted into a phospholipid vesicle.  The membrane potential was dissipated 
by the addition of Val and the proton gradient was dissipated by the addition of CCCP. 
e RCR is the ratio of the uncoupled rate of electron transfer (with both Val and CCCP 
present) to the basal rate of electron transfer, both rates are corrected for the auto-
oxidation of cytochrome c. 
f RCRval is the ratio of the uncoupled rate of electron transfer (with both Val and CCCP) 
to the Val rate of electron transfer, both rates are corrected for the auto-oxidation of 
cytochrome c. 
g H+/e- ratio refers to the proton to electron ratio measured in a stopped flow instrument.  
The absorbance changes of the pH indicator dye, phenol red, were monitored at 556 nm.   
h T.I.A. stands for turnover induced inactivation.  This process is measured in an oxygen 
electrode and time dependent. 
i SIII content was determined by immunoblots.  A cocktail of three different polyclonal 
antibodies were incubated with the blots and the blots were developed using a Fuji 
LAS3000 imager. 
Averages and standard deviation for wt and G239Stop3 are taken from two preparations 
of liposomes and averages and standard deviations for I/IIBD are taken from one 
preparation of liposomes.  
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proteolytic degradation, by α-chymotrypsin.  Finally, the enzymatic functions of 
reconstituted G239Stop3 resemble that of I/IIBD oxidase, except that the electron transfer 
activity is reduced by 64%, a result consistent with what was observed with soluble 
enzyme.  The effect of removing helix 7 on the function of the enzyme is unclear since 
there is such a low abundance of SIII in each of the preparations; however, due to the fact 
that the helix 7 deleted SIII becomes degraded during the growth of the bacteria it is clear 
that this helix serves an important role in maintaining the proper three dimensional 
structure in SIII.     
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IV. DISCUSSION 
 
 
 The overall goal of the work presented in this dissertation work was to further 
elucidate the role of SIII in the structure and function of COX.  SIII can be removed from 
the mitochondrially encoded forms of COX through the use of proteases and biochemical 
depletion (Prochaska and Reynolds 1986; Wilson and Prochaska 1990; Nguyen et al. 
2002); however genetic manipulation and site-directed mutagenesis of SIII has not been 
performed since SIII is encoded for by the mitochondrial DNA.  Therefore, using COX 
isolated from the bacterium R. sphaeroides it was possible to genetically and 
biochemically deplete SIII from the enzyme complex, by established methods (Bratton et 
al. 1999; Bratton et al. 2000).  Furthermore, this model allows for site-directed 
mutagenesis to be performed on the enzyme.  The experimental rationale was to first 
determine the structural consequences of SIII removal on the structures of SI and SII.  
Then to use site-directed mutagenesis to mutate specific highly conserved amino acids 
that were predicted to be involved in interhelical H-bonds.  Site-directed mutagenesis was 
also used to delete a highly conseved C-terminal helix of SIII, a mutation which mimics a 
human SIII mutation that leads to encephalopathy (Hanna et al , 1998).   
 The functional affects of SIII removal have been extensively studied and are well 
documented.  There is a general concensus that in the absence of SIII there are significant 
functional consequences, in both mitochondrial and bacterial COX enzymes.  Previous 
experiments have shown that proton pumping, proton uptake into the D-channel, and 
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sustained electron transfer activities are all affected in the absence of SIII (Prochaska and 
Reynolds 1986; Wilson and Prochaska 1990; Haltia et al 1994, Bratton et al 1999, 
Nguyen et al 2002; Gilderson et al, 2003; Mills et al, 2003).  Therefore, it has been 
hypothesized that SIII is responsible for maintaining the structure of the D-channel and 
prevents turnover induced inactivation.  There is little published evidence indicating that 
the removal of SIII affects the structure of COX.  Several studies have shown, using 
COX from P. denitrificans, that SIII functions in assembly and stabilization of the 
enzyme complex (Haltia et al. 1989; Haltia et al. 1991; Haltia et al. 1994).  The structural 
consequences of removing SIII from COX have not been addressed until now.   
 Energy minimizations calculations were performed in an effort to determine if it 
was possible to predict the structural changes in SI and SII when SIII was removed.  The 
results showed that there were significant changes (>0.5 Å) in the positions of amino 
acids located in helices 3-7 of SI (adjacent to SIII), while the remainder of SI showed 
virtually no movement.  Many of the amino acids that make up the D-channel are found 
within these helices, as well several well ordered water molecules, which serve as a 
proton conducting chain (Svensson-Ek et al. 2002).  The predicted movement of these 
helices could cause the water molecules, in the D-channel, to become less ordered.  As a 
result, the uptake of protons into the D-channel and subsequent movement through the D-
channel would be severely compromised.  Furthermore, the protons taken up by the D-
channel are the protons that are pumped.  This interpretation of the data is supported by 
the fact that in the absence of SIII, slower rates of proton uptake into the D-channel have 
been reported (Gilderson et al. 2003; Mills et al. 2003), and it has been known for quite a 
while that SIII removal reduces proton pumping efficiency (Thompson et al. 1985; 
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Wilson and Prochaska 1990; Mills et al. 2003).  Furthermore, if protons are not being 
taken up there is less positive charge entering SI.  As electrons flow to the active site 
there is a negative charge being introduced to the interior of protein that must be 
neutralized for electron transfer to proceed (Mitchell and Rich 1994; Verkhovsky et al. 
1995).  Failure to neutralize the negative charge could potentially short circuit the 
enzyme and cause electron transfer activity to slow down, which could account for the 
turnover induced inactivation observed in COX lacking SIII (Haltia et al. 1994; Bratton et 
al. 1999).  The change in SI conformation appeared to be a plausible explanation for the 
changes in the activity; however, more rigorous experimental analysis needed to be 
performed. 
 Further testing of this model also needed to be performed because a recent high 
resolution structure of I/II oxidase, from R. sphaeroides, has been resolved (Qin et al. 
2006).  The new crystal structure shows that there is no difference between the structures 
of SI in wild-type and I/II oxidase.  This is in contrast to what was observed in the energy 
minimization calculations; however, the energy minimization calculations were only 
theoretical.  Yet there are several explanations for the observed differences between the 
crystal structure and the energy minimization calculations.  First, there may not be any 
change in structure associated with SIII removal; however, this does not seem likely 
based on the functional characteristics of I/II oxidase.  Second, the high concentration of 
protein used in the crystallization forced SI into a "wild-type" conformation, which has 
been suggested for another membrane protein (Zhang et al. 2006) and is supported by the 
fact that the wild-type and I/II oxidase enzymes both crystallize as a nonphysiological 
dimers (Svensson-Ek et al. 2002; Qin et al. 2006).  Third, the enzyme used in the studies 
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was biochemically depleted of SIII; therefore, the remaining I/II oxidase is wild-type 
enzyme minus SIII that has not undergone catalysis after isolation.  The third explanation 
will be discussed in more detail later in this section.  To test the energy minimization 
model limited proteolysis was used to determine if new sites were being exposed after 
SIII removal.   
 There was the potential that simply removing SIII would expose otherwise 
unexposed aromatic residues along the interface of SI and SIII, but there was also the 
possibility that buried aromatic residues, in SI, would become solvent exposed and 
become accessible for α-chymotrypsin cleavage.  This methodology proved useful; 
however, the results seemed to support the results of Qin et al. 2006 rather than the 
energy minimization calculations.  Wild-type and I/II oxidase were rapidly degraded to 
the products SI' and SI'' within the first hour.  Over the course of three hours wild-type 
had about an equal distribution of SI' and SI'', while I/II oxidase contained about 25% SI' 
and 75% SI'', which meant that SI in wild-type and I/II oxidase was being cleaved in 
nearly the same regions but at different rates.  N-terminal sequencing, mass spectrometry, 
and histidine tag detection experiments confirmed that cleavage was occurring 
exclusively at the N- and C -termini.  One noticeable difference was identified in the N-
terminal sequencing result.  After α-chymotrypsin digestion the N-termini for wild-type 
and I/II oxidase was Gly8; however, I/II oxidase also had a minor sequences that 
indicated there was also cleavage occurring at Phe16 and Phe17.  A simple explanation for 
this result is that the N-terminus of SI interacts with the N-terminus of SIII and the loss of 
this interaction causes the N-terminus of SI to become more solvent exposed and more 
susceptible to proteolytic digestion.  This interpretation is supported by the crystal 
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structure of wild-type R. sphaeroides COX (Svensson-Ek et al. 2002).  In the crystal 
structure the first 13 amino acids of SI are absent which means that these amino acids are 
highly mobile and could not be resolved.  In addition, there are two potential hydrogen 
bond interactions between the N-terminus of SI and the N-terminus of SIII.  The first 
interaction is between Leu12 in SIII with Thr24 in SI.  The second interaction occurs 
among three amino acids Ser15 in SIII, Met22 in SI, and Ser23 in SI, which is mediated by 
a water molecule, located at the SI/SIII interface.  The removal of SIII would abolish 
these interactions and the N-terminus of SI would become more mobile and more 
susceptible to proteolytic digestion.  The remainder of SI, in wild-type and I/II oxidase, 
was more or less proteolytically resistant since the sum of the intensities for SI' and SI'' 
was equal to the intensity of undigested SI.  The results were not as expected because a 
totally different digestion pattern with I/II oxidase was anticipated; however, upon 
growing and isolating I/II oxidase that had SIII genetically deleted (I/IIGD oxidase) a new 
hypothesis emerged. 
 Functionally, I/IIGD oxidase was quite different from that of wild-type and I/IIBD 
oxidase.  The electron transfer activity of I/IIGD oxidase decreased over time, which 
indicated that it was undergoing turnover induced inactivation; however, the Vmax of 
I/IIGD oxidase was reduced by 75-80% compared to wild-type and I/IIBD oxidase.  The 
reduced α-peak of heme aa3 was also shifted to the blue by 4 nm.  These structural and 
functional characteristics were also observed in P. denitrificans COX that had SIII 
genetically deleted (Haltia et al. 1989).  This study also revealed that new sites of 
proteolysis occurred in SI and SII when SIII was absent.  They concluded that COX 
assembles inefficiently in the absence of SIII and that SIII may be involved in a late step 
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of complex assembly.  This would support the observation that there is an accumulation 
of free SI, which can be removed by high affinity anion exchange chromatography, when 
SIII is genetically deleted, and brings about the possibility that while in the membrane 
I/II oxidase is catalytically active but the lifetime of the enzyme is drastically reduced.  In 
other words, as the enzyme turns over it begins to change conformation and become 
catalytically inactive (ie. turnover induced inactivation).  The inactivation process would 
lead to dissociation of SI from SII and result in the observed free SI, and would also 
result in a heterogeneous population of purified enzyme that contains both active and 
inactive forms of I/IIGD oxidase.  The change in conformation could be similar to what 
was predicted by the energy minimization calculations presented earlier.  If there is a 
large change in conformation, as a result of turnover induced inactivation, then there 
should also be a change in the pattern of protoelytic digestion with I/IIGD, compared to 
wild-type and I/IIBD.  
 Digestion of I/IIGD oxidase with α-chymotrypsin showed that SI had become 
highly susceptible to proteolytic digestion.  In wild-type and I/IIBD oxidase the sum of the 
intensities from SI' and SI'' are equal to the intensity of undigested SI.  In contrast, with 
I/IIGD, 50% of the total intensity is lost in the first hour of digestion and about 70% of the 
intensity is lost at hour three.  This means that nearly 70% of the enzyme is in an altered, 
and most likely inactive conformation.  The reduction in electron transfer activity and 4 
nm blue shift is attributed to the inactive population having an altered active site.  
Turnover induced inactivation leads to the loss of CuB (Bratton et al. 1999), which could 
account for the shift in absorbance.  Mutation of the gene responsible for CuB insertion, 
Cox11p, results in an enzyme devoid of CuB, ∆COX11 (Hiser et al. 2000).   The purifed 
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enzyme displays a 4 nm blue shift in reduced α-peak absorbance of heme aa3, and is has 
a severely reduced electron transfer activity (Hiser et al. 2000).  It was concluded that the 
heterogeneous population of active and inactive I/IIGD oxidase was a result of turnover 
induced inactivation occurring in the membrane, due to the absence of SIII.  Therefore, it 
appeared as though I/IIGD oxidase underwent inactivation in the bacterial membrane 
during growth of the bacterium.  While this interpretation is speculative, it can be tested.  
I/IIBD has a Vmax that is comparable to that of wild-type; however, I/IIBD also displays 
turnover induced inactivation (Bratton et al. 1999).  Therefore, by inactivating I/IIBD and 
then digesting it with α-chymotrypsin the digestion pattern should resemble that of I/IIGD 
oxidase. 
 After catalytic inactivation, I/IIBD oxidase became highly susceptible to 
proteolysis and there was no evidence for the formation of SI' or SI''.  Therefore, the 
inactivation process induced a conformational change that resulted in amino acid 
residues, otherwise buried in the interior of SI, to become exposed and cleaved.  It was 
mentioned previously that CuB dissociates from the active site during turnover induced 
inactivation (Bratton et al. 1999).  The copper atom is coordinated by three histidine 
residues (His284, His333, and His334) (Shapleigh et al. 1992; Svensson-Ek et al. 2002).  
Loss of CuB center from I/II oxidase would be expected to weaken the interaction of 
helices 6 and 7 of SI (Hosler 2004), an interaction our energy minimization calculations 
already predicted to be weaker in the absence of SIII even in the presence of CuB.  
Therefore, in order for CuB to dissociate there must be a large scale change in 
conformation that causes these histidine residues to dissociate and release CuB from the 
active site.   
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 Proteolysis of a mutant, which lacks CuB (∆COX11) (Hiser et al. 2000), resulted 
in a proteolytic digestion pattern similar to that of inactivated I/IIBD oxidase.  The loss of 
CuB caused a large conformational change in SI, which made SI more susceptible to 
proteolytic digestion, but it remained unclear why CuB dissociated from the active site.  
One explanation was that the histidine ligands (located in helix 6 and a loop between 
helices 7 and 8 of SI) simply dissociated from CuB, which resulted in a global relaxation 
of SI.  Another explanation was that tyrosine residues around the active site became 
hydroxlyated and that this modification caused the peptide backbone, containing the 
histidine ligands of CuB, to change conformation and release CuB. 
 Both of these possibilities were examined by having the inactivated and digested 
I/IIBD oxidase sent out for peptide analysis and subsequent sequencing.  A single 
proteolytic peptide was identified in the inactivated samples, which was not present in the 
active samples.  Based on mass, alone, the peptide could be assigned residues 237-258 or 
residues 328-347.   It was also shown previously that α-chymotrypsin cleaved after a 
histidine residue (Table II).  When the possibility of any two amino acids being cleaved 
was also included in the analysis of the sequencing data three additional peptides were 
found.  Analysis of the peptide fragmentation data excluded all of the peptides except for 
237-258.  While this ruled out the possibility of a hydroxylation reaction being 
responsible for CuB dissociation it provided evidence that SIII helps prevent turnover 
induced inactivation by stabilizing the binuclear center.  This is because residues 237-258 
are adjacent to SIII and when SIII is absent these amino acids are less ordered and cause 
SI to adopt a more relaxed and open conformation, which leads to the dissociation of CuB 
from the active site.  This interpretation is also consistent with the proteolysis 
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experiments carried out with inactivated I/II oxidase and ∆COX11, which suggested that 
the exhaustive digestion occurring with inactivated I/II oxidase can be attributed to the 
loss of CuB. 
 Newly published results using hydrogen/deuterium exchange kinetics of the 
peptide backbone coupled with mass spectrometry during initial electron transport 
showed that there are differences in solvent accessibility in each of the catalytic 
intermediates (Busenlehner et al. 2006).  Most notable changes occurred in the SI 
peptides corresponding to residues 160-175 and residues 320-340.  Residues 160-175 are 
located below the globular domain of SII and residues 320-340 are located on a loop that 
is folded into the interior of SI (Svensson-Ek et al. 2002).  During the formation of the F 
intermediate (see Figure 7), deuterium exchange is restricted in the region harboring the 
peptide 160-175 while the exchange of deuterium is enhanced in the region peptide 
containing the peptide 320-340.  This was interpreted as peptide 160-175 acting as a 
water or proton gate and peptide 320-340 acting as the proton exit channel, suggesting as 
the proton exit channel opens to release protons, the gate closes to prevent the water or 
protons from leaking back into the interior of COX.  This observation supports the 
limited proteolysis result with inactivated COX.   A possible mechanism which occurs 
during the process of turnover induced inactivation is that the SI peptide 320-340 changes 
conformation and moves out of the interior of the protein.  At this point CuB dissociates, 
due to global relaxation of the peptide backbone surrounding the active site.  As a result 
peptide 320-340 is unable to assume its previous conformation, and becomes the central 
loci for exhaustive digestion.  Further proteolysis and mass spectrometry experiments 
need to be performed to determine if this is the correct mechanism.  Furthermore, it 
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would also be of great benefit to determine the structure of inactivated I/II oxidase, since 
the current structure (Qin et al. 2006) fails to address the fact that the enzyme crystallized 
has been created by depleting the wild-type enzyme of SIII.   
 It was discussed in some detail how removing SIII influences the structural 
conformation of SI.  The affects are not apparent until after catalytic turnover, but it is 
clear that SIII functions to maintain the proper three dimensional structure of the active 
site, and consequently the structure of SI.  The goal of Specific Aim II was to identify 
potential interhelical H-bonds in SIII and then disrupt the H-bonds through the use of 
site-directed mutagenesis.  It is hypothesized that these interactions are required for 
maintaining the proper three dimensional structure of SIII, and that the proper structure of 
SIII is necessary for sustained electron transfer activity and efficient proton pumping 
activities in SI. 
 The highly conserved amino acid Glu90 was shown to be covalently modified by 
DCCD (Casey et al. 1980; Prochaska et al. 1981).  The modification inhibited electron 
transfer and proton pumping activities in bovine heart COX (Casey et al. 1980; Prochaska 
et al. 1981).  However, site-directed mutagenesis of Glu98 (homologous to Glu90) in SIII 
of P. denitrificans had no effect on proton pumping or electron activity (Haltia et al. 
1991).  However, these experiments were performed in isolated bacterial membranes, 
which could account for the observed differences from the results presented in this work.  
However, it has also been shown that I/II oxidase from P. denitrificans pumps protons as 
well as the three subunit form of the P. denitrificans enzyme and the 13 subunit bovine 
heart enzyme (Hendler et al. 1991), which may also account for this discrepancy.  This is 
 206
in stark contrast to the R. sphaeroides SIII which has been shown to be indispensable in 
COX function. 
 Prior to performing site-directed mutagenesis it was determined that Glu90 from 
R. sphaeroides could potentially H-bond with His212 (identified by Dr. Christine 
Pokalsky).  As an extension to this observation further examination of potential 
interhelical H-bonds was performed using the computer program HBPLUS.  Two clusters 
of H-bonds were identified that were highly conserved in all three organisms. The first 
cluster (also referred to as the triad), involved (R. sphaeroides numbering) Glu90, 
His212, and Tyr246, and the second cluster involved the conserved amino acid R161, 
which makes two contacts with the backbone oxygen atoms of two nonconserved amino 
acids.  Another H-bond involving T138 is found in the bovine SIII, but is absent in P. 
denitrificans SIII.   The remaining H-bonds were not conserved, but when all of the H-
bonds are displayed on the structure R. sphaeroides SIII it becomes clear that these H-
bonds serve to provide complete connectivity among all of the transmembrane helices.  
Site-directed mutants were designed to disrupt the interhelical H-bond while attempting 
to prevent any large scale changes in the overall structure of SIII. 
 Mutating Glu90 to an alanine (E90A) resulted in a significant loss in SIII content.  
This is could be because in the absence of Glu90 the helix does not properly assemble 
and can not be inserted into the lipid bilayer properly.  This type of degradation was 
observed with another SIII mutation that was mutated to mimic a disease causing 
mutation (Bratton et al. 2003).  In this study, amino acids 94-98 were deleted and the 
purified enzyme only contained about 20-25% of its SIII content, compared to wild-type.  
Amino acids 94-98 are positioned above Glu90, on the same helix.  It is not unlikely that 
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deletion of this segment from helix 3 would alter the position of Glu90.  Since both E90A 
and ∆94-98 (Bratton et al. 2003) lose SIII content this which would suggest that Glu90 
must be in a specific location for SIII to be inserted proterly into the lipid bilayer.  Failure 
to do so results in degradation.  However, there is also the possibility that this mutation 
weakens the interactions between SI and SIII and that during purification of the enzyme 
SIII falls off.  The fact that this mutant does not undergo turnover induced inactivation in 
the membrane or have any shift in optical absorbance, like I/IIGD or G239Stop, would 
support this interpretation.  Immunoblots on the flow-through material during nickel 
column purification would quickly resolve this issue.  If low molecular weight species are 
being detected on the immunoblots it would support the first explanation for SIII loss 
(similar to what was observed with G239Stop), and if full length SIII is detected then it 
would support the second explanation.   
 In contrast to the E90A mutation, when His212 was mutated to an alanine or 
phenylalanine (H212A or H212F), or when Tyr246 was mutated to a phenylalanine 
(Y246F) there was no loss in SIII, compared to wild-type.  If one of these residues forms 
an H-bond with Glu90 it would further support the above suggestion that the position of 
Glu90 is required for proper insertion into the lipid bilayer.  The alternative explanation 
is that His212 or Tyr246 does not interact with Glu90; however, that is not the case.  The 
final interhelical H-bond mutant investigated was Arg161, which was mutated to an 
isoleucine (R161I).  This mutant also did not display any loss in SIII content when 
compared to wild-type. 
   All of the triad mutants were reconstituted into phospholipid vesicles and 
assayed for electron transfer activity and proton pumping function.  The Vmax 
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(uncontrolled rate of electron transfer) of H212A, H212F, and Y246F was comparable to 
wild-type enzyme.  However, the controlled rate of electron transfer (in the presence of 
membrane potential and proton gradient) was inhibited in the E90A and I/II oxidase, 
which leads to elevated RCR values.  Previous studies have shown that controlled 
electron transfer activity has been shown to use protons on the exterior of the liposome to 
compensate for the negative charge introduced by electron transfer into SI of COX (Mills 
et al 2003).  The addition of zinc or the removal of SIII has also been shown to inhibit the 
controlled electron transfer activity of COX by blocking or changing the conformation of 
the proton exit pathway, which is responsible for the backflow of protons (Mills et al. 
2002; Mills et al. 2003).  When proton backflow is blocked, the controlled rate of 
electron transfer is inhibited and as a result the RCR values become elevated (RCR is 
calculated by dividing the uncontrolled rate by the controlled rate).  The proton exit 
pathway of the other mutants (H212A, H212F, and Y246F) appears to be functioning 
properly in the controlled state since the RCR values are similar to that of wild-type.  
However, with the exception of Y246F, all of the triad mutants used in this study have 
elevated RCRval values.   
 In the presence of Val, the rate of electron transfer activity increased nearly 2.5 
fold for wild-type and Y246F.  The addition of Val stimulated the electron transfer rate of 
H212A and H212F by only 20 and 30%, respectively, and stimulated the electron transfer 
rate of E90A and I/II oxidase by 25 and 33%, respectively.  This inhibition of electron 
transfer in the presence of Val results in elevated RCRval ratios for: E90A, H212A, 
H212F, and I/II oxidase.  The elevated RCRval values could be a result of the proton exit 
channel being blocked, but it was already established that H212A and H212F have 
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functional proton exit pathways in the presence of a membrane potential and proton 
gradient (controlled state).  This type of inhibition appears to be similar to that of zinc, in 
the controlled state, but is occurring in the absence of a membrane potential.  Since 
electron transfer activity is reduced it is likely that either the proton exit pathway or 
proton uptake pathway is impeded, because it has been shown that for electron transfer 
activity to proceed protons must be present to neutralize the negative charge of the 
incoming electrons (Mitchell and Rich 1994; Verkhovsky et al. 1995; Mills et al. 2003).  
Therefore, there must be either a change in the proton exit pathway or proton uptake 
channel occurring after dissipation of the membrane potential, while the proton gradient 
is still intact, that leads to the observed inhibition of electron transfer in the presence of 
Val.   
 A mechanism that could explain this observed inhibition is based on two pieces of 
evidence already mentioned.  First, Mills et al. (2002) showed that when the membrane 
potential is dissipated the inhibition imposed by zinc is alleviated.  This meant that the 
proton exit channel is open and proton pumping can proceed.  In other words, there is a 
conformational change in SI that causes the proton exit channel to open.  Second, 
Ogunjimi et al. (2000) showed that when Glu90, in bovine COX, is labeled with DCCD 
SIII underwent a conformational change, which caused SIII to become more labile to 
proteolytic digestion.  This modification was also shown to inhibit electron transfer 
activity (Casey et al. 1980; Prochaska et al. 1981). Therefore, it is proposed that upon 
dissipation of the membrane potential the interaction between Glu90 and His212 breaks. 
After the interaction between Glu90 and His212 is lost, SIII undergoes a conformational 
change, which is translated to SI, causing the proton exit channel to open.  This control 
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mechanism is lost in E90A, H212A, and H212F because these mutants are not able to 
form the bond since the H-bond partner has been removed via mutagenesis.  The His212 
mutants could prove to be valuable tools for investigating this proposed mechanism since 
contains wild-type levels of SIII. 
 Another line of evidence supporting this mechanism arose when identifying 
potential interhelical H-bonds.  It was found that the interaction between Glu90 and 
His212 changed depending on the redox state of the bovine enzyme.  This supports the 
hypothesis that SIII undergoes conformational changes during turnover that are 
controlled by the Glu90-His212 interaction.  These conformational changes could be 
translated to SI in order to achieve sustained electron transfer activity and efficient proton 
pumping.  The loss of this interaction would cause SIII to adopt a static conformation that 
appears to downregulate the electron transfer activity over time (ie. turnover induced 
inactivation).  This interpretation is supported by the results of Lincoln et al (2003), 
which reported both upregulation and downregulation of electron transfer activity when 
COX was incubated with site-specific antibodies.  There are several techniques that could 
be employed to examine SIII conformational changes more accurately: fluorescence 
resonance energy transfer (FRET) experiments and cysteine mutagenesis.  The use of 
FRET would allow the investigator to determine which regions of SIII are moving and 
this could potentially be correlated with specific intermediates in the catalytic cycle.  This 
would be particularly useful with H212A and H212F, which have wild-type amounts of 
SIII and appear to already be in a static conformation incapable of undergoing necessary 
conformational changes.  Cysteine mutagenesis could be used to introduce disulfide 
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bonds into SIII, which could restrain mobile regions of SIII, and could also be used in the 
proposed FRET experiments.   
 It was shown in Figure 34 that when E90A, H212A, H212F, and I/II oxidase, in 
liposomes, are uncoupled after 6 minutes of catalytic turnover in the presence of both a 
membrane potential and proton gradient that there is a significant amount of inactivation 
in the maximum rate of electron transfer when compared to the rates of electron transfer 
when the enzymes are uncoupled at the zero minute time point (maximum rate of electron 
transfer in a phospholipids vesicle).  It was also shown previously that the detergent 
solubilized H212A enzyme did not exhibit this process; however when this mutant is 
reconstituted into a phospholipid vesicle it inactivates and loses electron transfer activity 
over time.  This suggests that the interaction between SI and SIII in the reconstituted 
His212 mutants is different than when the enzymes are solubilized in DM micelles.  An 
explanation for the differences in solubilized and reconstituted electron transfer activity is 
that the membrane potential and proton gradient is inducing a conformational change in 
SIII (of the H212 mutants), which is translated to SI, which induces a conformational 
change in the structure of the proton exit or proton uptake channels.  This change in 
conformation of the channels either inhibits proton backflow or proton uptake into SI, 
thereby preventing a positive charge from entering which would compensate for the 
negatively charged electron, a process that has been shown to be necessary for the 
electron transfer (Mitchell and Rich 1994; Verkhovsky et al. 1995; Mills et al. 2003).  As 
a result, SI slows down the electron transfer process to prevent the accumulation of a 
large negative charge at the active site, which could generate reactive oxygen species.  
Therefore, SIII may be responsible for regulating the activity of COX by downregulating 
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electron transfer activity when the conditions on the outside of the membrane are not 
favorable, or when mutation has altered the native conformation of the enzyme.   
 Since this turnover induced inactivation phenotype is observed in SIII mutants it 
is likely that SIII undergoes a conformational change which is translated to SI, and causes 
a reaarangement of amino acids in either the proton exit or proton uptake channels.  
Evidence for SIII undergoing conformational changes comes from a study in which 
Glu90 in bovine COX was labeled with DCCD, a modification shown to inhibit electron 
transfer and proton pumping (Ogunjimi et al. 2000).   After covalent modification with 
DCCD, SIII became highly susceptible to α-chymotrypsin digestion.  If the proton exit or 
proton uptake channels are changing conformation and cause the observed inhibition in 
the electron transfer activity of E90A, H212A, H212F, and I/II oxidase then it seems 
likely that these mutants would also pump protons less efficiently, due to the limited 
number of protons reaching the active site or leaving SI. 
 In order to monitor proton pumping, two sets of data are collected.  One set 
contains COX mixed with Val and the other set contains COX mixed with Val and 
CCCP, and changes in absorbance are monitored with the pH indicator dye phenol red.  
In the presence of both Val and CCCP, there is an increase in absorbance, due to protons 
flowing from the outside of the liposome to the inside to reduce molecular oxygen and 
the net change in absorbance is unaffected regardless of the enzyme or mutation.  The 
samples containing only Val represents proton pumping, because as protons are moved 
from the inside of the liposome to the outside there is an increase in pH, which results in 
a decrease in absorbance.   The extent of absorbance change, in the presence of Val, can 
vary depending on how well the enzyme pumps protons.  In the presence of Val, the 
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enzymes E90A, H212A, H212F, and I/II oxidase all display smaller changes in 
absorbance, compared to wt, in other words the proton pumping function is inhibited.  
Since the proton pumping of these mutants is significantly inhibited, this further 
emphasizes that the proton exit or proton uptake channel is not in the proper orientation, 
thus not allowing protons to be released to the outside or taken up from the inside, of the 
liposome.  Similar results in proton pumping activity have been reported with D-channel 
mutations (Fetter et al. 1995; Pawate et al. 2002).  In contrast, the Y246F mutant showed 
no changes in proton pumping activity, thus excluding this residue as an H-bond partner 
of Glu90 and as a critical amino acid residue for COX function.   
 The optical spectra and the solubilized activity of the R161I mutant suggested that 
the mutation had no effect on the structure of the active site or the activity of the enzyme.  
However, some functional effects are not apparent until the enzyme is reconstituted into a 
phospholipid vesicle, as was the case with the H212A mutant.  The R161I was not 
reconstituted into a vesicle, therefore these activities were not investigated.  Recently an 
arginine residue (Arg226) that is in close proximity to the R161 residue was mutated 
(Varanasi et al. 2006).  The reconstituted enzyme had wild-type activity; however, after 
removing the phospholipid surrounding the enzyme, the mutant enzyme displayed 
turnover induced inactivation.  It was believed that the arginine was responsible for 
coordinating a lipid molecule in the cleft of SIII and that because this lipid molecule was 
loosely attached, after reconstitution the lipid molecule was lost.  Based on the crystal 
structure R161 does not coordinate any lipid molecules.  It does; however, appear to 
provide structural stability by bridging two transmembrane helices.  The loss of this 
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interaction could possibly lead to a less stable SIII.  Future studies in which this mutant is 
reconstituted into phospholipid vesicles are required to investigate this possibility. 
 Specific Aim II was designed to investigate specific highly conserved H-bonds in 
SIII of COX, which were thought to be necessary for maintaining the proper three 
dimensional structure of SIII.  As an extension of this investigation the removal of an 
entire helix was performed.  Helix 7 of SIII is highly conserved and various mutations 
and truncations within this helix have been reported (Manfredi et al. 1995; Hanna et al. 
1998), which lead to a variety of mitochondrial disorders. 
 Helix 7 is a highly conserved and is the final helix in SIII.  The amino acid 
composition of this helix is remarkably high among all species expressing COX.  
Furthermore, it has been shown that deletion of the last 13 amino acids leads to the 
progression of encepholpathy (Hanna et al. 1998).  Attempts at trying to express this 
mutation in yeast were not successful, which suggested that this mutation was deleterious 
(Bratton et al. 2003).  Using a slightly different approach, a mutation which deletes the 
entire helix 7 from SIII was constructed and expressed in R. sphaeroides.  It was 
hypothesized that this helix was responsible for maintaining the proper three dimensional 
structure of SIII through interhelical H-bonds.  Visual inspection of helix 7 shows that 
four of the helices pack around this helix, and as a whole these helices make up the five 
helical bundle that is separated from the other two helices by a V-shaped cleft (Svensson-
Ek et al. 2002). 
 Three preparations of G239Stop were grown and analyzed for SIII content.  In all 
three preparations there was a large decrease in the amount of SIII present, a shift in 
optical absorbance, and decreased electron transfer activity.  The amount of SIII present 
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ranged from 13-25%; however, in each preparation there were lower molecular weight 
peptides (approximately 6 kD) detected by the polyclonal site-directed antibodies to SIII.  
Polyclonal antibodies directed towards amino acids 64-77 and 225-238 reacted with full 
length helix 7 deleted SIII and lower molecular weight peptides, while the polyclonal 
antibody directed towards amino acids 110-123 only reacted with the full length helix 7 
deleted SIII.  MALDI-TOF mass spectrometry determined the mass of these low 
molecular weight peptides.  It was assumed that SIII was being inserted into the bacterial 
inner membrane and then degraded, probably as a result of misfolding (Bratton et al, 
2003).   
 A protease inhibitor cocktail was included, during the purification process, in the 
second preparation, to determine if the proteolysis was occurring during purification of 
the enzyme.  This increased the SIII content slightly from 13% to 19%; however, this was 
not interpreted as being a significant increase.  The possibility of proteolysis occurring 
during the growth of the bacterium was also investigated.  It has been shown that protein 
degradation is highly active during late stationary phase of cell growth (Bratton et al. 
2003).  Therefore, it was decided to stop the growth of the bacteria at mid-log phase 
(OD660=0.75) to minimize protein degradation.  This resulted in an approximate 2-fold 
increase in SIII content compared to G239Stop1, as determined by immunoblot analysis.  
It was concluded that the degradation process was occurring during the growth of the 
cells and that it was due to helix 7 deleted SIII being structural unstable.  Proteolytic 
degradation has been shown to take place with proteins that are misfolded (Gottesman 
and Maurizi 1992), and the bacterial protein degradation mechanism, in E. coli, has been 
shown to remove such proteins (Makrides 1996).  While the precise mechanism could not 
 216
be ascertained in this work, there are two possibilities.  The first is that the removal of 
helix 7 resulted in an unfavorable C-terminus.  It has been shown that nonpolar amino 
acids are destabilizing when placed at the 5 C-terminal amino acid residue positions, and 
that charged and polar residues are stabilizing (Parsell et al. 1990).  This is not a likely 
scenario since it was shown that one of the smaller peptides contained the new C-
terminus, generated by the helix deletion.  The second possibility, which has been shown 
to occur in both prokaryotes and eukaryotes, is that some proteins have protease 
recognition sites (Gottesman and Maurizi 1992).  These sites are unexposed in the native 
conformation of the protein; however, if the protein becomes misfolded the sites can 
become exposed and are then recognized by the protease.  This seems like a reasonable 
explanation based on the fact that helix 7 deleted SIII appears to be inserted into the 
membrane and then degraded, since the proteolytic fragments remain bound after two 
rounds of purification.        
 The detergent solubilzed electron transfer activity of wild-type, I/IIBD oxidase, 
and G239Stop1-3 were measured in an oxygen electrode.  The electron transfer activity of 
G239Stop1 was inhibited by 79%, G239Stop2 was inhibited by 83%, and G239Stop3 was 
inhibited by 66%.  While it was expected that there would be some change in electron 
transfer activity, the level of inhibition was not expected.  Based on the immunoblot data 
and electron transfer activity data there is not a correlation between SIII content and 
activity.  However, there is a rough correlation between the shift in α-peak absorbance 
and electron transfer activity, such that as the blue shift in the α-peak increases the 
electron transfer activity of the enzyme decreases.  In the first part of the discussion 
(Specific Aim I) it was shown that I/IIGD oxidase displayed a 4 nm shift in the α-peak, 
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which resulted in nearly 80% inhibition, compared to wt.  It was also shown that there 
was a large fraction of SI that was exhaustively digested way during limited proteolysis 
(about 70%).  Therefore, the source of inactivation was determined to be a result of 
turnover induced inactivation occurring in the bacterial membrane, which resulted in the 
loss of CuB.  It was concluded that the isolated I/IIGD oxidase contained a mixed 
population of active and inactive enzyme, which is consistent with what was found in the 
P. denitrificans enzyme (Haltia et al. 1989).  The immunoblot result showed that the SIII 
content varied between 13-26% in the G239Stop mutants, which means that 74-87% of 
the enzyme is in the form of I/II oxidase.  Therefore, there was a possibility that the 
electron transfer activity was that of I/II oxidase.  As a means to determine whether the 
observed activity of the G239Stop mutants was that of I/II oxidase, pH dependency 
experiments were performed. 
 The pH dependence of wt COX has been shown to have a pKa value of about 9.0 
(Gilderson et al. 2003).  In the absence of SIII, I/IIBD, this pKa value shifts to a more 
acidic value of about 7.4 (Gilderson et al. 2003).  If the observed electron transfer 
activities, for G239Stop1-3, are similar to that of I/II oxidase, then the pKa value should 
be the same as I/II oxidase.  If the population of enzyme, which contains the helix 7 
deletion, is contributing to the observed electron transfer activity, then it should have a 
pKa value different than the pKa value of I/II oxidase.  Alternatively, there is the 
possibility that G239Stop mutant enzyme is significantly inhibited and does not 
contribute to the observed electron transfer activity, which would result in a pKa value 
similar to I/II oxidase.  When wt and I/IIBD were assayed at different pH values between 
pH 7 and 10, pKa values similar to what has been reported in the literature were found for 
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wt and I/IIBD (Gilderson et al, 2003).  All three preparations of G239Stop also had pKa 
values equal to that of I/II oxidase.  This means that the measured activity of the 
G239Stop is actually the activity of the population of I/II oxidase present in each of the 
preparations.  However, it was not possible to determine if the inhibition of electron 
transfer activity was a result of turnover induced inactivated I/II oxidase or inactive 
G239Stop enzyme.  Regardless of which species of enzyme is inhibiting the electron 
transfer activity, it is clear that there is an inactive population of enzyme present in each 
of the G239Stop preparations.  Using the limited proteolysis method developed in 
Specific Aim I, it was possible to estimate the amount of enzyme that has an active 
conformation and the amount of enzyme that has an inactive conformation.  Once it was 
determined how much active enzyme was present it would then be possible to determine 
what effect the mutation had on the activity of the enzyme.   
The structure of the active site has already been discussed.  In all three 
preparations of G239Stop, there is blue shift in the reduced α-peak of heme aa3.  There is 
also a rough correlation between the amount of inhibition and the amount of blue shift, 
such that as the amount of blue shift increases the electron transfer activity decreases.  
Therefore, it can be assumed that there are structural changes in the active site which may 
account for the changes in activity.  It has been shown previously that turnover induced 
inactivation leads to the loss of CuB from the active site (Bratton et al 1999).  It has also 
been shown in the literature that removal of SIII has little or no affect on the aborption 
maximum of the reduced α-peak (Prochaska and Reynolds 1986; Gregory and Ferguson-
Miller 1988), with the exception of the study by Haltia et al. (1989).  While it has not 
been demonstrated in the literature that the turnover induced inactivation leads to a blue 
 219
shift in the reduced α-peak, the mutant lacking CuB (∆COX11) has a characteristic 
reduced α-peak absorption maximum of 602 nm (Bratton et al 2000).  A logical extension 
of this finding is that the shift in absorbance is a result of an inactive population of 
enzyme being present in each of the preparations of enzyme.  It was shown previously 
that SI is digested at a faster rate in the absence of SIII, and that after undergoing 
turnover induced inactivation the enzyme becomes highly susceptible to proteolysis.  
Therefore, if there is a population of enzyme that is inactive, in the G239Stop 
preparations, limited proteolysis with α-chymotrypsin should result with SI of the active 
portion being digested to SI’ and SI’’, while SI in the inactive portion should be 
exhaustively digested away.   
This was tested using wt, I/IIBD, I/IIGD, and G239Stop1-3, at fixed time point of 2 
hours.  After two hours wt, I/IIBD underwent limited proteolysis which resulted in the 
formation of SI’ and SI’’, and the sum of the intensities from SI’ and SI’’ was equal to 
the intensity of undigested SI.  I/IIGD also formed SI’ and SI’’, but total intensity of the 
two bands was only 60% of the original, which meant that 40% of SI was exhaustively 
digested away, and was presumably inactive.  If 40% of the enzyme was inactive then the 
theoretical electron transfer rate would be approximately 372 s-1 (Based on 40% of the 
Vmax measured for I/IIBD), which is not significantly different from the observed value of 
322 s-1.  A significant portion of SI was also digested away in G239Stop1 and G239Stop2, 
25% and 40%, respectively.  In other words, either 75% of the enzyme in G239Stop1 or 
60% of the enzyme in G239Stop2 is in an active conformation.  An extension of the 
analysis applied above would suggest that the theoretical electron transfer rates of these 
enzymes should be 699 s-1 and 559 s-1 (75% and 60% of the Vmax measured for I/IIBD, 
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respectively).  In contrast, only 10% G239Stop3 of SI was undetectable, which means that 
90% of this enzyme is presumably in an active conformation and should have a 
theoretical electron transfer rate of 838 s-1.  The observed rates of electron transfer for 
G239Stop1, G239Stop2, and G239Stop3 were 301, 236, and 469 s-1, respectively, and 
differ from the theoretical rates of electron transfer by 57%, 58%, and 44%, respectively 
(Table XIV).   Therefore, a fraction of the inhibition detected in the G239Stop mutants is 
a result of inactivated I/II oxidase (25% for G239Stop1, 40% for G239Stop2, and 10% for 
G239Stop3) as was seen in I/IIGD ; however, a larger fraction of the inhibition is due to the 
presence of either helix 7 deleted SIII or the proteolytic fragments (57% for G239Stop1, 
57% for G239Stop2, and 44% for G239Stop3).   
An explanation for there being more turnover induced inactivated enzyme present 
in the G239Stop1 and G239Stop2 preparations is that these were grown to higher optical 
densities than G239Stop3, and probably underwent more inactivation while embedded in 
the bacterial membrane.  However, it was shown above that a larger fraction of the 
inhibition is due to the presence of helix 7 deleted SIII, or the proteolytic fragments 
associated with SI and SII.  The reason this fraction of enzyme was not exhaustively 
digested by α-chymotrypsin is because it is not inactivated by turnover, but rather 
inhibited by the presence of helix 7 deleted SIII or the proteolytic fragments.  Since 
G239Stop3 exhibited the smallest shift in α-peak absorbance, had the highest electron 
transfer activity, and was most resistant to proteolysis this mutant enzyme was 
reconstituted in phospholipid vesicles and assayed for activity. 
 The effects of the G239Stop3 mutation on electron transfer of COX in liposomes 
was examined by two distinct methods; first assayed as initial rates in the presence and  
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Table XIV 
Observed and Theoretical Electron Transfer Activities of G239Stop Mutants  
Compared to I/II Oxidase 
 
Enzyme Obs. TN a % Inhibited b Theo. TN
 
c 
Theo. 
% Inhibit d 
% Active 
Enzyme e 
% Difference 
Between Theo. 
and Obs. TN f 
I/IIBD 931  0 931 0 100 NA 
I/IIGD 322  65 372 60 40 13 
G239St1 301  67 699 25 75 57 
G239St2 236  75 559 40 60 58 
G239St3 469  50 838 10 90 44 
 
a Observed turnover numbers were measured in an oxygen electrode under the conditions 
described in Material and Methods and Table XII. 
b Percent inhibition refers to the decrease in maximum turnover number compared to 
I/IIBD. 
c Theoretical turnover number is calculated by multiplying the observed turnover number 
by the percent active enzyme, as determined by limited proteolysis and density 
measurements 
d Theoretical percent inhibited is the percentage of theoretical turnover number compared 
to I/IIBD. 
e Active enzyme was determined by limited proteolysis and density measurements 
f This number represents the percent difference between the theoretical and observed 
turnover numbers for each enzyme. 
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absence of ionophores and second, during the kinetics of inactivation at pH 7.4.  The 
initial controlled rate in the absence of ionophores and in the presence of a membrane 
potential and proton gradient was inhibited by 50% and 88% in I/II and G239Stop3 when 
compared to wt.  This inhibition is similar to what has been reported with zinc in wild-
type enzyme and is the result of the proton exit channel being blocked (Mills et al. 2002; 
Mills et al. 2003). However, the strong inhibition of electron transfer rate displayed by 
G239Stop3 indicates that this enzyme is much more sensitive to the membrane potential 
and proton gradient than I/II oxidase.  This is another piece of evidence in favor of 
G239Stop inhibiting the electron transfer activity of COX, and indicates that the observed 
electron transfer activity is not simply that of I/II oxidase.  The addition of Val stimulated 
the electron transfer rates of wt and I/II by about 2 fold, but only stimulated the electron 
transfer rate of G239Stop3 by 20%.  This is due to the inhibitory effect imposed by the 
blockage of the proton exit or proton uptake channel, which is similar to what was seen 
with E90A, H212A, and H212F in Specific Aim II.  The uncoupled electron transfer 
activity of reconstituted G239Stop3 was inhibited by about 64% compared to uncoupled 
wt and I/II oxidase.  Under each condition, the electron transfer rate of G239Stop3 was 
severely inhibited, a result that supports the previous suggestion that either the full length 
helix 7 deleted SIII or the proteolytic fragments are causing an inhibitory effect on 
electron transfer activity.  Furthermore, G239Stop3 undergoes turnover induced 
inactivation at the same rate as I/II oxidase; however, since the initial Vmax is inhibited in 
the G239Stop3 the inactivation process being measured is likely that of I/II oxidase.  
Additonally, the proton pumping of the G239Stop3 was comparable to that of I/II  
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oxidase, which was also expected since it has been established that the activity of 
G239Stop3 is the activity of I/II oxidase present in the preparation.   
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V.  CONCLUSIONS 
 
 Previously it had been shown that proton uptake, proton pumping, and sustained 
electron transfer activities are all affected by SIII removal.  The energy minimization 
calculations suggested that there are significant changes in the structure if the D-channel 
in the absence of SIII, which would support the functional data.  However, limited 
proteolysis experiments failed to confirm that prediction.  In contrast, upon catalytic 
inactivation and subsequent proteolytic digestion large scale conformational changes 
were found in the inactivated I/II oxidase.  A proposed mechanism for this inactivation 
requires that SI undergo significant conformational changes, which lead the release of 
CuB.  Once CuB has dissociated from the active SI, SI is highly susceptible to proteolysis 
and becomes exhaustively digested.  This is a significant finding and provides a structural 
model for turnover induced inactivation.  It was then necessary to address the structural 
factors involved SIII stabilization.     
 Site-directed mutagenesis was performed towards the goal of disrupting 
conserved interhelical H-bonds within SIII.  Glu90 appears to be indispensable in COX 
SIII structure and COX function, which is consistent with the functional work performed 
with DCCD labeled bovin heart COX.  In the absence of Glu90 SIII fails to insert 
properly into the lipid bilayer and appears to be targeted for degradation.  Tyr246 could 
be excluded as a potential H-bond partner of Glu90 based on functional data.  His212, on 
the other hand, appears to be the H-bond partner of Glu90.  The functional effects of 
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His212 mutation on the function of the enzyme are not apparent until after reconstitution 
into a phospholipid vesicle.  The observed inhibition of electron transfer, in E90A, 
H212A, H212F, and I/II oxidase, in the absence of the membrane potential and in the 
presence of the proton gradient suggests that the inhibition is due to the proton exit 
channel or proton uptake channel changing conformation upon membrane potential 
dissipation.  This change in conformation prohibits protons from either being taken up 
into the enzyme or pumped out of the enzyme.  Furthermore, SIII may act to 
downregulate electron transfer activity and proton pumping when conditions are not 
favorable.  It is hypothesized that the interaction between Glu90 and His212 stabilzes SIII 
during catalytic turnover.  Since this interaction occurs across the V-shaped cleft in SIII it 
may function to hold this cleft in a proper orientation.  Alternatively, since this 
interaction is an H-bond, it is possible that pH could modulate the structure of SIII 
through this interaction, such that as proton concentration increases the interaction may 
form or become disrupted.  As a result SIII would change conformation, which is then 
translated to SI which would then regulate electron transfer activity.  Specific Aim II was 
designed to investigate specific highly conserved H-bonds in SIII of COX.  As an 
extension of this investigation the removal of an entire helix was performed.  Helix 7 of 
SIII is highly conserved and various mutations and truncations have been reported, which 
lead to a variety of mitochondrial disorders. 
 Specific Aim III investigated the role of helix 7 in the structure and function of 
COX.  Upon removal of the helix, SIII fails to insert properly into the lipid bilayer and is 
degraded.  This degradation process occurs during the growth of the bacteria and can be 
limited by growing the bacteria to a lower optical density.  As a result of the degradation 
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process at least three populations of enzyme were present in the G239Stop enzyme: I/II 
oxidase, I/II oxidase plus helix 7 deleted SIII, and I/II oxidase plus retained proteolytic 
fragments of SIII.  Furthermore, all three preparations of enzyme exhibit a shift in optical 
absorbance.  The electron transfer activity of this mutant is severely inhibited and it was 
determined that a small fraction of the inhibition was due to inactivated I/II oxidase 
present in the preparations; however, a larger portion of the inhibition was attributed to 
the helix 7 deleted SIII or the proteolytic fragments.  
 Taken together the data demonstrates the importance of SIII in COX structure and 
function.  SIII is required for maintaining the proper conformation of the D-channel, so 
that protons can be efficiently taken up into the enzyme and pumped out of the enzyme. 
Furthermore, it is possible to "inactivate" by disrupting an interhelical H-bond.  The 
Glu90-His212 stabilizes SIII, and in the absence of this interaction there are severe 
functional consequences.  Finally, helix 7 is also extremely important in the structure of 
SIII.  In the absence of this helix SIII fails to assemble properly and is rapidly degraded.  
This not only emphasizes that SIII must be present, but also demonstrates that there are 
specific interactions within SIII that must form.  In the absence of these specific 
interactions there are severe structural consequences in SIII, that are translated to SI, 
which lead to a functional impaired enzyme complex.    
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Appendix B 
Table of Mutagenic Primers Used to in the Site-Directed Mutagenesis of SIII. 
The nucleotides colored blue represent the codons that were mutated, using the 
 QuikChange kit, from Stratagene. 
 
 
5’ Forward Primer 3’ SIII Mutant 
5’ Reverse Primer 3’ 
 
E90A Mutant was made at the University of Mississippi, in the laboratory
of Dr. Jon Hosler. 
 
CCACGGCTTCGCCGTCATCGTGG H212A 
CCACGATGACGGCGAAGCCGTGG 
 
GATTCCACGGCTTCTTCGTCATCGTGGG H212F 
CCACGATGACGAAGAAGCCGTGGAATCC 
 
GCGGCGATCTGGTTCTGGCACTTCGTC Y246F 
GACGAAGTGCCAGAACCAGATCGCCGC 
 
GGTGCATGAGAACAATATCCGCGACGTGGCCTG R161I 
CAGGCCACGTCGCGGATATTGTTCTCATGCACC 
 
CTGCCGCTCATCAACGTGCTGATCCTGCTCTG T138V 
CAGAGCAGGATCAGCACGTTGATGAGCGGCAG 
 
CCCCGAGAAGCATGTCTAATTCGAGGCGGCGATCTG G239Stop 
CAGATCGCCGCCTCGAATTAGACATGCTTCTCGGGG 
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Appendix C 
 
Figure 1.  Plasmids pMB301 and pMB307 were digested with restriction enzymes and 
run on a 1.0% TAE agarose gel (BioRad).  Digestion of pMB301 with EcoRI results in 
linearization of the plasmid, which has a size of 4.3 kb.  The SIII gene in pMB301 is 
flanked by two SmaI cut sites, and digestion with SmaI results in DNA fragments that are 
3.4 kb and 0.9 kb.  The gene for SIII is found in the 0.9 kb fragment, which is denoted by 
the asterisk.  
 
 
 
Lane 1: 500 bp ruler, Lane 2: pMB301 EcoRI, Lane 3: pMB301 SmaI, Lane 6: pMB307 
SmaI, Lane 7: pMB307 EcoRI/HindIII, Lane 8: 1 kb ruler.   
 
 
 
 
 
 
 
 
 
 
 
 
 
*
 230
 
 
 
 
 
 
 
Appendix C 
 
Figure 2.  Once it was verified that the correct plasmids were purified, both pMB301 and 
pMB307 were digested with SmaI and run out on a 1% TAE agarose gel.  The gels were 
then placed on a ultraviolet light box and the 7.9 kb band corresponding the linearized 
pMB307 and the 0.9 kb band corresponding to the SIII gene, from pMB301, were 
excised and gel purified.  These DNA fragments would then be used in the ligation 
reaction, which yields a new plasmid containing genes for SI (his-tagged), SII, and  
mutant SIII along with the cox10 and cox11 accessory genes.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lane 2: 1 kb ruler, Lane 3: pMB307 (1 µL), Lane 4: pMB307(3 µL),  
Lane 5: pMB301 (1 µL), Lane 6: pMB301 (3 µL), Lane 7:  500 bp ruler 
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Appendix C 
 
Figure 3.  Using the New England Biolabs Quick Ligation Kit the 0.9 kb SIII gene is 
then ligated into the 7.9 pMB307 plasmid.  This is done overnight at 14°C.  The ligation 
reaction is then transformed into XL10-Gold Ultracompetent cell, purchased from 
Stratagene. Colonies are then screened for insertion and proper orientation using 
restriction digests. 
If the 0.9 kb insert is ligated into the vector in the correct orientation then the linear 
plasmid should have a size of 8.8 kb.  Digestion with EcoRI/HindIII will result in DNA 
fragments with sizes of 6.2 and 2.6 kb.  Digestion with SmaI will result in DNA 
fragments with sizes 7.9 and 0.9 kb.  Digestion with XhoI will result in DNA fragments 
with sizes 6.2 and 2.6 kb.  If the insert is inserted into the vector in the wrong orientation 
then digestion with XhoI will result in DNA fragments with sizes of 5.7 and 3.1 kb. 
 
 
 
 
Lane 2: 500 bp ruler, Lane 3 EcoRI, Lane 4: EcoRI/HindIII, Lane 5: XhoI, Lane 6: SmaI, 
Lane 7: 1kb ruler. 
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Appendix C 
 
Figure 4.  The 8.8 kb pMB307 plasmid containing the mutant SIII gene is digested with 
EcoRI and HindIII, resulting in bands that are 6.2 and 2.6 kb.  The 6.2 kb band is then gel 
purified.  The 10.5 kb pRK415-1 is linearized with EcoRI and HindIII and also gel 
purified.  Using the New England Biolabs Quick Ligation Kit the 6.2 kb band containing 
SI, II, and III is then ligated into the 10.5 pRK415-1 plasmid.  This is done overnight at 
14°C.  The ligation reaction is then transformed into JM109 cells, purchased from 
Stratagene.   
 
 
 
 
Lane 1:  1 kb ruler, Lane 2: pRK415-1, Lanes 3-5: 6.2 kb EcoRI/HindIII fragment from 
ligation of pMB307+SIII gene, Lanes 6-8:  λDNA digested with HindIII 
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Appendix C 
 
Figure 5.  The ligation reaction is then transformed into JM109 cells, purchased from 
Stratagene.  Colonies are then screened for insertion using restriction digests.  Plasmids 
that contain the insert should have DNA fragment sizes of 10.5 and 6.2 kb when digested 
with the restriction enzymes EcoRI and HindIII.                  
 
 
 
 
 
Lanes 2, 3, 5, and 9:  EcoRI/HindIII of clone that has insert, Lanes 1, 4, 6-8, 10 and 11: 
EcoRI/HindIII of clone with no insert, Lane 12: 1kb ruler.   
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Rhodobacter --MAHAKN-----HDYHILPPSIWPFMASVGAFVMLNGAVLWMHGS--------GPWMGL 45
Paracoccus --MAHVKN-----HDYQILPPSIWPFFGAIGAFVMLTGAVAWMKGITFFGLPVEGPWMFL 53
Jannaschia --MAHAKR-----HDYHILPPSIWPLIAAAGAFAMLFGGVNWMHAG--------TPWLFL 45
Silicibacter --MAHAKN-----HDFHILPPSIWPLLSSLGAFVMLFGAVLWMHDY--------TAWLFW 45
Rhodopseudomonas MATAHVKH-----HDYHLVDPSPWPFVGSVSAFVMALGAVSWMHHMYQG-----APIVFG 50
Cheetah               --MTHQT------HAYHMVNPSPWPLTGALSALLMTSGLAMWFHYN--------STLLLT 44
Seal                  --MTHQT------HAYHMVNPSPWPLTGALSALLMTSGLIMWFHFN--------SMYLLM 44
Sheep                 --MTHQT------HAYHMVNPSPWPLTGALSALLMTSGLIMWFHFN--------STALLT 44
Gazelle               --MTHQT------HAYHMVNPSPWPLTGALSALLMTSGLIMWFHFN--------STTLLM 44
Bovine                --MTHQT------HAYHMVNPSPWPLTGALSALLMTSGLTMWFHFN--------SMTLLM 44
Lemur                 --MTHQT------HAYHMVNPSPWPLTGALSALLMTSGLAMWFHFN--------SSMLLS 44
Human                 --MTHQS------HAYHMVKPSPWPLTGALSALLMTSGLAMWFHFH--------SMTLLM 44
Mouse                 --MTHQT------HAYHMVNPSPWPLTGAFSALLLTSGLVMWFHYN--------SITLLT 44
Aardvark              --MTHQT------HAYHMVNPSPWPLTGALSALLLTSGLIMWFHFN--------SSTLLT 44
Opposum --MTHQT------HAYHMVNPSPWPLTGALSALLLTSGLIMWFHYN--------SSTLMF 44
Paddlefish            --MAHQA------HAYHMVDPSPWPLTGAVAALLMTSGLAVWFHFN--------STVLMT 44
Silver                --MAHQA------HAYHMVDPSPWPLTGATAALLLTSGLAVWFHYH--------STVLML 44
Hawk-Eagle            --MAHQA------HSYHMVDPSPWPIFGAAAALLTTSGLIMWFHYN--------SSQLLS 44
Yeast                 --MTHLERSRHQQHPFHMVMPSPSPIVVSFALLSLALSTALTMHGYIG------NMNMVY 52
:*        * :::: **  *:  : . :    .    ::             :  
Rhodobacter IGLVVVLYTMFGWWSDVVTESL-EGDHTPVVRLGLRWGFILFIMSEVIFFSAWFWSFFKH 104
Paracoccus IGLVGVLYVMFGWWADVVNEGE-TGEHTPVVRIGLQYGFILFIMSEVMFFVAWFWAFIKN 112
Jannaschia AGFAAVLYVMYAWWADVVAESG-EGDHTPVVRIGLRYGFIMFIMSEVMFFVAWFWAFFKH 104
Silicibacter AGLVAVLYSAFCWWSETIAENK-AGDHTPVVLIGLRYGFILFVMSEVMFFFAWFWSFFKH 104
Rhodopseudomonas VGVIGVLYTMASWWSDVIREAQYQHDHTRVVQLSHRYGMILFIASEVMFFVAWFWAYFNA 110
Cheetah               LGMTTNLLTMYQWWRDIVRESTFQGHHTPIVQKGLRYGMILFIVSEVFFFAGFFWAFYHS 104
Seal                  LGLTTNTLTMYQWWRDIVRESTFQGHHTPIVQKGLRYGMILFIVSEVFFFAGFFWAFYHS 104
Sheep                 LGLTTNMLTMYQWWRDVIRESTFQGHHTPAVQKGLRYGMILFIISEVLFFTGFFWAFYHS 104
Gazelle               LGLTTNMLTMYQWWRDVIRESTFQGHHTPNVQKGLRYGMILFIISEVLFFTGFFWAFYHS 104
Bovine                IGLTTNMLTMYQWWRDVIRESTFQGHHTPAVQKGLRYGMILFIISEVLFFTGFFWAFYHS 104
Lemur                 LGMLTNLLTMYQWWRDIVREGTFQGHHTSIVQKGLRYGMVLFIISEIFFFAGFFWAFYHS 104
Human                 LGLLTNTLTMYQWWRDVTRESTYQGHHTPPVQKGLRYGMILFITSEVFFFAGFFWAFYHS 104
Mouse                 LGLLTNILTMYQWWRDVIREGTYQGHHTPIVQKGLRYGMILFIVSEVFFFAGFFWAFYHS 104
Aardvark              LGLLTNILTMYQWWRDIIRESTYQGHHTPVVQKGLRYGMILFIISEVFFFAGFFWAFYHS 104
Opposum MGLTTMLLTMYQWWRDIIREGTFQGHHTPVVQKGLRYGMILFILSEVFFFIGFFWAFYHS 104
Paddlefish            MGLILLLLTMYQWWRDIIREGTFQGHHTPPVQKGLRYGMILFITSEVFFFLGFFWAFYHS 104
Silver                LGLTLMLLTMYQWWRDVIRESTYMGHHTPPVQKGLRYGMILFITSEVFFFLGFFWAFFHS 104
Hawk-Eagle            MGILSMLLVMLQWWRDIVRESTFQGHHTPTVQKGLRYGMILFITSEAFFFLGFFWAFFHS 104
Yeast                 LALFVLLTSSILWFRDIVAEATYLGDHTMAVRKGINLGFLMFVLSEVLIFAGLFWAYFHS 112
..         *: :   *     .**  *  . . *:::*: ** ::* . **:: : 
Appendix D 
 
Shown is a multiple sequence alignment of 19 organisms that express COX 
SIII.  In red, are the amino acids that were mutated in the investigation of 
interhelical H-bonds.  Gly239 is colored in blue, and is the amino acid mutated 
to a stop codon.  As a result of the premature stop codon the last 27 amino 
acids were deleted.  
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Rhodobacter ALYPMGPE----SPIIDGIFPPEGIITFDPWHLPLINTLILLCSGCAATWAHHALVHENN 160
Paracoccus ALYPMGPD----SPIKDGVWPPEGIVTFDPWHLPLINTLILLLSGVAVTWAHHAFVLEGD 168
Jannaschia TLFPMN-------TFEASTYIPPEIYQVDPFHLPLINTLVLLLSGCLVTWAHHALVHGGS 157
Silicibacter AMYPME-------EYVGTEYVAPDIYPVDAFHLPLINTLVLLLSGCAVTWAHHALVHDND 157
Rhodopseudomonas ALFPADPVHATREALFGGVWPPKGIETFDPWHLPLLNTLILLTSGTTVTWAHHALLQ-ND 169
Cheetah               SLAPTP--------ELGGCWPPTGIIPLNPLEVPLLNTSVLLASGVSITWAHHSLME-GN 155
Seal                  SLAPTP--------ELGGCWPPTGITPLNPMEVPLLNTSVLLASGVSITWAHHSLME-GN 155
Sheep                 SLAPTP--------ELGGCWPPTGIHPLNPLEVPLLNTSVLLASGVSITWAHHSLME-GN 155
Gazelle               SLAPTP--------ELGGCWPPTGIHPLNPLEVPLLNTSVLLASGVSITWAHHSLME-GN 155
Bovine                SLAPTP--------ELGGCWPPTGIHPLNPLEVPLLNTSVLLASGVSITWAHHSLME-GD 155
Lemur                 SLAPTP--------ELGGCWPPTGIHPLNPLEVPLLNTAVLLASGVSITWAHHSLME-GN 155
Human                 SLAPTP--------QLGGHWPPTGITPLNPLEVPLLNTSVLLASGVSITWAHHSLME-NN 155
Mouse                 SLVPTH--------DLGGCWPPTGISPLNPLEVPLLNTSVLLASGVSITWAHHSLME-GK 155
Aardvark              SLAPTP--------ELGGCWPPTGIFPLNPMEVPLLNTAILLASGVTITWAHHSLME-GN 155
Opposum SLAPTP--------ELGGCWPPTGIHPLNPLEVPLLNTSILLASGVSITWAHHSLME-GN 155
Paddlefish            SLAPTP--------ELGGCWPPTGIIPLDPFEVPLLNTAVLLASGVTVTWAHHSIME-RE 155
Silver                SLAPVP--------ELGGCWPPTGITPLDPFEVPLLNTAVLLASGVTVTWAHHSLME-GQ 155
Hawk-Eagle            SLAPTP--------ELGGQWPPAGINPLNPLEVPLLNTAILLASGVTVTWTHHSIME-GN 155
Yeast                 AMSPDV--------TLGACWPPVGIEAVQPTELPLLNTIILLSSGATVTYSHHALIA-GN 163
:: *               : .  *  .:. .:**:** :** **   *::**:::   .
Rhodobacter RRDVAWGLALAIALGALFTVFQAYEY----SHAAFGFAG---NIYGANFFMATGFHGFHV 213
Paracoccus RKTTINGLIVAVILGVCFTGLQAYEY----SHAAFGLAD---TVYAGAFYMATGFHGAHV 221
Jannaschia RKDVETGLLGAVVLGVAFTGLQAYEYYELIAHHHWQFGGPDGDKFYSTFFMATGFHGFHV 217
Silicibacter RKGLVNGLAIGIALGIFFTALQAYEYVHLL-HEGWEFGG---DEFYSNFFMATGFHGFHV 213
Rhodopseudomonas RKGLKQGLICTVLLGATFSCVQVYEY----SHATFSFAG---NIYGATFFMATGFHGFHV 222
Cheetah               RKHMLQALLITISLGVYFTLLQASEY----YETPFTISD---GIYGSTFFMATGFHGLHV 208
Seal                  RKHMLQALFITISLGVYFTLLQASEY----YETPFTISD---GIYGSTFFMATGFHGLHV 208
Sheep                 RYHMLQALFITIALGVYFTLLQASEY----YEAPFTISD---GVYGSTFFVATGFHGLHV 208
Gazelle               RNHMLQALFITITLGVYFTLLQASEY----YEAPFTISD---GIYGSTFFVATGFHGLHV 208
Bovine                RKHMLQALFITITLGVYFTLLQASEY----YEAPFTISD---GVYGSTFFVATGFHGLHV 208
Lemur                 RVQMLQALLITITLGLYFTLLQASEY----FETSFTISD---GVYGSTFFMATGFHGLHV 208
Human                 RNQMIQALLITILLGLYFTLLQASEY----FESPFTISD---GIYGSTFFVATGFHGLHV 208
Mouse                 RNHMNQALLITIMLGLYFTILQASEY----FETSFSISD---GIYGSTFFMATGFHGLHV 208
Aardvark              RTQMIQALFITISLGVYFTLLQASEY----YEAPFTIAD---GIYGSTFFVATGFHGLHV 208
Opposum RKQMIQALLITISLGLYFTILQAMEY----YEASFTISD---GVYGSTFFVATGFHGLHV 208
Paddlefish            RKQTIQALTLTILLGFYFTALQAMEY----YEAPFTIAD---GVYGSTFFVATGFHGLHV 208
Silver                RKEAIQSLFLTILLGCYFTMLQAMEY----YEAPFTIAD---GVYGSTFFVATGFHGLHV 208
Hawk-Eagle            RKQAIHALTLTILLGFYFTALQAMEY----YDAPFSIAD---SVYGSTFFVATGFHGLHV 208
Yeast                 RNKALSGLLITFWLIVIFVTCQYIEY----TNAAFTISD---GVYGSVFYAGTGLHFLHM 216
*     .*   . *   *   *  **     .  : :..   : . *: .**:*  *:
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Rhodobacter IVGTIFLLVCLIRVQRGHFTPEKHVGFEAAIWYWHFVDVVWLFLFASIYIWGQ------- 266
Paracoccus IIGTIFLFVCLIRLLKGQMTQKQHVGFEAAAWYWHFVDVVWLFLFVVIYIWGR------- 274
Jannaschia VIGTIFLFICYLRVRKGHFTAEKHIGFEAAAWYWHFVDVVWLFLFVAVYIWGQ------- 270
Silicibacter ILGTIFLIVCLIRAMRGDFTPKSHAGFEMAAWYWHFVDVVWLFLFVAVYIWGTAGLAH-- 271
Rhodopseudomonas LVGTIFLLVCLIRAYAGHFTPKQHLGFEFAAWYWHFVDVVWLFLFVCIYVWGHGASTMAH 282
Cheetah               IIGSTFLIVCFLRQLKYHFTSNHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS------- 261
Seal                  IIGSTFLIVCFMRQLKFHFTSNHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS------- 261
Sheep                 IIGSTFLIVCFFRQLKFHFTSSHHFGFEAAAWYWHFVDVVWLFLYMSIYWWGS------- 261
Gazelle               IIGSTFLIVCFFRQLKFHFTSSHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS------- 261
Bovine                IIGSTFLIVCFFRQLKFHFTSNHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS------- 261
Lemur                 IIGSTFLTVCFFRQLSFHFTSNHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGSYSFSIDP 268
Human                 IIGSTFLTICFIRQLMFHFTSKHHFGFEAAAWYWHFVDVVWLFLYVSIYWWG-------- 260
Mouse                 IIGSTFLIVCLLRQLKFHFTSKHHFGFEAAAWYWHFVDVIWLFLYVSIYWWGS------- 261
Aardvark              IIGSTFLSVCFLRQLKFHFTSNHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS------- 261
Opposum IIGSTFLIVCLLRQLFYHFTSTHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGSYFSSMIS 268
Paddlefish            IIGSTFLAVCLLRQIQYHFTSEHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS------- 261
Silver                IIGTTFLAICLLRQIKYHFTSQHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS------- 261
Hawk-Eagle            IIGSSFLSVCLLRLINFHFTSNHHFGFEAAAWYWHFVDVIWLFLYMTIYWWGS------- 261
Yeast                 VMLAAMLGVNYWRMRNYHLTAGHHVGYETTIIYTHVLDVIWLFLYVTFYWWGV------- 269
:: : :* :   *    .:*   * *:* :  * *.:**:****:  .* **        
Rhodobacter -------------
Paracoccus -------------
Jannaschia -------------
Silicibacter -------------
Rhodopseudomonas GG----------- 284
Cheetah               -------------
Seal                  -------------
Sheep                 -------------
Gazelle               -------------
Bovine                -------------
Lemur                 MQLTSN------- 274
Human                 -------------
Mouse                 -------------
Aardvark              -------------
Opposum TTDFQSLSSGSNQ 281
Paddlefish            -------------
Silver                -------------
Hawk-Eagle            -------------
Yeast                 -------------
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LIST OF ABBREVIATIONS 
 
 
A280:   absorbance measured at 280 nm 
A420:   absorbance measured at 420 nm 
ATP:   adenosine 5’-triphosphate 
AcN:   acetonitrile 
bp:   basepair 
BSA:   bovine serum albumin 
CAPS:   N-cyclohexyl-3-aminopropanesulfonic acid 
CCCP:   carbonyl cyanide m-chlorophenylhydrazone 
CHCA:  α-cyano-4-hydroxysuccinnamic acid 
CHES:   N-cyclohexyl-2-aminoethanesulfonic acid 
COV:   phopholipid vesicles containing cytochrome c oxidase 
COX:   cytochrome c oxidase 
DCCD:  N, N’-dicyclohexylcarbodiimide 
DM:   dodecyl-β-D-maltoside 
DNA:   deoxyribonucleic acid 
DNase:  deoxyribonuclease 
EAM:   energy absorbing matrix 
EDTA:  ethlenediaminetetraacetic acid 
EM:   electron microscopy 
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FAD+:   flavin adenine dinucleotide 
FADH2:  reduced flavin adenine dinucleotide 
FPLC:   fast protein liquid chromatography 
G239Stop1:  helix 7 turncation grown similarly to wild-type 
G239Stop2:  helix 7 turncation grown similarly to wild-type and purified in the  
   presence of protease inhibitors 
 
G239Stop3:  helix 7 turncation grown to a lower optical density 
H+/e-:   ratio of protons translocated to electrons transferred 
H-bond:  hydrogen bond 
HEPES:  N-(2-hydroxyethyl) piperazine-N’-2-ethanesulfonic acid 
HRP:   horseradish peroxidase 
I/IIBD oxidase:             subunit III biochemically depleted cytochrome c oxidase 
I/IIGD oxidase:             subunit III genetically deleted cytochrome c oxidase 
kD:   kilodalton 
kb:   kilobase 
KLH:   Keyhole Limpet Hemocyanin 
LB:   Luria-Bertani 
mA:   milliamps 
MALDI-TOF:  matrix assisted laser desorption time of flight 
MWCO:  molecular weight cut off 
m/z:   mass to charge ratio 
NAD+:   nicotinamide adenine dinucleotide 
NADH:  reduced nicotinamide adenine dinucleotide 
OD660:   optical density measured at 660 nm 
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PDB:   protein databank 
pH:   -log [H+] 
PMSF:   phenylmethylsulfonylfluoride 
PVDF:   polyvinylidene difluoride 
PYE:                           Phytone yeast extract 
RCR:   respiratory control ratio 
RCRval :  respiratory control ratio determined in the presence of valinomycin 
SI:   subunit I 
SII:   subunit II 
SIII:   subunit III 
SIV:   subunit IV 
SDS:   sodium dodecyl sulfate 
SDS-PAGE:  sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SDS-Urea-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis with 
6M urea 
 
SPA: sinapinic acid 
SPDBV: Swiss protein databank viewer 
TBS-B: tris buffered saline containing 5% powdered milk 
TBST: tris buffered saline tween-20 
TFA: trifluoroacetic acid 
TMPD: N, N, N’, N’, -tetramethyl-p-phenylenediamine 
TN: turnover number (number of electrons transferred per second per 
mole of cytochrome c oxidase 
 
Tris: Tris (hydroxymethyl) aminoethane 
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TX-100: Triton X-100 
Val: valinomycin 
wt: wild-type Rhodobacter sphaeroides cytochrome c oxidase  
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